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Summary
Synthesis of polysaccharide intercellular adhesin (PIA), accumulation associated 
protein (Aap) and extracellular matrix binding protein (Embp) are major mechanisms 
used by Staphylococcus epidermidis to evade immunity through biofilm formation. 
These evasion strategies are particularly suited for colonisation of medical devices 
such as heart valves, joint prostheses and central venous catheters resulting in 
significant patient morbidity. Two biological activities of PIA, Aap and Embp 
contribute to their role as an evasion molecules. Firstly their ‘barrier’ function 
limiting penetration of immune cells and antibiotics. Secondly, their 
‘immunomodulatory’ properties which influence cytokine responses. At present 
little is known about these functional activities in physiological media and biological 
fluids.
This thesis uses a cell biology approach to study the environment necessary for PLA 
production. Specifically in vitro modelling of biofilm formation, PIA production and 
S. epidermidis leukocyte co-culture experiments have been used to assess conditions 
that are conducive for PIA production.
This thesis has identified that:
• Specific cell culture media cause unique profiles of biofilm accumulation 
with differential production of PIA, Aap and Embp.
• Fetal bovine serum and pooled human serum support S. epidermidis growth 
but differentially affect biofilm formation by PIA, Aap and Embp.
• Large scale production of PIA (~20mg) can be achieved by culturing in 
Iscove's Modified Dulbecco's Media which has allowed streamlining of 
current isolation procedures.
• PIA induction of cytokines, including IL-8 and TNF is dependent on being 
tethered to the bacterial membrane.
• Macrophages can penetrate into a S. epidermidis produced PIA ‘barrier’.
• Immunosuppression of whole blood with dexamethasone unmasks the 
pathogenic advantage of PIA in S. epidermidis expressing PIA compared to 
negative controls.
• Whole blood killing of S. epidermidis is dependent on CD1 lb/CD 18.
• PIA induces whole blood killing dysfunction which is likely related to C5a 
production.
• PIA can be produced in a whole blood environment.
• Inocula of -10  colony forming unit of S. epidermidis are required to form 
biofilms in whole blood.
This study suggests the importance of studying clinically important biofilm 
production mechanisms under conditions that closely resemble those in human 
disease.
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Chapter 1
Introduction
1.1 Infectious Diseases
1.1.1 Introduction
The World Health Organization (WHO) defines infectious diseases as the diseases 
caused by pathogenic microorganisms, such as bacteria, viruses, parasites or fungi. 
These diseases can be spread, directly or indirectly, from one person to another (WHO, 
2012). Infectious diseases are the leading causes of death in low income countries, and 
in 2011 infectious diseases killed 7.7 million people all over the world (WHO, 2011).
1.1.2 Healthcare associated infections (HAI)
HAI are defined as infections acquired in hospital or other healthcare facilities by a 
patient admitted for reasons other than that infection, and includes infections acquired in 
the hospital, but appearing after discharge and occupational infections among staff of 
health facilities (Benenson, 1995; Ducel G., 2002).
The term ' Healthcare associated infections ’ (HAI) describe infections related to medical 
care; and can be caused by a wide variety of bacteria, fungi and viruses. These infections 
can be very severe and sometime fatal (WHO, 2012). HAI play a great role in 
increasing the cost of the healthcare, through increasing the length of stay in the 
hospital and the use of antibiotics (Rosenthal VD, 2005; Higuera and Rangel-Frausto, 
2007; Rosenthal, 2008).
HAIs are a significant global problem as they continue to increase even in highly 
developed countries. For example the cost of HAIs in USA increased from $4.5 billion 
in 1992 (Scott, 1992) to $28.4-33.4 billion in 2007 (Rosenthal, 2008). There are over 1.4 
million people worldwide suffering from an HAI at any one time (Tikhomirov, 1987). 
The rates of HAIs in developing countries are 3 to 5 times higher than those reported 
globally (Rosenthal, 2008).
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1.1.2.1 Predisposing factors for healthcare associated infections
Many factors contribute to the increasing burden of HAIs across the world. A key factor 
is in the injudicious use of antimicrobial agents in hospitals, which has contributed to the 
emergence of multi-drug resistant (MDR) microorganisms. For example, 60-70% of 
Staphylococcus aureus strains isolated among inpatients in many countries are resistant 
to methicillin and often several other first-line antibiotics (Levy and Marshall, 2004; 
Aboelela, 2007). In addition the lack of compliance with hygiene guide lines by 
healthcare personnel, especially hand hygiene facilitates the transmission of pathogens 
to and between patients, thereby promoting spread of HAIs (Allegranzi and Pittet, 2009). 
Furthermore, patients in hospitals can be more vulnerable to infection because their 
immune systems are often in a weakened state either due to their illnesses or certain 
treatment regimens. Thus immuno-suppression in organ transplant patients and 
chemotherapy treatment for cancer patients, the elderly and newborn are all considered 
at risk because of reduced immune function (Abramczyk, Carvalho et al., 2003; Pittet, 
2008). Finally, the increased use of implanted medical devices and invasive medical 
procedures including attachment of urinary catheters, endotracheal intubation and 
ventilation of patients in the intensive care unit (ICU), intravascular catheter, prosthetic 
heart valve, surgical drains and tracheostomy, all bypass the body’s natural lines of 
defense against pathogens and provide an easy route for infection (Collignon, 1994; 
Richards, Edwards et al., 1999). Furthermore, the medical devices provide a surface for 
bacterial attachment, aggregation and secretion of extracellular matrix to form biofilm 
(Schierholz and Beuth, 2001). Recent studies show that at least half of all cases of HAIs 
are associated with medical devices (Guggenbichler, Assadian et al., 2011).
1.1.2.2 Pathogenesis of healthcare associated infections
The most common pathogens causing HAIs are methicillin sensitive and resistant 
Staphylococcus aureus (MSSA and MRSA), Escherichia coli,, Enterococci, 
Pseudomonads spp, and coagulase-negative Staphylococci such as S. epidermidis (Jarvis 
and Martone, 1992). Candida species account for (72.1%) of fungal nosocomial 
infection especially in immunocompromised patients who are at high risk for
3
candidemia (Jarvis, 1995). Also, Aspergillus jumigatus is a common nosocomial fungal 
infection in the immunocompromised especially in patients with leukaemia, undergoing 
bone marrow transplant, and organ transplant recipients on long term 
immunosuppressive therapy, where inhalation of fungal spores can lead to aspergillosis 
(French, 2005; Nicolle, Benet et al., 2011). The most common viral nosocomial 
infections are caused by Respiratory Syncytial Virus (especially in children), influenza 
and para influenza virus, and norovirus (Welliver and McLaughlin, 1984; Sukhrie, 
Teunis et al., 2012). Cryptosporidiosis, caused by the protozoa Cryptosporidium parvum 
is a gastrointestinal pathogen associated with nosocomial transmission and is responsible 
for multiple outbreaks in child care centers and amongst immunocompromised patients 
in the hospital environment (Navarrete, Stetler et al., 1991; Ravn, Lundgren et al., 1991; 
Tangermann, Gordon et al., 1991). Frequently encountered healthcare associated 
infections and their causative pathogens are summarized in Table 1.1.
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1.1.2.3 Mode of transmission of healthcare associated infections
There are five main routes of transmission of pathogenic microorganisms that cause 
HAIs:
1) Contact transmission is the most common method and can be direct and indirect. 
Direct-contact transmission happens when the infectious agent is transmitted from an 
infected or colonized person to a susceptible host. This can occur between medical staff 
and patients during patient care activities, or between two patients (Rosen, 1997). 
Indirect-contact transmission occurs by contact with contaminated objects such as 
instruments, needles, dressings or contaminated gloves (Zachary, Bayne et al., 2001; 
Siegel, Rhinehart et al., 2007).
2) Droplet transmission occurs when droplets carrying infectious agents are generated 
from infected individuals during coughing, sneezing, talking or when performing certain 
procedures such as bronchoscopy or endotracheal intubation and then travel to mucosal 
surfaces of the recipient (Papineni and Rosenthal, 1997; Fowler, Guest et al., 2004).
3) Airborne transmission of infectious microorganisms occurs with droplets or dust 
particles of less than 5pm, which are generated again by coughing, sneezing, talking or 
procedures such as bronchoscopy. Microorganisms transmitted this way can remain in 
the air for several hours and can be spread widely within a room or over longer distances 
and then inhaled by susceptible individuals who have not had direct contact with the 
infectious individual. Microorganisms frequently transmitted by this route include 
Mycobacterium tuberculosis, spores of Aspergillus spp, and the measles virus (Bloch, 
Orenstein et al., 1985; Beck-Sague, Dooley et al., 1992).
4) Vehicle transmission includes microorganisms transmitted to the host by 
contaminated items such as food, water, devices, and equipment.
5) Vector borne transmission occurs when vectors such as mosquitoes, flies and rats 
transmit microorganisms (Siegel, Rhinehart et al., 2007).
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1.1.3 Medical device-related infections
Infections related to implanted medical devices are frequent HAIs. During recent years, 
and as a result of increased use of interventional instrumentation and invasive 
procedures (e.g. intravascular catheters, indwelling urinary catheters, ventriculo- 
peritoneal shunt, prosthetic joint and prosthetic cardiac valves) there has been an 
increase in the incidence of medical device associated infections. To highlight this, the 
numbers of total hip and knee replacement procedures in England and Wales have 
increased from around 130,000 in 2005-2006 to about 179,000 in 2010-2011 (National 
Joint Registry 8th Annual Report, 2011). In the USA alone, each year there are 2 million 
cases of nosocomial infection with half of them being associated with indwelling 
devices (Darouiche, 2004). Medical device-related infection is considered to be a 
leading cause of morbidity and mortality in hospitalized patients, with infections usually 
leading to device failure and the need for replacement (Bjomson, 1993).
1.1.3.1 Pathogenesis of medical device-related infection
The presence of foreign material within patients is known to increase their vulnerability 
to infection. Even when small numbers of microorganisms colonize implanted plastic 
devices, they can form thick biofilms within 24 hours (Chambless, Hunt et al., 2006). 
The presence of a foreign body has been found to decrease by > 100,000-fold the 
minimal infecting dose of S. aureus and can lead to permanent abscess (Zimmerli, 
Waldvogel et al., 1982).
There are many factors that play a role in the pathogenesis of medical device infections 
including those related to the host, the device, and the causative microorganisms. It is 
the sum of these factors which influence pathogenesis.
Important host factors include any underlying disease, nutritional status, obesity, 
immune status and age. A wide range of medical devices have been implicated in device 
related infections. These include prosthetic joints often used in patients with rheumatoid 
arthritis (Chu, Crosslin et al., 2005), intravenous catheters (Raad, Hanna et al., 2007), 
urinary catheters (Ostrowska, Strzelczyk et al., 2013), prosthetic heart valves (Krikunov, 
Kharchenko et al., 2013), endotracheal tubes (Machado, Tarquinio et al., 2012) and oral
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prostheses (Sakka, Baroudi et al., 2012). Even when such devices are placed in a patient, 
additional variables can determine likelihood of infection. For example patients with 
rheumatoid arthritis have a higher risk of prosthetic joint infection than those with 
osteoarthritis (Sia IG, 2005). Factors influencing infection risk after placement of a 
catheter included the condition under which the catheter was placed (e.g., elective or 
urgent), catheter materials; silicone catheters more susceptible to infection than catheters 
made from other materials (O'Grady, Alexander et al., 2002).
The fundamental factor associated with the microbe is its ability to adhere and 
accumulate on biomaterials to form a multilayered structure called a biofilm (discussed 
in section 1.1 .3.2 ) which is central to the pathogenesis of prosthetic device infection 
(Mack, Rohde et al., 2006). S. epidermidis and S. aureus are the most common 
microorganisms causing implanted device associated infection. Pooled data from 1992 - 
1999 show that coagulase-negative staphylococci (CoNS) followed by S. aureus, are the 
most frequently isolated causes of hospital-acquired bloodstream infections (BSI)s, 
accounting for 37% and 12.6% respectively (National Nosocomial Infections
Surveillance, 1999). Prosthetic joint infection occurs at a frequency of 1-2% after joint 
replacement, the major causative organisms being CoNS and S. aureus, accounting for 
30-43% and 12-23% respectively (Trampuz and Zimmerli, 2005), urinary tract infection 
(UTI) in patients with indwelling catheters also have a high incidence of CoNS such as 
S. epidermidis and S. haemolyticus isolates accounting for 45.9% and 34% respectively 
(Nicolle, Hoban et al., 1983; Orrett and Shurland, 1998; Kumari, Rai et al., 2001). The 
ability of CoNS and to a lesser extent S. aureus to form biofilms on a biomaterial surface 
is a major reason behind their high incidence in medical device related infections 
(Laverty, Gorman et al., 2013)
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1.1.3.2 B iofilm s
Biofilms (Figure 1.1) arc communities of microorganisms that are attached to a surface 
or connected to each other, embedded in an extracellular matrix. The extracellular 
polymeric substance (EPS) matrix accounts for ~90% of the biofilm biomass. 
Extracellular matrix composed of exopolysaecharides, proteins and extracellular DNA 
that was secreted by the microorganisms themselves (Vilain, Pretorius et al., 2009; 
Flemming and Wingcnder, 2010). Extracellular DNA is vital for early attachment of S. 
epidermidis to both plastic and glass surfaces (Qin, Ou et al., 2007), and for P. 
aeruginosa biofilms formation (Whitchurch, Tolker-Nielsen et al., 2002).
There are three essential components needed for biofilm formation; a surface, 
microorganisms and a polymeric matrix (Dunne, 2002). In general the basic steps of 
biofilm formation arc: 1. The movement of planktonic (free floating cells) to a surface 2. 
Adhesion and attachment of planktonic cells to a surface 3. Growth and accumulation of 
cells in multiple layers 4. Secretion of extracellular matrix 5. Maturation and 6. 
Detachment and dispersal of planktonic cells (Figure 1.1).
6.Dispersioi
l .F ree  Floating p lank ton ic  cell 5 .M a tu re  Biofilm
4.Extracellular  Matrix
3 .A ccum ula t ion  and  g ro w th  ^
2 .A t tac h m e n t
Figure 1.1 Schematic representation of the steps in biofilm formation.
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In case of biofilms associated with chronic infections, the bacteria in the biofilm are 
often protected from the killing effect of the immune system either by impaired 
neutrophils and macrophages phagocytosis, limited penetration of leukocytes into the 
biofilm, or by prevent bacterial opsonization through prevention of immunoglobulins 
and complement deposition on bacterial surface (Jesaitis, Franklin et al., 2003; Leid, 
Willson et al., 2005; Cerca, Jefferson et al., 2006; Kristian, Birkenstock et al., 2008; Fey, 
2010; Kostakioti, Hadjifrangiskou et al., 2013). In addition, bacteria in biofilm produce 
catalase enzyme that decay hydrogen peroxide produced by phagocytic cells (Estela and 
Alejandro, 2012). Bacteria in biofilm also resist the killing effect of administrated 
antibiotics either by produce a small number of dormant cells called persisters that 
survive lethal concentrations of antibiotics without any specific resistance 
mechanisms (Lewis, 2005; Lewis, Spoering et al., 2006; Lewis, 2008), or biofilm matrix 
itself delay antibiotic penetration through acting as a physical barrier (Duguid, Evans et 
al., 1992; Souli and Giamarellou 1998, Apama and Yadav, 2008). Antimicrobial 
concentrations needed to inactivate biofilm associated microorganisms are much higher 
compared to planktonic cells (Donlan, 2001). Furthermore, bacteria inside biofilm 
produce enzyme can degrade or modify the activity of antibiotics via different 
mechanisms like hydrolysis (P-lactams), phosphorylation, glycosylation and transfer of 
thiol groups (Wright, 2005; Gallant, Daniels et al., 2005). Multidrug efflux pumps are 
another mechanism of antibiotic resistance (Leid, 2009). Efflux pumps are transport 
proteins that are able to expel toxic compounds such as antibiotics from the cell into the 
outside (Gallant, Daniels et al., 2005).
Shifting from planktonic microorganisms to cells that are part of surface-attached 
community occurs in a sequence of different events, including initial cell-to-surface or 
cell-to-cell attachment, micro-colony formation, biofilm maturation, and biofilm 
dispersal (Costerton, Montanaro et al., 2005). Quorum sensing is an important signaling 
process triggering biofilm formation by which bacterial cells communicate with each 
other. Quorum sensing uses signaling molecules called auto inducers to activate specific 
sites on DNA that induce protein formation involved numerous processes including 
biofilm formation (Hentzer, Eberl et al., 2003; Daniels, Vanderleyden et al., 2004).
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The increased use of implanted medical devices has lead to an associated increase in 
infections associated with biofilm formation (Tenke, Riedl et al., 2004; Fey, 2010).
In 1988, Gristina described foreign body implant infections as a “race for the surface”; a 
competition between host tissue cells and bacteria to occupy the biomaterials surface, if 
the host wins it greatly reduces the possibility of bacterial colonization and as a result 
decreases the chance of infection (Gristina, Naylor et al., 1988). When an implanted 
device surface is covered by a film of the host serum including protein like albumin, 
collagen, fibrin or cells, it also presents conditions conducive for bacteria to attach 
(Gristina, 1994).
The first step in biofilm formation is attachment, which is largely dependent on the 
properties of the biomaterial surface and the bacterial cell surface. Hydrophobic 
materials like Teflon, plastics, and silicone are more liable to develop biofilm than 
hydrophilic materials like metals (Donlan, 2001).
A study on oral biofilm formation shows that surface roughness of dental/oral implants 
like crowns, implant abutments, and denture bases play an important role in bioflm 
formation by stabilizing the initial bacterial adhesion to the surface, which is usually 
weak and reversible (Teughels, Van Assche et al., 2006). Regarding the bacterial cell 
surface properties, the presence of flagella, pili, or fimbriae, may affect the rate of 
microbial attachment to the surfaces (Donlan, 2001), the presence of thin pili in 
Acinetobacter spp play important roles in their ability to attach to biotic and abiotic 
surface and form biofilms (Gohl, Friedrich et al., 2006).
After bacteria attach to a surface they begin to divide, proliferate and accumulate to form 
micro-colonies, then secrete an extracellular matrix and become a mature biofilm 
(McCann, Gilmore et al., 2008). There are different inter cellular adhesions that support 
biofilm accumulation, including the extracellular polysaccharide polysachariede 
intercellular adhesin (PIA)(Mack, Nedelmann et al., 1994) and the proteinous dependent 
biofilm accumulations; accumulation associated proteins (Aap)(Rohde, Burdelski et al., 
2005) and extracellular matrix binding proteins (Embp)(Christner, Franke et al., 2010). 
From mature biofilm matrix, bacteria begin to disperse and may attach to other sites to 
form new biofilm. The loss of bacterial cells from biofilm occurs passively due to shear
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stresses forces or as a result of alteration in nutrient availability, oxygen deprivation or 
accumulation of toxins inside the biofilm (Costerton, Stewart et al., 1999; Sauer, Cullen 
et al., 2004; Rowe, Withers et al., 2010; Kostakioti, Hadjifrangiskou et al., 2013).
1.2 Staphylococci and human disease
1.2.1 Microbiology
Staphylococcus species are Gram-positive bacteria that come from the family 
Staphylococcaceae. Under the microscope these bacteria arrange in grape-like clusters; 
they are facultative anaerobes and when grown on solid media, form white colonies as in 
the case of S. epidermidis or golden colonies in the case of S. aureus. Staphylococci are 
catalase positive and oxidase negative bacteria. Staphylococci may be coagulase positive 
(CoPS) like S. aureus and S. intermedius or coagulase negative (CoNS) like S. 
epidermidis, S. saprophyticus, and S. haemolyticus. Although the Staphylococcus genus 
includes more than 40 species, only Staphylococcus aureus and Staphylococcus 
epidermidis are considered important human pathogens (Kloos and Schleifer, 1975; 
Kloos, 1980; Kloos and Bannerman, 1994; Harris, Foster et al., 2002). In the annual 
report of the National Healthcare Safety Network between 2006-2007 which involved 
463 hospitals, the CoNS and S. aureus were top of the 10 most common microorganisms 
causing healthcare associated infections (accounting for 84% of any HAIs) (Hidron, 
Edwards et al., 2008). In the USA, MRSA USA300 genotype emerged as a significant 
cause of nosocomial pneumonia in the intensive care unit (Pasquale, Jabrocki et al., 
2013).
1.2.2 Disease cause by Staphylococci
Diseases caused by Staphylococci vary in severity according to the species. The CoNS 
like S. epidermidis and S. haemolyticus which are part of the normal flora of the human 
skin, used to be considered commensal organisms; however during recent years there 
has been an increase in the incidence of HAIs and medical device infection attributed to 
these two strains; recent studies revealed that CoNS are the third major cause of HAIs 
and a common cause of bloodstream infections (BSI) (Rahman, Hosaain et al., 2012).
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Both S. epidermidis and S. haemolyticus resist tlhe immune system by their ability to 
produce biofilm and overcome the effect of antibiotics through methicillin resistant 
mechanisms (de Allori, Jure et al., 2006). Moreover, 15-40% of prosthetic valve 
endocarditis are due to CoNS (Wang, Athan et al., 2007). In contrast S. aureus is a 
human pathogen which causes different types o f infections that vary in severity from 
mild skin infection to severe surgical site infections, pneumonia and osteomyelitis. 5. 
aureus can colonize the nasal passages in healthy individuals, and play important roles 
in HAIs. A recent study showed that pretreatmient of S. aureus nasal carriers with 
mupirocin ointment and chlorhexidine can reduce incidence of surgical site infection 
(SSI) to 4% compared to 11% in untreated S. aureus carriers, and 3% in non-carriers 
(Tai, Borchard et al., 2013).
1.3 Staphylococcus epidermidis
S. epidermidis is a Gram positive coccus whose cells arranged in grape-like clusters. 
This species is non-motile, and forms white colonies, approximately 1-2 millimeters in 
diameter after overnight incubation. They are facultative anaerobes, catalase positive, 
oxidase negative, and have the ability to produce urease and are non-hemolytic on blood 
agar.
S. epidermidis is part of the normal microflora that colonizes the human skin and 
mucosal surface and maintains a healthy component of skin microflora by out competing 
more harmful bacteria (Lina, Boutite et al., 2003). Studies show that the interaction of S. 
epidermidis peptides, the phenol soluble modulins (PSMs) gamma and delta, with 
human skin antimicrobial peptides (AMPs) enhances killing of some skin pathogens like 
S. aureus (Cogen, Yamasaki et al., 2010a; Cogen, Yamasaki et al., 2010b).
In the immunocompetent, host S. epidermidis acts as a commensal but it can cause 
severe infection in immunocompromised patients (von Eiff, Proctor et al., 2001). 
Currently CoNS (mostly S. epidermidis) are considered to be a major cause of HAIs and 
a common cause of infections on indwelling medical devices (CDC., 2004). The 
increase in the rate of HAIs attributed to S. epidermidis during the recent years is due to 
increases in the use of invasive medical techniques and implanted medical devices.
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Colonization of the skin by S. epidermidis provides the opportunity for contamination of 
the medical device during implantation and can result in numerous infections, like 
intravenous catheter infection, prosthetic joint infection, surgical site infection, central 
nervous system shunt infection, ventilator-associated pneumonia, and catheter- 
associated urinary tract infection (Longauerova, 2006; Piette and Verschraegen, 2009). 
CoNS were the most common pathogens isolated from BSI in pediatric and intensive 
care units in the United States (Richards, Edwards et al., 1999; Richards, Edwards et al., 
1999).
Multiple virulence factors play a role in the ability of CoNS to cause HAIs. These 
factors include biofilm formation, antibiotic resistance (as 55-75% of CoNS HAIs 
isolates are methicillin resistant), expression of surface proteins with adhesive properties 
which enable S. epidermidis to adhere to abiotic surfaces and to host matrix proteins that 
coat implants after implantation, and production of phenol soluble modulins (PSMs). 
Studies show a correlation between biofilm formation properties and antibiotic 
resistance compared to biofilm-negative isolates (Francois, Vaudaux et al., 1998; Otto, 
2004; Klingenberg, Ronnestad et al., 2007; Granslo, Gammelsrud et al., 2008).
Treatment of S. epidermidis infections is difficult and thus, measures directed towards 
prevention are particularly important. Improvement in hygiene standards applied during 
implantation of peripheral intravenous cannula can reduce the possibility of infection 
which lead to a reduction in patient morbidity rates and the duration of the treatment 
(Morris and Heong Tay, 2008; Aziz, 2009).
1.4 Staphylococcus epidermidis virulence
1.4.1 Biofilm formation in Staphylococci
Biofilm formation is a major virulence mechanism involved in S. epidermidis infection 
particularly in those associated with an indwelling medical device (Fey and Olson, 
2010). Biofilm formation is the major cause of implant failure in orthopaedic joint 
replacements, which often demand orthopaedic revision surgery as bacteria inside the 
biofilm remain protected from the immune system and antibiotic killing (Neut, van Horn 
et al., 2003). Often it is difficult to identify the causative agent of these infections using
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routine methods of swabbing of the infected area, taking small tissue samples or pre- 
prosthetic tissue for culture and sensitivity always helpful (Costerton, 2005; Donlan, 
2005). Recent studies by Trampuz et al (Trampuz, Piper et al., 2007) show that 
sonication of the removed hip or knee joint prostheses can help in diagnosis of causative 
agents by separating and dislodging bacteria embedded in biofilm formed on these 
prostheses. A case study by Palmer et al (Palmer, Costerton et al., 2011) demonstrated 
the presence of methicillin-resistant Staphylococcus epidermidis (MRSA) biofilm in a 3 
year non healing tibia bone fracture where other standard cultures were negative. 
Increased use of more advanced techniques like the Ibis T5000 Universal Biosensor; 
pathogens diagnoses based on broad-range PCR and high performance mass 
spectrometry (Ecker, Drader et al., 2006) and fluorescence in situ hybridization (FISH) 
can detect the presence of pathogens in previously negative samples.
Biofilm structure comprises a multilayered community of bacteria encased in a self­
produced polymeric matrix, which is thought to protect it from the effect of antibiotics 
and the immune response (Mack, Rohde et al., 2006).
After the free floating S. epidermidis reversibly attach to a surface, the second stage of 
biofilm formation starts as the cells attach irreversibly to the surface via adhesions. 
There are 10 adhesins found in S. epidermidis which have been reported to bind to a 
number of host cell extracellular matrix proteins summarized in (Table 1.2). Cell wall 
teichoic acid also bind to fibronectin (Gross, Cramton et al., 2001). These extracellular 
substance (DNA, surface proteins, lipids, and lipopolysaccharides) facilitates binding to 
materials coated with proteins such as fibrinogen, fibronectin, vitronectin, and collagen 
(Von Eiff, 2002; Renner and Weibel, 2011).
15
Table 1.2 Adhesins found in S. epidermidis
Adhesive Attachment References
Autolysin (Aae) Binds fibrinogen, vitronectin, and 
fibronectin
(Heilmann, Thumm et al., 
2003)
Autolysin (AtlE) Binds vitronectin (Heilmann, Hussain et al., 
1997)
Fibrinogen-binding protein (Fbe)
Also identified as SdrG (serine- 
aspartate repeat protein G)
Binds fibrinogen (Davis, Gurusiddappa et al., 
2001)
SdrF surface proteins belong to 
the serine-aspartate repeat (Sdr) 
family
Binds Collagen (Arrecubieta, Lee et al., 
2007; Arrecubieta, Toba et 
al., 2009)
Surface proteins 1 and 2 (Sspl 
and Ssp2)
Binds to polystyrene surface (Veenstra, Cremers et al., 
1996)
Extracellular lipase glycerol ester 
hydrolase (GehD)
Binds collagen (Bowden, Visai et al., 2002)
Extracellular matrix binding 
protein (Embp)
Bind fibronectin (Christner, Franke et al., 
2010)
Elastin binding protein S (EbpS) Binds elastin (Downer, Roche et al., 2002)
Bap homologous protein (Bhp) Binds polystyrenes (Tormo, Knecht et al., 2005; 
Lasa and Penades, 2006)
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In the third stage of biofilm formation bacteria start to proliferate and form 
microcolonies, and in the fourth stage bacteria secret an extracellular matrix. There are 
three different mechanisms mediating biofilm accumulation. They are: production of 
polysaccharide intercellular adhesin (PIA), accumulation associated protein (Aap) 
protein, and extracellular matrix binding protein (Embp) (Mack, Haeder et al., 1996; 
Rohde, Burdelski et al., 2005; Rohde, Burandt et al., 2007; Christner, Franke et al., 
2010). In addition extracellular teichoic acids are also considered as integral parts of the 
extracellular matrix and mature biofilm.
In the fifth stage of biofilm formation the bacterial cells begin to disperse from the 
mature biofilm under the influence of peptides called phenol-soluble modulins and 
become free floating bacteria leading to dissemination of the infection and repeated 
cycles of biofilm formation (Sadovskaya, Vinogradov et al., 2005; Yao, Sturdevant et 
al., 2005; Wang, Khan et al., 2011).
Studies shows that biofilm production is the most important virulence factor attributed to 
invasiveness of S. epidermidis infection (Gad, El-Feky et al., 2009; Mekni, Bouchami et 
al., 2012), followed by antibiotic resistance. Indeed the majority of S. epidermidis strains 
causing catheter infection and catheter-related bacteremia are biofilm-producing and 
methicillin-resistant bacteria (Abbassi, Bouchami et al., 2008; Kitao, Ishimaru et al., 
2010). Methicillin resistance, mediated by the mecA gene, is present in 80% of device 
associated infections caused by S. epidemidis (Kozitskaya, Cho et al., 2004). However, 
there are several biofilm properties that influence antibiotic resistance such as limiting 
antibiotic penetration (Mah and O'Toole, 2001) and reduction of metabolic activity of 
bacteria (e.g. cell division, protein synthesis, and DNA replication) due to decreases in 
the amount of oxygen and nutrient diffusing within biofilm. As antimicrobial often act 
on actively dividing cells, a low metabolic activity by biofilm cells leads to greater 
tolerance of biofilm cells to the agent. Also, the presence of persister cells in biofilm 
mean that once treatment is over the biofilm cells can regrow and cause a recurrence of 
infection (Lewis, 2008; Fauvart, De Groote et al., 2011).
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1.4.1.1 Mechanisms of biofilm accumulation
1.4.1.1.1 Polysaccharide intercellular adhesin (PIA)
PIA is the main functional element for intercellular adhesion in S. epidermidis biofilms 
(Mack, Nedelmann et al., 1994; Mack, Davies et al., 2009). PIA is also detected in other 
bacterial species, e.g. S. aureus, Escherichia coli, Yersinia pestis, Bordetella spp, 
Aggregatibacter actinomycetemcomitans (Mack, Haeder et al., 1996; Cho, Naber et al., 
2002; Cafiso, Bertuccio et al., 2004; Rohde, Burandt et al., 2007; Rohde, Frankenberger 
et al., 2 0 1 0 ) suggesting that it is a more general mechanism of biofilm formation.
PIA is a homoglycan of (3-1, 6 -linked N  -acetylglucosamine of at least 130 residues, PIA 
both positively charged due to free 2-amino groups (no N  -acetylation) and negatively 
charged due to O -succinoyl ester residues. These charge properties are essential for 
intercellular adhesion (Figure 1.2).
A
■-0
AcHN
AcHNGlcNH- GlcNAc
GlcNAc
GlcNH-
B
icaD
icaR icaA
icaB icaC
Figure 1.2 PIA structure and ica operon
A. Schematic representation of PIA structure. B. Schematic representation of ica 
operon.
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PIA is encoded for by the icaADBC locus which produces a membrane bound enzyme 
complex (Heilmann, Schweitzer et al., 1996; Gerke, Kraft et al., 1998). PIA existing as 
two polysaccharide species, major polysaccharide I (>80%) and minor polysaccharide II 
(<20%) which is moderately anionic (Mack, Fischer et al., 1996; Mack, Davies et al., 
2009). Polysaccharide I is a linear homoglycan of (3-1, 6 -linked 2-amino-2- deoxy-D- 
glucopyransoyl residues, about 80-85% are N-acetylated and the rest non N-acetylated. 
Polysaccharide II, structurally related to polysaccharide I but contain less N-acetylated 
D- glucosaminyl residues, in addition to ester- linked succinate and phosphate (Mack, 
Nedelmann et al., 1994; Mack, Fischer et al., 1996).
Thus icaADBC is a major virulence factor that is found in most S. epidermidis strains 
associated with severe nosocomial and medical device associated infection. Importantly 
this operon is uncommon in S. epidermidis isolated from the community (Arciola, 
Campoccia et al., 2006; OGara, 2007). The operon comprises four open reading frames; 
IcaA, IcaC and IcaD are all membrane protein, while IcaB is a secreted protein. 
Synthesis of functionally active PIA molecules requisite all the four icaADBC genes 
(Gerke, Kraft et al., 1998; Gotz, 2002). IcaA is a glycosyltransferase that directs the 
syntheses of 0-1,6 -linked N-acetylglucosamine (GlcNAc) oligosaccharides using 
Uridine diphosphate N-acetylglucosamine (UDP-GlcNAc), IcaD is required for full 
activity of IcaA. IcaC is responsible for elongation and extemalization of the growing 
polysaccharide across the cytoplasmic membrane (Gerke, Kraft et al., 1998). IcaB, is 
deacetylase responsible for de-N-asetylation of PIA, which is crucial for PIA activity, 
biofilm formation and immune evasion of S. epidermidis (Vuong, Kocianova et al.,
2004). Deletion of IcaB gene from S. epidermidis prevented deacetylation and produced 
PIA poorly attached to the cell surface (Vuong, Kocianova et al., 2004; Cerca, Jefferson 
et al., 2007). IcaB deacetylated around 3-8% of the amino groups (Maira-Litran, Kropec 
et al., 2002), Figure 1.3 Summarize the PIA biosynthesis mechanism.
The expression of ica locus regulated by both positive and negative regulators. The 
intercellular adhesin regulator (/caR) is a negative regulator act as a transcriptional 
repressor of ica operon in S. epidermdis. IcaR is located upstream of the icaADBC 
operon (Conlon, Humphreys et al., 2002). Ethanol represses icaR expression, lead to 
induction of ica operon (Conlon, Humphreys et al., 2002).
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Q  GlcN 
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Figure 1.3 Scheme of the PIA biosynthesis mechanism in S. epidermidis as proposed 
by Gotz(Gotz 2002). IcaA by the help of IcaD using UDP-GlcNAc to synthesis (3-1, 6- 
linked GlcNAc oligomers, which is elongated and translocate across the cytoplasmic 
membrane by IcaC. IcaB is responsible for removing some (approximately 15%) of 
acetyle groups from GlcNAc residues.
The teicoplanin —associated locus regulator (TcaR) also acts as a transcriptional 
repressor of ica operon (Jefferson, Pier et al., 2004). The Staphylococcal accessory 
regulator A (SarA) and the general stress alternative sigma factor Sigma B (SigB) are a 
positive transcriptional regulator of ica operon (Handke, Slater et al., 2007; Pintcns, 
Massonet et al., 2008).
The positive regulation of SigB on ica operon in S. epidermidis is due to its negative 
regulation on icaR (Handke, Slater et al., 2007; Jager, Jonas et al., 2009). In addition to 
the above regulators, there are several environmental and nutritional conditions were 
proving to regulate PIA biosynthesis, e.g. anaerobic growth conditions lead to increased 
polysaccharide expression in S. epidermidis (Cramton, Ulrich et al., 2001), 
Subinhibitory concentrations of different antibiotic (e.g. tetracycline, streptogramin and 
quinupristin-dalfopristin ) were found to enhance ica expression in S. epidermidis 9- to 
11-fold (Rachid, Ohlsen et al., 2000). Studies suggested a relationship between
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icaADBC expression and metabolism; the presence of glucose in growth media affected 
/caADBC expression and PIA production (Dobinsky, Kiel et al., 2003). Also, PIA 
synthesis enhanced during tricarboxylic acid (TCA) cycle stress (Vuong, Kidder et al.,
2005).
1.4.1.1.2 Accumulation associated protein (Aap)
Accumulation associated protein (Aap) is a cell surface associated protein mediating 
intercellular adhesion and biofilm accumulation in a PIA-independent way (Sun, 
Accavitti et al., 2005). Aap is synthesized as a pre-protein and is anchored via an 
LPXTG motif and comprises domain A, which itself contains a lectin-like domain, and a 
repetitive domain B, composed of a variable number of 128 amino acid repeats. Domine 
B repeats contain G5 domains which may bind V-acetylglucosamine (Bateman, Holden 
et al., 2005). G5 domines mediate intercellular accumulation through Zn (2+)-mediated 
homodimerization (Gruszka, Wojdyla et al., 2012). S. epidermidis biofilm formation 
repressed by Zn (2+) chelation (Conrady, Brescia et al., 2008). Proteolytic processing of 
Aap leads to removal of the N  -terminal domain A, exposing domain B, which gives Aap 
intercellular adhesive properties causing biofilm accumulation. The proteolytic 
activation may be mediated either by staphylococcal exoproteases or by the host, as part 
of the early immune response against S. epidermidis (Rohde, Burdelski et al., 2005). 
Protein-dependent biofilms mediated by Aap were found in S. epidermidis strains 
isolated from total hip arthroplasty (Rohde, Burandt et al., 2007)
1.4.1.1.3 Extracellular matrix binding protein (Embp)
The Extracellular matrix binding protein Embp is a cell surface associated protein that 
mediates attachment to host extracellular matrix and biofilm accumulation. The 
intercellular adhesive properties first revealed in a clinical isolates of S. epidermidis 
1585 from blood culture of catheter infection which was icaADBC negative and Aap 
negative did not form biofilm in vitro, with subsequent culturing a biofilm positive S. 
epidermidis 1585V variant obtained. Embp is a giant lMDa fibronectin-binding protein, 
harboring 59 so-called Found in Various Architectures (FIVAR) domains and 38 protein 
G-related albumin-binding (GA) domains. The FIVAR domains of Embp mediate
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binding of S. epidermidis to fibronectin, the first step of biofilm formation on 
conditioned surfaces (Williams, Henderson et al., 2002; Christner, Franke et al., 2010). 
Under standard in vitro conditions, Embp is not expressed; however Embp expression 
induced in biofilm negative wild type S. epidermidis 1585 in the presence of goat serum, 
leading to biofilm formation (Christner, Franke et al., 2010). The Embp mediated 
biofilm protects 5. epidermidis from phagocytosis by macrophages (Schommer, 
Christner et al., 2011).
1.4.2 Phenol soluble modulins
S. epidermidis produces a number of exoenzymes including lipases, proteases, 
hemolysin, nuclease (DNAse) and Thermonuclease (TNAse). In addition, S. epidermidis 
synthesizes toxins like phenol soluble modulins (PSMs) and enterotoxin C (SEC). These 
enterotoxins have superantigens properties and can stimulate the overproduction of 
cytokines such as interferon-y (IFN-y), interleukin-1 (IL-1), interleukin-2 (IL-2), and 
tumor necrosis factor alpha (TNFa). The release of these enzymes and toxins contribute 
to the persistence of S. epidermidis infection and also results in injury to host tissue 
(Otto, 2004; Cunha Mde, Rugolo et al., 2006). Phenol soluble modulins are peptide 
toxins with pro- inflammatory effects on the host. The production of PSMs is controlled 
by the quorum-sensing accessory gene regulator (agr) (Vuong, Durr et al., 2004) and 
agr-dependent PSMs production could disrupt cell-cell contacts in the biofilm and 
encourage cell detachment. There are three PSMs peptides encoded in S. epidermidis, 
PSM-a, PMS-P and PSM-5. These peptides facilitate biofilm dispersion and 
dissemination of biofilm-associated infection, especially PSM-(3 which is a key effecter 
of S. epidermidis biofilm maturation and detachment (Wang, Khan et al., 2011). PSM-5 
has strong cytolytic activity, lysing neutrophils and erythrocytes when present at high 
concentrations (Cheung, Rigby et al., 2010).
22
1.5 Immune system
The immune system is responsible for protecting the host against microorganisms that 
invade the body such as bacteria, viruses, fungi and protozoa. The host immune defense 
can be divided into two major categories: the innate (natural) immune system which 
recognizes conserved residues in microorganisms and the adaptive immune system 
which recognizes unique structural motifs (Beck and Habicht, 1996) and is beyond the 
scope of this thesis.
1.6 Innate immunity
Innate immunity is the first line of defense against infections. Innate immune 
mechanisms are rapidly activated by microbes before adaptive immune responses, and 
are nonspecific. The innate immune system uses cellular immunity and humoral 
immunity to complete its function. Thus, cellular innate immunity involves pathogen 
recognition through cell surface pattern recognition receptors (such as toll-like 
receptors) and pathogen removal through phagocytosis and killing by phagocytic cells 
(such as neutrophils and macrophages). Humoral innate immunity involves intercellular 
signaling and amplification of the inflammatory response by cytokines and complement 
cascades. Innate immunity plays an important role in limiting infection in its early 
stages (Abbas, Lichtman et al., 2010).
1.6.1. Barriers as part of the innate immune system
Anatomical barriers covering the outer body surface (e.g. skin), and mucus membranes 
covering the inner body surface (respiratory system, urinary system, gastrointestinal 
system) are also part of the innate immune system. These membranes act as mechanical 
barriers preventing pathogens from penetrating and entering the body. Any damage to 
the integrity of these barriers caused by factors such as bums, wounds or surgical 
procedures, give pathogens an opportunity to enter the body, multiply and cause 
infection. In addition skin and mucous membranes contain chemical barriers. Epithelial 
cells produce antibacterial peptides (e.g. defensins), sebum secreted by skin sebaceous 
glands can inhibit bacterial and fungal growth (fatty acid and lactic acid), gastric acid
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kills microorganism and lysozyme in tears and nasal secretion have antibacterial 
properties, secretary immunoglobulin A found in tears, saliva and on the nasal and 
bronchial surface plays an important role in pathogen opsonization. Finally, the normal 
microbial flora of the skin and mucus membrane also acts as a microbiological barrier to 
prevent the growth of pathogenic bacteria. Disturbance to the normal microflora caused 
by antibiotic usage can lead to decreased normal flora and enhanced growth of 
pathogenic bacteria (Helbert, 2006; Parham, 2009).
1.6.2 Cellular immunity
1.6.2.1 Neutrophils
Neutrophils, also known as polymorphonuclear leukocytes (PMN), are considered a 
major defence mechanism against bacterial invasion. Neutrophils which represent two- 
thirds of peripheral blood leukocytes, have a major function of killing invading 
microbes. Neutrophils have a short life span, 8-12 hours in circulation and 1-4 days in 
tissues, with everyday turnover of human neutrophils approximately 0 .8- 1.6  x 109 cells 
per kg of body weight. Thus to maintain cellular homeostasis under physiological 
conditions equivalent numbers of neutrophils are cleared (Akgul, Moulding et al., 2001; 
Xu, Loison et al., 2009). Severe bacterial infections occur if neutrophils are few in 
number (neutropenia) or are deficient in function, as in chronic granulomatous disease 
(CGD) (Lakshman and Finn, 2001).
Neutrophils have multi-lobed nuclei and cytoplasmic granules called lysosomes and 
contain a variety of degradative enzymes which are important in the bactericidal action 
of these cells (Yamashiro, Kamohara et al., 2001; Levinson, 2006). After migrating to 
the site of infection, neutrophils encounter invading microbes and engulf pathogens into 
a phagosome. In phagosomes, there are two major antimicrobial effects. The first effect 
involves fusion of phagosomes with neutrophil granules. Azurophilic granules contain 
lysozyme, defensins, proteases, whilst specific granules contain lactoferin, lysozyme and 
several membrane proteins including NADPH oxidase. All these are essential enzymes 
for neutrophil function and assembled in phagosomes following fusion with azurophilic 
and specific granules (Hampton, Kettle et al., 1998). The second antimicrobial effect
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involves pre-synthesized subunits of the NADPH oxidase assembling at the phagosomal 
membrane and transfering electrons to oxygen to form superoxide anions. These anions 
dismutate spontaneously or catalytically to oxygen and hydrogen peroxide and 
collectively are called reactive oxygen species (ROS). Discharging antimicrobial 
peptides, enzymes and ROS, are collectively responsible for microbial digestion and 
killing in neutrophils (Parham, 2009).
Activated neutrophils undergo programmed cell death or apoptosis and this prevents the 
release of enzymes and ROS in to surrounding tissue (Savill, Wyllie et al., 1989; Haslett 
and Savill, 2001). The dead neutrophils are then phagocytes by macrophages which 
prevent local tissue damage that would otherwise occur through exposure to the retuned 
enzymes and toxin from the neutrophils (Akgul, Moulding et al., 2001; Maianski, 
Maianski et al., 2004).
Recently, another mechanism of killing has been identified in neutrophils which is the 
generation and release of neutrophil extracellular traps (NETs) from gaps or breaks in 
the cell membrane. NETs are extracellular fibrous structures composed of granule 
protein and chromatin that have the ability to bind and kill invading pathogens and 
prevent them from spreading (Brinkmann, Reichard et al., 2004; Brinkmann, Laube et 
al., 2010). This antimicrobial process is also aided by the generation of ROS by NADPH 
oxidase (Fuchs, Abed et al., 2007).
The vast array of toxic products produced by neutophils have two contrasting effects. 
Firstly a powerful microbicidal activity essential for an effective host defence and 
secondly a toxic effect resulting in excessive inflammation and tissue damage as 
observed in rheumatoid arthritis and inflammatory bowel disease and acute lung injury 
(Cook, Pisetsky et al., 2004; Himmel, Hardenberg et al., 2008).
1.6.2.2 Macrophages
Macrophages are found in all body tissues, and in considerable numbers in the liver, 
spleen and lung, where they are responsible for activating acquired (adaptive) immune 
processes. Their anatomical location in tissues means they are the first cells to deal with 
invading pathogens and they also send chemical messages in the form of chemokines 
CXCL8 (IL-8) to recruit other cells of the immune system from the blood, e.g.
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neutrophils and monocytes (monocytes differentiated into macrophages when enter the 
tissue) into the infected area. Macrophages express different surface markers such as 
C D llb , CD18, CD68  and FC receptors (Murray and Wynn, 2011). Both CDllb/CD18 
(also called CR3) function as adhesion molecules and complement receptors in the 
binding of C3b, and thus stimulate recognition and phagocytosis of the invading 
pathogens (Ehlers, 2000).
Macrophages have several key function and these are: 1) The phagocytosis of opsonized 
organisms, cellular debris and apoptotic cells 2) The killing of phagocytosed organisms 
by reactive nitrogen species (RNS) 3) Antigen presentation on class II major 
histocompatibility complex (MHC) molecules, and 4) Secretion of cytokines e.g. IL-1, 
IL-6 , IL-12, TNF - a  that promote immune responses (Levinson, 2006; Menendez- 
Benito and Neefjes, 2007).
Macrophages are activated either by cytokines (e.g. gamma interferon (IFN-y) produced 
by innate immune cells such as natural killer cells ( NK), or Thl T cells), or by 
microbial products such as lipopolysaccharide (LPS), peptidoglycan (PGN) and 
mannans collectively called pathogen-associated molecular pattems(PAMPs). PAMPs 
stimulate macrophage activation through toll-like receptors (TLRs) (Schnare, Holt et al., 
2000; Young, 2006). Bacterial pathogens prompt inducible nitric oxide synthase (iNOS) 
enzyme which induce release of antimicrobial molecules RNS derived from nitric oxide 
(NO), RNS act with ROS as potent antimicrobial to damage pathogens (Lyons, Orloff et 
al., 1992; Aktan, 2004; Fang, 2004).
On recognition of a pathogen in host tissues, macrophages utilise cytokines in several 
ways in order to generate an effective response. Secreted chemokines such as IL-8  serve 
to attract neutrophils to the site of infection, whilst the release of cytokines such as TNF, 
prostaglandin and platelet activating factor act on endothelium and change blood vessels 
permeability to allow neutrophils and monocytes to leave the blood and enter the tissues. 
Macrophages do not just kill invading pathogens, but also eliminate the waste and debris 
of dead or damaged tissues. Macrophages also ingest apoptotic neutrophils thereby 
acting as scavengers that continue to survive after phagocytosis (Dale, Boxer et al., 
2008; Silva, 2010).
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1.6.2.3 Phagocytosis
Phagocytosis is the process of ingestion and killing of microbes by phagocytic cells, the 
main phagocytes are neutrophils and macrophages along with dendritic cells. Phagocytes 
use different methods to recognize pathogens. These include the presence of pattern 
recognition receptors like toll-like receptors, complement receptors, or Fc receptors to 
recognize pathogens-associated molecular patterns (PAMPs) present on microbes. 
These recognition mechanisms are important to facilitate the attachment of the pathogen 
to the phagocyte (Aderem and Underhill, 1999; Underhill and Goodridge, 2012). 
Phagocytosis is an actin- dependent mechanism that involves polymerization of 
monomeric G- actin to polymeric F-actin (Swanson and Baer, 1995; Greenberg and 
Grinstein, 2002). Phagocytes extend membrane protrusions called pseudopodia around 
ingested particles to engulf them into the phagosome (Dale, Boxer et al., 2008). 
Phagosomes fuse with endosomes and lysosomes to form phagolysosomes (Stuart and 
Ezekowitz, 2005). Pathogens inside the phagolysosomes are killed by the effect of 
respiratory burst, which involves production of hypochlorous acid, hydrogen peroxide 
and nitric acid. Additional antimicrobial effect occure due to antimicrobial peptides e.g. 
defensins that are secreted into the phagosome (Underhill and Ozinsky, 2002; 
Flannagan, Jaumouille et al., 2011; Sarantis and Grinstein, 2012). Furthermore, 
NADPH-oxidase kill the internalized pathogens by release of reactive oxygen 
intermediates and activation of proteases (Reeves, Lu et al., 2002).
An important function of phagocytes is to act as the link between the innate and acquired 
immune systems. This link occur due to the phagocyte presenting antigen via class II 
MHCs to activate CD4 T cells (Stuart and Ezekowitz, 2005; Kagan and Iwasaki, 2012).
1.6.2.4 Pattern recognition receptors
To detect pathogens, cells of the innate immune system have receptors called pattern 
recognition receptors (PRRs) which detect conserved structural motifs on pathogenic 
organisms called pathogens-associated molecular patterns (PAMPs) (Reynolds and 
Dong, 2013). Important PRRs are Toll-like receptors (TLRs), (Hallman, Ramet et al., 
2001; Nishiya and DeFranco, 2004), mannose receptors and, collectins such as C lq and 
mannose binding lectin (MBL). Both neutrophils and macrophages express TLRs on
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their cell surfaces, endosomes and in their cytoplasm (Underhill and Ozinsky, 2002; 
Parker, Whyte et al., 2005; Takahashi, Ishida et al., 2010). TLR activation leads to up- 
regulation of phagocytosis, maturation of leukocytes and cytokine release (Heine and 
Ulmer, 2005). Young children with deficiencies in the complement recognition molecule 
mannose-binding lectin are more susceptible to S. aureus infections (Park, Kurokawa et 
al., 2 0 1 0 ).
There are 11 TLRs each recognizing different PAMPs. For example TLR-4 binds 
lipopolysaccharide (LPS), TLR-2 binds peptidoglycan and lipopeptides, and TLR-3 
binds viral RNA. The interaction of TLRs with their specific PAMP induces activation 
of signal transduction pathways including activation of the nuclear factor kappa-light- 
chain-enhancer of activated B cells (NF-kB) pathway, leading to secretion of pro- 
inflammatory cytokines such as tumour necrosis factor (TNFa), IL-1 (3, IL-6  and IL-12. 
Furthermore, activation of mitogen-activated proteins (MAP) kinase family pathways, 
including extracellular signal-regulated protein kinases ERK, c-Jun amino-terminal 
kinases (JNK) and p38 MAP kinases, are also fundamental for complete host defence 
including cell growth and differentiation, control of inflammation, apoptosis, 
macrophage activation and the expression of IL-12. Molecules released following TLR 
activation, signal to other cells of the immune system to increase production of 
neutrophils in bone marrow and recruit neutrophils to site of the infection making TLRs 
essential elements of both innate and adaptive immunity (Pearson, Robinson et al., 2001; 
Zhang and Dong, 2005; Carpenter and O'Neill, 2007).
1.6.3 Humoral immunity
1.6.3.1 Complement system
The complement system is composed of more than 30 serum and cell membrane proteins 
forming an enzymatic cascade (Walport, 2001). Hepatocytes produce the majority of 
serum complement proteins, as inactive zymogens. Once activated, zymogens are 
cleaved and become proteases activating downstream zymogens in the cascade. The 
complement system plays an important role in host defence against bacterial and viral 
infection (Wood, 2011). Activation of the complement cascade is initiated by three
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mechanisms; the classical pathway, the lectin-binding pathway and the alternative 
pathway. The three pathways join in a final common pathway through cleavage of the 
central component C3. C3 cleavage subsequently activates C5, C6 , C7, C8 and C9 
initiating the aggregation of C5b, C6 , C7, C8 and C9 into the membrane attack complex 
(MAC) that bind to the pathogen cell wall inducing cytolysis (Cole and Morgan, 2003).
The classical complement pathway is activated by antigen-antibody complexes. Clq 
(pattern recognition receptor; PRR) interacts with the Fc portion of immunoglobulin 
(IgG, IgM) to activate C ls protease leading to cleavage of C4 into C4a and C4b, and 
cleavage of C2 into C2a and C2b. The C4bC2a complex is the formed which promotes 
C3 cleavage into C3a and C3b. C3b activates the common final pathway allowing MAC 
assembly (Pettigrew, Teuber et al., 2009; Carroll and Georgiou, 2013). The Lectin- 
binding pathway is similar to the classical pathway and is activated when the PRR 
mannose-binding lectin (MBL) binds to monosaccharides such as mannose, N- 
acetylglucosamine, N-acetylmannosamine on microbial surfaces. This serves to activate 
MBL-associated serine protease MASP-2 leading to cleavage and activation of C4 and 
C2 which finally cleave C3 into C3a and C3b which activate the common final pathway 
(Sorensen, Thiel et al., 2005). The alternative pathway is activated by microbial surfaces 
and cell surface components (e.g. LPS and teichoic acid) which lead to cleavage of C3 
into C3a and C3b. In addition to forming MAC, the C3a fragment increases vascular 
permeability stimulating phagocyte transmigration to the site of infection and C3b acts 
as an opsonin to coat pathogens and to enhance phagocytosis (Pettigrew, Teuber et al., 
2009).
Activation of the complement system produces a plethora of cleavage fragments with 
important functions in host defence; 1) C3b is an opsonin that binds to pathogens and 
interacts with phagocytic receptors (CR1, CR2, CR3, and CR4) on the surface of 
phagocytes; 2) C3a and C5a induce phagocyte chemotaxis and increase vascular 
permeability to enhance cell migration; 3) The MAC complex induces direct killing of 
pathogens by inducing pores in the cell membrane; 4) C3b and C4b bind immune 
complexes to aid clearance from the circulation in the liver, by recognition of Cl
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receptors on the erythrocytes; 5) C3d coating of antigens activates B lymphocytes which 
promote antibody production (Actor, 2012).
In contrast, excess releases of complement cleavage fragment have harmful effects on 
cellular function within the innate immune system, especially in the critically ill patient. 
For example in patient with sepsis, C5a has inhibitory effects on neutrophil phagocytic 
function, migration and release of ROS in response to pathogens (Conway Morris, 
Kefala et al., 2009; Morris, Brittan et al., 2011).
1.6.3.2 Cytokines
Cytokines are protein messenger molecules used for intercellular communication, 
between cells of the immune system. The main families of cytokines are Interleukins 
(ILs), Colony Stimulating Factors (CSFs), Interferons (IFNs), Tumour Necrosis Factors 
(TNFs), Chemokines (CKs) and Growth Factors (GFs). Cytokines control cell growth, 
proliferation, function and leukocyte migration (Helbert, 2006).
Interleukins (ILs) are a large group of proteins with immune modulatory function that 
control cell growth, differentiation and migration during the immune response. 
Interleukins have both pro-inflammatory and anti-inflammatory actions. Based on 
structural features, ILs can be divided into 4 main groups; ILl-like cytokines, the class I 
helical cytokines (IL4-like, y-chain and IL6/12-like), the class II helical cytokines (IL10- 
like and IL28-like) and the IL17-like cytokines (Commins, Borish et al., 2010).
The colony-stimulating factors (CSFs) are a group of cytokines that play important roles 
in the regulation of hematopoiesis of blood cells through their effect on hematopoietic 
stem cells. This group consists of the macrophage-CSF (M-CSF), granulocyte-CSF (G- 
CSF), granulocyte/macrophage-CSF (GM-CSF), and multi-CSF (IL-3) (Barreda, 
Hanington et al., 2004). M-CSF controls the proliferation, differentiation, and survival 
of macrophages, monocytes and their precursors cells and increases their phagocytic and 
chemotactic activity (Stanley, Berg et al., 1997). G-CSF promotes neutrophil 
proliferation and maturation, whereas, GM-CSF has much broader effects on multiple 
cells including macrophages, eosinophils and neutrophils. G-CSF and GM-CSF are 
produced by macrophages, monocytes, fibroblasts, stromal cells and endothelial cells.
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The production of both G-CSF and GM-CSF is triggered by bacterial LPS, but GM-CSF 
production can also be triggered by antigens which induce its production and release 
from T lymphocytes as part of the specific immune response (Barreda, Hanington etal.„
2004).
The tumour necrosis factor (TNFs) cytokine family includes numerous cytokines. TNFs 
include TNF-a (cachectin) which is primarily produced by macrophages, T lymphocytes 
and natural killer cells. TNF-a plays a major role in the inflammatory response *nd 
induce the acute phase reaction with IL-1 and IL-6 , causing fever and cachexia. The 
anti tumor effects of TNF-a are used in treatment of sarcoma and melanoma patieflts, 
TNF-P (Lymphtoxin-alpha and beta) is secreted by lymphocytes with cytotoxic effects 
on tumors. Fas ligand (FasL or CD95L) is a cytokine that induces cell apoptosis (ViFek 
and Lee, 1991; Suda, Takahashi et al., 1993; van Horssen, Ten Hagen et al., 2006).
Chemokines (CKs) are a family of more than 50 small proteins secreted by a variety of 
cell types. CKs have the ability to chemoattract cells of the immune system to the site of 
infection (Ding, Xiong et al., 2001). IL-8 is a major chemokine produced mainly by 
macrophages and epithelial cells during the inflammatory response. IL-8  attracts 
neutrophils, lymphocytes and basophils to the site of infection (Actor, 2012).
Growth factors (GFs) are a large family of proteins able to stimulate cell proliferation 
and growth, regulate tissue morphogenesis, angiogenesis, cell differentiation, 
maintenance of tissue homeostasis and wound healing. The most important GF is 
Transforming growth factor beta (TGF-P) which is produced by activated Thl cells (T- 
helper), macrophages and NK cells. TGF-P has an anti-inflammatory effect and inhibits 
the inflammatory response in macrophages, attenuates lymphocyte proliferation, and 
promotes wound healing (King, 2013; Peplow and Chatterjee, 2013; Seaman and Gold, 
2013).
Interferons (IFNs) are cytokines with antiviral and antitumor activity. Type I interferons 
include IFN-a, 1FN-P and IFN- cd and these have antiviral activity by preventing viruses 
from replicating within host cells (Fensterl and Sen, 2009). Type II IFNs include IFN-y 
which is secreted primarily by cytotoxic CD8+ T-cells to enhance the presentation of
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antigen to T-helper (CD4+) cells (Helbert, 2006) and increases the bacteriocidal capacity 
of macrophages by inducing RNS through inducible nitric oxide synthase (Lyons, Orloff 
et al., 1992)
1.7 Immune evasion by Staphylococci
The role of the immune system is to eradicate microorganisms and return the body to a 
state of homeostasis. Successful pathogens have however evolved numerous strategies to 
evade eradication and thus allow their successful survival in the host niche.
Strategies of evasion include S. aureus changing its cell membrane charge by 
incorporating positively charged lipoteichoic and teichoic acid in the cell wall which 
increases electrical dissonance with the cationic AMP (Peschel, Otto et al., 1999). 
Secretions of proteolytic enzymes which inactivate AMP, and down regulate bacterial 
surface binding proteins prevent AMP effects (Sieprawska-Lupa, Mydel et al., 2004). 
Furthermore, S. aureus secretes proteins that inhibit complement activation and 
neutrophil chemotaxis and lyse neutrophils (Foster, 2005). Also, S. aureus expresses a 
number of exotoxins with superantigen properties that alter the humoral immune 
response, resulting in immunosuppression (Foster, 2005; Iwatsuki, Yamasaki et al.,
2006).
In addition, some bacteria prevent recruitment of phagocytes to the site of infection by 
interfering with the chemoattractants IL-8  and complement component C5a. This is 
accomplished in many strains of S. aureus by production of the chemotaxis inhibitory 
protein (CHIPS), which binds to the leukocyte receptors for C5a, preventing attachment 
of specific chemo attractants (Postma, Poppelier et al., 2004; Edwards, Taylor et al.,
2005).
Other strategies by which 5. aureus evade the innate immune system are by secreting a 
number of other proteins. The extracellular complement-binding protein (Ecb) impairs 
complement activation by binding to the C3d domain of C3. The effect of this is to 
inhibit C3 convertases (alternative pathway) and C5 convertases (all complement 
pathways) and block C5a formation. The extracellular fibrinogen-binding protein (Efb)
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also blocks both complement activation and neutrophil adhesion to fibrinogen (Hammel, 
Sfyroera et al., 2007; Jongerius, Kohl et al., 2007).
1.8 Staphylococcus epidermidis interaction with innate immune system
It is well established that a biofilm growth phase protects bacteria within the polymeric 
matrix from the phagocytic effect of polymorphonuclear neutrophils (Rodgers, Phillips 
et al., 1994; Vuong, Voyich et al., 2004). To date, knowledge on the effect of 
phagocytes on S. epidermidis biofilms, is largely confined to PIA interactions. These 
studies have identified two contrasting roles for PIA-one of ‘immune priming’ and the 
other of ‘immune evasion’. This situation is often complicated by the fact that priming 
and evasion can often be measured simultaneously in the same model. Thus, Stevens and 
co-workers (Stevens, Sadovskaya et al., 2009) showed that purified PIA could stimulate 
IL-8  production through toll-like receptor- 2 (TLR-2). Granslo et al (Granslo, 
Klingenberg et al., 2013) also found that the PIA biofilm forming strain of S. 
epidermidis (1457) induced higher IL-8  and IL-6  secretion, but less complement 
activation in neonatal cord blood compared to adult blood. Kristian et al (Kristian, 
Birkenstock et al., 2008) demonstrated induction of complement component 3, but 
decreased deposition of C3b and IgG on the bacterial surface. Similar findings were 
confirmed by Fredheim et al who showed that PIA induced complement activation 
together with a simultaneous decrease in the activation of granulocytes (Fredheim, 
Granslo et al., 2011). Furthermore, a study by Heinzelmann et al (Heinzelmann, Herzig 
et al., 1997) showed that planktonic, slime-producing S. epidermidis RP62A induced 
increased phagocytosis and production of reactive oxygen intermediates (ROI) during 
oxidative burst by PMNs compared with its non-slime-producing phenotypic variant 
RP62A-NA. The importance of the specific mechanism of biofilm accumulation was 
confirmed by Schommer et al (Schommer, Christner et al., 2011) who demonstrated that 
PIA, Aap and Embp dependent S. epidermidis biofilms can escape phagocytic uptake by 
macrophages and reduce NF-kB activation and IL-ip production. Clinical studies also 
support the case that immune evasion by biofilm positive strains could be due to an 
attenuated immune response. In an ex vivo study using whole cord vein blood from term 
and preterm infants, Hartel et al found significant decreases in IL-6  production from
33
whole blood culture infected with a biofilm positive S. epidermidis compared to those 
infected with biofilm negative strains (Hartel, Osthues et al., 2008). In addition, lower 
C- reactive protein (CRP) levels have been detected in serum samples of neonates 
infected with biofilm positive S. epidermidis sepsis (Klingenberg, Aarag et al., 2005).
Animal models also suggest a survival advantage of S. epidermidis biofilm positive 
strains. Begun et al (Begun, Gaiani et al., 2007) showed that PIA-producing S. 
epidermidis has a significant survival advantage over /ca-deficient S. epidermidis within 
the intestinal tract of the nematode Caenorhabditis elegans. Similarly, in models of 
mouse biomaterial associated infection and rat intravascular catheter related infection 
PIA positive S. epidermidis caused a more severe infection than its isogenic mutant 
(Rupp, Ulphani et al., 1999a; Rupp, Ulphani et al., 1999b; Rupp, Fey et al., 2001).
To date, few clinical studies have assessed the function of leukocytes isolated from 
patients suffering from biofilm positive S. epidermidis directly. However studies in 
patients with post-traumatic osteomyelitis, where a high percentage of isolates are 
Staphylococci, show that neutrophils migrate to the infection site but are unable to 
control the infection and instead cause tissue damage due to excessive release of 
superoxides (Wagner, Deppisch et al., 2003; Wagner, Kaksa et al., 2004; Wagner, 
Hansch et al., 2006). In an in vitro catheter infection, Leid et al showed that leukocytes 
penetrated S. aureus biofilm, but were unable to engulf and kill bacteria (Leid, Shirtliff 
et al., 2002). Interestingly, Guenther et al found that the neutophils response to S. aureus 
biofilm differed to that of S. epidermidis biofilm. Time-lapse video demonstrated that 
neurophils could pass through S. aureus biofilm and phagocytose bacteria while they 
became paralysed when in contact with S. epidermidis biofilm. Furthermore, S. aureus 
biofilm induced apoptotic killing in 80% of neutrophils in comparison to S. epidermidis 
for which this figure was 50%. The effect seen with S. epidermidis was due to 
phagocytosis of biofilm cells and not due to associated toxic effects (Guenther, Stroh et 
al., 2009). Finally, implanted medical devices in osteomyelitis associated with biofilm 
formation lead to T lymphocytes activation and infiltration to the sites of infection with 
excessive synthesis of IFN-y which activate phagocytic cells (Wagner, Heck et al., 2006; 
Kotsougiani, Pioch et al., 2010).
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1. 9 Aims of the study
Both in vitro and in vivo studies suggest a role for S. epidermidis derived PIA in immune 
priming and evasion. To date, the physiological/pathological conditions that determine 
which of those responses predominates and whether PIA is produced at all is unknown. 
Furthermore, very little data is available on the physiological cues responsible for PIA 
production.
This thesis uses a cell biology approach;
i) To compare PIA production and biofilm formation in S. epidermidis cultured in 
cell culture media and human serum versus traditional broth culture.
ii) To investigate the inflammatory response produced by purified PIA and PLA 
dependent biofilm using in vitro and ex vivo modelling in both a macrophage cell 
line and whole blood.
Specifically the thesis has been organized as follows:
• In chapter 3 the nutrients necessary for PIA production will be identified.
• In chapter 4 PIA will be purified in cell culture media supporting biofilm 
formation.
• In chapter 5 the effect of soluble, cell-associated and biofilm- associated PIA on 
THP-1 cells will be studied thereby identifying the importance of tethering for 
cytokine production.
• In chapter 6  the effect of soluble, cell-associated and biofilm-associated PIA on 
whole blood will be analysed and along with the importance of humoral 
immunity, C5a and immunosuppression.
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Chapter 2
Materials and Methods
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2.1 Chemicals and reagents
2.1.1 Chemicals
Table 2.1: Chemicals used in this study
Chemicals Sources
Triton X-100 Sigma Aldrich
Trypan Blue Fisher Scientific
Tween 2 0 Sigma Ultra
Trisbase Fisher Scientific
Sodium nitrite (NaN0 2 ) Sigma Aldrich
Iron chloride hexahydrate (FeC U ^O ) Sigma Aldrich
Picric acid VWR/PROLABO
Acetic acid glacial Fisher Scientific
37% Formaldehyde Fisher Scientific
Sodium chloride (NaCl) Fisher Scientific
Disodium hydrogen (Na2HPC>4) Fisher Scientific
Potassium dihydrogenphosphate (KH2PO4) Fisher Scientific
Ammonium sulfamate Sigma Aldrich
Saturated Phenol VWR international LTD
Crystal violet ACS reagent Sigma Aldrich
Glycerol Sigma Aldrich
Agar bacteriological Oxoid
Sodium azide (NaNs) Fisher Scientific
Sure Blue TMB 1-component Microwell Peroxidase KPL/Insight Biotechnologies
Bradford Reagent Sigma Aldrich
3-Methyl-2-benzothiazolonehydrazone 
hydrochloride (MBTH)
Sigma Aldrich
Hydrochloric acid (HC1) Sigma Aldrich
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Bovine serum albumin fraction v Fisher Scientific
Fixing solution (Methyl alcohol) Merck Millipore
Color reagent red (eosin) Merck Millipore
Color reagent blue (azur) Merck Millipore
2.1.2Enzymes
Table 2.2: Enzymes used in this study
Enzymes Sources
Dispersin B Gift from Kaplan JB (Kaplan 2009)
Trypsin Invitrogen
2.1.3. Fluorescent stains
Table 2.3: Reagents used for fluorescent staining experiments
Fluorescent stain Source
SYT09 Invitrogen
Rhodamine-conjugated Wheat Germ Agglutinin Invitrogen
Propidium iodide Invitrogen
AlexaFluor 488 Invitrogen
Cell mask cell membrane stain Invitrogen
38
2.1.4 Blocking Antibodies
Table 2.4 Blocking antibodies used in this study
Blocking Antibodies Sources
Antihuman CD1 lb Biolegend
Antihuman CD 18 Biolegend
Antihuman CD 16 Biolegend
Mouse IgG, K Isotype Biolegend
2.1.5 Miscellaneous materials
Table 2.5: Miscellaneous materials used in this study
Materials Sources
Nunclon cell culture plates (6 , 24, and 96) wells Thermo Scientific
Microplate, 96 well, half-area, flat bottom for ELISA Greiner bio-one
Disposable sterile cell lifters Fisher Scientific
Cuvettes Fisher Scientific
Vectashield mounting medium for fluorescence Vector
Single use syringe filter 0.45pm Sartorius stedim
DPX Mountant for histology Sigma Aldrich
Shandon cytoclip Thermo Scientific
Shandon single cytofunnel Thermo Scientific
Shandon Filter card Thermo Scientific
Shandon* Single Cytofunnel* with white filter cards Thermo Scientific
FACS Lysis solution for lysing whole blood BD Biosciences
Centrifugal filter units Millipore (3K, 10K, and30K) Amicon Ultra
Combitips plus 1.0 ml Eppendorf
ELISA Kits R and D system
RayBio Human Cytokine Antibody Array Ray Biotech
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NUNC NUNCLON cell culture dishes 100mm Invitrogen
L-Glutamine Invitrogen
Penicillin/S treptomycin Invitrogen
Cytochalasin D Sigma Aldrich
Anti-rabbit IgG, HRP-linked Antibody Sigma Aldrich
The Pierce LAL Chromogenic Endotoxin 
Quantitation kit
Thermo Scientific
2.2 Instruments
Table 2.6: Instruments used in this study
Instruments Sources
Light Microscope Zeiss Axio vision
Epi-fluorescent Microscope Zeiss Axio vision
Confocal Laser Scanning Microscope Carl Zeiss
Fluo Star Plate Reader Omega Fluo Star
Centrifuge Eppendorf Centrifuge 581 OR
Digital dry bath Jencons-PLS
CO2 Air Jacketed incubator supply NUAIRE
Shandon Cytospin Cytocentrifuge Thermo Scientific
Cell culture Hood ScanLAF cell culture hood Mars
Sonicator Branson digital Sonifer
Vacuum system Vacusafe Comfort
Axiovert 40C Inverted Microscope Carl Zeiss
Avanti J-20XP Centrifuge Beckman Coulter
Rotator Stuart
Gel Doc Chemiluminescence imaging 
system
BIO-RAD
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2.3 Staphylococci used in this study
2.3.1 Staphylococcus epidermiduis strains used in this study
Table 2.7: S. epidermidis strains used in this study were:
Strain Source Biofilm
accumulation
Reference
1457 Central venous catheter infection PIA dependent Mack et al. (1992)
1457-M10 A PIA negative isogenic mutant of 
strain 1457 that was produced by 
insertion of transposon T n9/7 at 
nucleotide 931 in the icaA gene of 
the icaADBC gene locus
Biofilm negative Mack et al. (1999)
8400 Central venous catheter infection, 
biofilm positive, and PIA positive
PIA dependent Mack et al. (1992)
9142 Central venous catheter infection, 
biofilm positive, and PIA positive
PIA dependent Mack et al. (1992)
5179 CSF-Shunt Infection, biofilm 
negative, and PIA negative strain; 
/caA:IS257
Biofilm negative Mack et al. (1992)
5179-R1 Biofilm positive revertant of the 
respective parent strain
Aap dependent Mack et al. (1992)
1585 Isolated from port-catheter 
infection; biofilm negative, Aap 
negative, icaADBC negative and 
PIA negative
Biofilm negative Rohde et al. (2005)
1585-RA Biofilm positive revertant of the 
respective parent strain
Embp dependent Rohde et al. (2005)
2.3.2 Staphylococcus aureus strain used in this study
S. aureus Cowan I strain used in this study which obtained from human, from septic 
arthritis fluid, was obtained from H PA cultures.
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2.4 Cell sources
• Human monocytic cell; THP-1 cell line, derived from the peripheral blood of a 1 
year old male with acute monocytic leukaemia (Tsuchiya, Yamabe et al. 1980; 
Tsuchiya, Kobayashi et al. 1982).
• Whole blood from healthy volunteers.
2.5 Media
2.5.1 Tryptose Soy Media (TSB) based broth (+/- Dextrose)
Thirty grams of TSB powder (+/- Dextrose) was added to 1000 ml of distilled water 
(dHzO) mixed, and autoclaved in a pressure vessel autoclave at 121°C for 20 minutes 
and then stored at room temperature.
2.5.2 Cell culture media
Five different cell culture media were used in this study all obtained from Invitrogen: 
Iscove's Modified Dulbecco's Media (IMDM), Dulbecco's Modified Eagle Medium 
(DMEM), Dulbecco's Modified Eagle Medium: Nutrient Mixture F-12 (DMEM/F12), 
Roswell Park Memorial Institute media with GlutaMAX (RPMI+), and Roswell Park 
Memorial Institute media without glutamine (RPMI-). Table 2.8 summaries media 
specification.
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Table 2.8 Cell culture media formulations:
Components IMDM
21056-023
DMEM 
41965- 039
DMEM/F12
31331
RPMI+1640 
72400- 021
RPMI-1640 
31870- 025
Amino acids
Glycine + + + + +
L-Alanine + +
L-Alanyl -L-Glutamine + +
L-Arginine hydrochloride + + +
L-Arginine + +
L-Asparagine-H20 + +
L-Asparagine + + +
L-Aspartic acid + + + +
L-Cysteine hydrochloride +
L-Cystine 2HCL + + +
L-Cystine + +
L-Glutamic acid + + + +
L-Glutamine + +
L-Histidine hydrochloride 
H2o
+ + +
L-Histidine + +
L-Hydroxyproline + +
L-Isoleucine + + + + +
L-Leucine + + + + +
L-Lysine hydrochloride + + + + +
L-Methionine + + + + +
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L-Phenylalanine + + + + +
L-Proline + + + +
L-Serine + + + + +
L-Threonine + + + + +
L-Tryptophan + + + + +
L-Tyrosine disodium salt + +
L-Tyrosine + + +
L-Valine + + + + +
Vitamins
Biotin + + + +
Choline chloride + + + + +
D-Calcium pantothenate + + + + +
Folic acid + + + + +
Niacinamide + + + + +
Para-Aminobenzoic Acid + +
Pyridoxal hydrochloride + + + + +
Riboflavin + + + + +
Thiamine hydrochloride + + + + +
Vitamin B12 + + + +
i-Inositol + + + + +
Inorganic Salts
Calcium chloride + + +
Calcium nitrate + +
Cupric sulfate +
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Ferric Nitrate + +
Ferric sulfate +
Magnesium Chloride +
Magnesium Sulfate + + + + +
Potassium Chloride + + + + +
Potassium Nitrate +
Sodium Bicarbonate + + + + +
Sodium Chloride + + + + +
Sodium Phosphate 
monobasic
+ + +
Sodium Phosphate dibasic + + +
Sodium Selenite +
Zinc sulfate +
Other components
D-Glucose + + + + +
Glutathione + +
HEPES + +
Sodium Pyruvate +
Phenol Red + + + +
Hypoxanthine Na +
Linoleic Acid +
Lipoic Acid +
Putrescine 2HCL +
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2.6 Agar
2.6.1 TSB agar plates
Thirty grams of TSB powder and lOOg agar (1%) was added to 1000 ml of dH20, mixed 
together, and then autoclaved at 121°C for 20 minutes. The agar was cooled to around 
50°C, then poured into sterile plates and placed stored inverted at 4°C.
2.6.2 Columbia blood agar with horse blood
Ready-made blood agar plates were used in this study (Oxoid).
2.7 Buffers and Stains
2.7.1 Phosphate buffered saline (PBS)
Eight grams of sodium chloride (NaCl), 0.2g of potassium chloride (KC1), 1.44g sodium 
phosphate (Na2H P04) and 0.24g potassium phosphate (KH2P 0 4) were mixed with 1L 
dH20  before autoclaving and storage at room temperature.
2.7.2 1M Tris-HCl, PH=7.5
Prepared by adding 2.36g of Trisbase, 12.7 g Tris-HCl to 89ml dH20 , then autoclaved 
and stored at room temperature.
2.7.3 Sodium Phosphate buffer pH=7.5
Two solutions were prepared separately and then combined:
Stock solution A; 2M monobasic sodium phosphate / sodium dihydrogen NaH2P 0 4.2H2O, 
78.005g was added to 250 ml of dH2 0
Stock solution B;2M dibasic sodium phosphate /disodium hydrogen Na2H P04. I2H2O, 
179.07g was added to 250 ml dH20
Then 16ml of solution A was mixed with 84 ml of solution B and corrected to pH =7.5, 
then diluted to 200ml to give a 1M phosphate buffer.
2.7.4 ELISA wash buffer
Prepared by adding 500pl Tween 20 and 8gNaCl to 500ml PBS.
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2.7.5 RBC Lysis Buffer pH=7.5
Prepared by dissolving 4.15g Ammonium Chloride in 50ml 0.1M Tris HCL. The 
solution was then adjusted to 500ml with dHzO.
2.7. 6 Reagent diluent
Prepared by dissolving 0.1% BSA and 0.05% Tween 20 in Tris-buffer saline, pH 7.2- 
7.4.
2.7.7 Triton 1%
One ml of Triton X-100 was added to 100ml of PBS and then filtered sterilised.
2.7.8 Phenol
Five milliliters of phenol was dissolved in 95ml dH2 0  to generate a 5% phenol solution.
2.7.9 Bouin's fixative
In a fume hood, 7.5ml of picric acid, 2.5ml of 40% paraformaldehyde, and 0.5ml of 
concentrated glacial acetic acid were mixed together and the fixative used immediately.
2.7.10 Crystal violet
Prepared by adding O.lg of crystal violet to 100ml dHzO. The stored bottle was covered 
with foil to avoid light exposure.
2.8 Microbiological Methods
2.8.1 Biofilm assay
A single bacterial colony was picked from a blood plate and suspended in 5 ml of TSB 
broth and then incubated at 37°C for 18 hours with shaking at 200rpm. Subsequently 
pre-culture was diluted (1:100) with fresh TSB, and 200pl aliquoted into each well of 
NUNC 96-well plate. The plate was incubated for 18 hours at 37°C without shaking. 
After incubation the media was carefully removed and the wells washed (X3) with 
200pl PBS. In a fume hood, 150pl of Bouin's fixative was added to each well and 
incubated for 15 minutes. The Bouin's fixative was removed and the wells washed once 
with PBS and left to air dry. Adherent biofilms were then stained with 150pl of crystal 
violet for 5 minutes, and washed (X5) under running tap water and left it to air dry. The
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optical density of biofilms was measured at 570 nm using an Omega Fluo Star plate 
reader.
2.8.2 Determination of bacterial growth
A single bacterial colony was picked from a blood plate and suspended in 5 ml of TSB 
broth and then incubated for 18 hours. The pre-culture was diluted (1:100) with fresh 
TSB or cell culture media (IMDM, DEMEM/F12, and RPMI-) and 200pl aliquoted into 
a 96-well plate and incubated for 18 hours at 37°C. The optical density of each well was 
then determined using an Omega stare plate reader at 600nm.
2.8.3 Determination of viable counts (colony forming units)
Experimental samples (whether in TSB, cell culture media, blood or serum) were diluted 
50:50 in 0.2% triton and pipetted gently for 10 seconds. Serial dilutions ranging from 
101 -106 (depending on specific experiment) were generated. A 50pl volume of the final 
2 dilutions were spread using a sterile disposable spreader on a TSB agar plate in 
duplicate. Plates were incubated overnight at 37°C and the viable count then determined 
by enumerating visible colonies.
2.8.4 Preparation of crude overnight culture supernatants
Overnight cultures of S. epidemidis 1457 and its isogeic mutant S. epidermidis 1457- 
M10 in IMDM were sonicated twice at 70% power for 10 seconds, centrifuged at 
4000rpm for 30 minutes. The supernatant was then decanted and filtered with 0.45pm 
syringe filter.
2.8.5 Bradford protein assay
The Bradford assay (Bradford 1976; Redinbaugh and Campbell 1985) was done using 
bovine serum albumin (BSA) as a standard protein. One hundred microlitres of Bradford 
Reagent was added to each well of a 96 well plate pre-coated with different 
concentration of pooled human serum. The preparation was incubated for 5 minutes and 
absorbance read on a plate reader at OD= 595 nm.
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2.9 Polysaccharide intercellular adhesin (PIA): Purification and 
conformation assays
2.9.1 Purification of PIA from S. epidermidis 1457
Five milliliters of IMDM was inoculated with one colony of S. epidermidis 1457 and 
incubated overnight (18 hours) at 37°C with shaking at 200rpm (Pre-culture). On the 
next day 20ml volume of sterile IMDM was then added to each of 24 sterile NUNC cell 
culture plates. To each plate 200pl of the pre-culture was then added. Plates were 
incubated for 48 hours without shaking at 37°C. Biofilms were removed from the plates 
using a sterile cell scraper and decanted into centrifuge tubes. Bacteria were sedimented 
by centrifugation at 6000rpm (JA 8.1000 rotor) for 30min in two 1L bottles, the medium 
was discarded by inverting the bottles (<30 min to prevent drying out). The cell pellets 
were re-suspended in a combined volume of 20 ml of 50mM Sodium Phosphate Buffer 
(pH=7.5) in a 50 ml centrifuge tube and sonicated (X4) on ice with consecutive bursts at 
intervals of 30s at 70% power (Branson Digital Sonifier). Bacteria were sedimented at 
4000 rpm for 15 min and the supernatant transferred (containing PIA) to a 50ml tube. 
Supernatant was aliquoted to 2 ml microcentrifuge tubes and any remaining bacteria / 
debris were sedimented by centrifugation at 12000rpm for 5 min in a minifuge, prior to 
filter sterilization (0 .2 2 pm).
The PIA supernatant was concentrated 5 fold by using centrifugal filter units millipore 
(Amicon Ultra) by centrifugation at 3000 rpm in 10 min intervals. It was found that 5ml 
of PIA preparation took 10 minutes to run through the amicon. Then two Q-Sepharose 
anionic exchange columns were prepared by adding filter disks to two PD-10 columns 
and a packed bed of 7 cm was generated.
The columns were equilibrated with at least 20ml of 50mM Sodium Phosphate buffer 
(pH=7.5). A 2 ml PIA preparation was gently applied and allowed to flow into each 
column. Fifteen consecutive 2ml fractions were then taken by washing successive 2ml 
fractions of 50mM sodium phosphate buffer through the column. PIA fragment 1 does 
not bind to this column so will elute in fractions following the void volume (Vo). 
Experiments demonstrated PIA was in fractions 3-7 giving 5 fractions per column in a 
volume of 2 0 ml.
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2.9.2 PIA confirmatory assay
PIA confirmatory assays were done to test all the primary fractions before testing pooled 
fractions with higher titers for PIA. Assays included: PIA ELISA, Co-agglutination 
assay, Hexosamine assay and Hexose assay.
2.9.2.1 PIA ELISA
2.9.2.1.1 Optimization of PIA ELISA
PIA ELISA confirmatory assay performed on the pooled fractions of two preparation 
(PI and P2) of PIA obtained from growing of S. epidermidis 1457 (PIA/biofilm+) in 
TSB and one preparation of S. epidemidis 1457-M10 (PLA/biofilm-) which used as 
negative control (NC). However the ELISA readings were high even in the negative 
control extract and so an attempt to optimize PIA ELISA was performed by changing 
the block (Bovine serum albumin (BSA) is the usual block) and the concentration of the 
primary antibody (anti-PIA antibody usual dilution 1:800 in PBS) and the dilution of the 
secondary antibodies (anti-rabbit IgG HRP antibody usual dilution 1:2000 in PBS).
Optimization of the block
One hundred microlitres per well of 4% BSA in PBS was the usual block for PIA 
ELISA. However different types of block were investigated including dried Milk and 
Fetal bovine serum (FBS) in addition to BSA. BSA, milk and FBS were used at 4%. 
Pooled fractions of PIA were obtained from growing S. epidermidis 1457 
(PLA/biofilm+) in TSB diluted 1:500, the negative control extract (NC) obtained from S. 
epidermidis 1457-M10 (PLA/biofilm-) was used with the same dilution. The best block 
was still 4% BSA in compared to milk and FBS as shown in Table 2.9, BSA shows the 
highest reading in fractions 3-7 in compare to milk and FBS when read by the 
microplate reader.
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Table 2.9 The PIA ELISA blocked with BSA, milk and FBS.
BSA
Fractions 1457 (Pl)/nm 1457 (P2)/nm 1457-M10/nm
1-2 0.452 0.368 0.355
3-7 1.276 0.974 0.369
8 -1 0 0.442 0.37 0.395
11-15 0.379 0.394 0.452
Milk
Fractions 1457 (Pl)/nm 1457 (P2)/nm 1457-M10/nm
1-2 0.363 0.334 0.291
3-7 0.823 0.584 0.296
8 -1 0 0.331 0.305 0.335
11-15 0.319 0.317 0.371
FBS
Fractions 1457 (Pl)/nm 1457 (P2)/nm 1457-M10/nm
1-2 0.314 0.37 0.328
3-7 1.241 0.821 0.36
8 -1 0 0.406 0.343 0.422
11-15 0.373 0.379 0.445
Optimization of PIA ELISA antibody conditions
ELISA optimization was further investigated by adjusting detergent and secondary 
antibody concentration. The ELISA plate was prepared as before with samples diluted 
1:500, blocked with 4% BSA and treated with three different detergent concentrations; 
PIA without Tween, PIA with 0.05% Tween and PIA with 2% Tween. Furthermore, 
secondary antibody dilutions of anti-rabbit antibody were investigated from 1 /2 0 0 0  to 
1/5000. The 0.05% and 2% Tween had a mild inhibitory effect on the readings of the 
PIA extract and NC extract by the plate reader. Increasing the dilution of secondary anti 
body (anti rabbit) to 1/5000 decreased the reading of the extract and thus the background 
signal (that can be seen in the second column) as in Table 2.10.
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Table 2.10 Optimization of detergent and secondary antibody concentration
1457/PI
fraction
PIA
without Tween/nm
PIA
0.05% Tween/nm
PIA 
2% Tween/nm
1-2 0.225 0.178 0.172
3-7 1.677 1.586 1.454
8-10 0.399 0.332 0.275
11-15 0.286 0.192 0.184
1457/P2
fractions
PIA
without Tween/nm
PIA
0.05% Tween/nm
PIA 
2% Tween/nm
1-2 0.168 0.186 0.195
3-7 1.12 1.248 1.231
8 -1 0 0.151 0.182 0.178
11-15 0.181 0.183 0.187
1457-M10
fractions
PIA
without Tween/nm
PIA
0.05% Tween/nm
PIA 
2% Tween/nm
1-2 0 .2 2 2 0.198 0.171
3-7 0.19 0.214 0.119
8-1 0 0.249 0.226 0.218
11-15 0.215 0.192 0.192
Optimization of primary anti-PIA antibody
In order to define the optimal concentrations of anti-PIA antibody for use in the ELISA, 
various dilutions of anti-PIA antibody were added to PIA ELISA plate whilst 
maintaining all other condition constant; i.e. blocking with 4% BSA, use of anti-rabbit 
antibody diluted 1/5000 and the test samples diluted 1:500.
The 1/8000 dilution of anti-PIA antibody proved the optimal dilution; as the reading 
were high in the 3-7 fractions ( 3rd column) which should contain PIA extract obtained 
from S. epidermidis 1457 whilst the readings were low in all negative control extracts 
(NC) as in Table 2.11.
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Table 2.11 Optimization of anti PIA antibody concentration
Dilution
of
primary
antibody
Fractions 
1-2 /PIA 
nm
Fractions 
3-7/ PIA 
nm
Fractions
8-10/PIA
nm
Fractions 
1-2/NC 
nm
Fractions 
3-7/NC 
nm
Fractions 
8-10/NC 
nm
1 /1000 1.882 2.857 2.473 2.317 2.113 2.383
1 /2000 1.29 3.255 1.279 1.172 2.277 1.348
1/4000 0.596 2.483 0.639 0.577 0.762 0.665
1/8000 0.304 1.308 0.295 0.287 0.281 0.277
1/16000 0.15 0.677 0.155 0.132 0.141 0.14
1/32000 0.083 0.404 0.083 0.084 0.087 0.084
1/64000 0.05 0.199 0.052 0.05 0.053 0.054
1/128000 0.048 0.143 0.048 0.049 0.05 0.044
2.9.2.1.2 Optimized PIA ELISA
Fifty microlitres of sample (PIA extract and NC extract) was added to a 96-well flat 
bottom half area plate and incubated over night at 4° C. This was then washed 3 times 
with 120 pi of ELISA wash buffer. Then 100 pi of BSA (4%) in PBS was added and 
incubated for lh. The preparation was washed 3 times with 120 pi buffer before 50 pi of 
primary rabbit anti-PIA antibody (diluted 1/8000 in PBS) was added and incubated for 
lh. Plates were washed 3 times with 120 pi buffer, before 50 pi of secondary antibody 
(anti-rabbit HRP diluted 1/5000 in PBS) was added and incubated for lh. Plates were 
washed 3 times with 120 pi buffer, before 50pl of TMB substrate was added. The plate 
was incubated for up to 30 minutes in the dark and then 50pl of stop solution (1M 
H2S 04) was added before the plate was read at OD45onm by the Omega plate reader.
2.9.2.2 Detection of PIA by coagglutination in bacterial extracts 
Preparation of S. aureus Cowan I for coagglutination
A bacterial colony of S. aureus Cowan I was inoculated into 5ml TSB and allowed to 
grow overnight. A 5 ml volume of this pre-culture was then inoculated into 800ml of 
TSB and incubated for 20h at 37°C with shaking. Bacterial cells were sedimented by 
centrifugation at 6000rpm for 30min in 1L bottles (JA 8.1000 rotor) and the pellets 
washed twice in PBS containing 0.05% NaN3. The wet weight of the cell pellet 
(approximately 5.5g) as suspended to a density of 10% (w/v) in the same buffer.
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Formaldehyde was added to a final concentration of 1.5% and cells were gently mixed 
on a magnetic stirrer for 90 minutes at room temperature. Cells were sedimented, by 
centrifugation at 4000rpm and suspended in the same volume of buffer as described 
above, before being transferred to a glass beaker. The cell suspension was heated in a 
water bath at 80°C for 5 min before being cooled rapidly in an ice bath. Cells were 
washed twice in PBS containing 0.05% (w/v) NaN3, and weighed. A 3 gram pellet was 
suspended in the same buffer at a concentration of 10% (w/v). Suspensions were stored 
in 1 ml volumes at -80° until use.
Preparation of coagglutination reagent
On milliliter of S. aureus Cowan I suspension was centrifuged at 12000 rpm for 5 
minutes and the pellet washed twice in PBS containing 0.05%(w/v) NaN3 and re­
suspended in 900 pi of the same buffer. Rabbit anti-PIA antiserum (lOOpl) (Mack, 
Siemssen et al., 1992) was added and incubated at room temperature for 15 min with 
occasional mixing. Then the sensitized S. aureus Cowan I cells were sedimented in a 
microcentrifuge (13000 rpm for 1 min) and washed three times with PBS containing 
0.05% (w/v) NaN3. Finally, the sensitized cells were re-suspended in 10 ml of PBS 
containing 0.05% (w/v) NaN3 and stored at 4°C for a maximum of 2 weeks.
Detection of PIA by coagglutination in bacterial extracts
Five microliters of purified PIA fractions were mixed with 15 pi of coagglutination 
reagent on microscope slides. One standard microscope slide allowed three different 
samples to be tested simultaneously. Then the slides were inverted back and forth for 3 
minutes and agglutination evaluated in bright light against a dark background. Controls 
included bacterial extracts from PLA negative strains (e.g. S. epidermidis 1457-M10) and 
PBS. These were used to evaluate the cutoff point for positive coagulation. Quantitation 
of antigen in bacterial extracts was performed by analysis of serial 2 -fold dilutions of 
the respective extracts in PBS and the antigen titers were defined as the highest dilution 
displaying a positive coagulation test.
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2.9.2.3 Hexosamine assay (Smith and Gilkerson 1979)
N-acetylglucosamine used as a positive control in concentration of 1000|ig/ml, then a 
1:2 serial dilution done to create a standard curve. Two hundred microliters of standard 
samples and purified PIA were decanted to small glass bottles with lids before adding 
200 pi of 0.5M HC1. Bottles were vortexed and heated to 110°C for 2 h. Samples were 
then cooled to room temperature in a water bath. Within a fume hood, 400 pi of 2.5% 
NaNC>2 was added, vortexed and allowed to stand at room temperature for 15 minutes. 
Following this, 200 pi of 12.5% ammonium sulfamate was added and the bottles 
vortexed, and allowed to stand at room temperature for 5 minutes, to allow the liberation 
of excess NaNC>2. Then 200pl of 0.25% 3-Methyl-2-benzothiazolonehydrazone 
hydrochloride (MBTH) was added and the bottles, vortexed before incubating at 37°C 
for 30 minutes. Finally 200 pi of 0.5% FeC^ was added and incubated at 37°C for an 
additional 5 minutes, before allowing the samples to cool to room temperature. The 
optical density of the solutions was determined at 650 nm in an Omega plate reader.
2.9.2.4 Hexose assay
Two hundred microliters of samples, glucose as standard (containing up to lOOpg 
carbohydrates) or control solutions were mixed with 200pl of 5% phenol. Then, 1 ml of 
concentrated sulphuric acid was rapidly added directly to the solution surface without 
touching the sides of the tube. Solutions were left undisturbed for 10 minutes before 
shaking vigorously and further incubated for 30 minutes before the determination of 
absorbance at 490nm.
0 H--------- 1--------- 1--------- \--------- 1--------- 1--------- 1--------- 1
0 10 20 30 40 50 60 70
c o n c e n t r a t io n  (^ ig /m l)
Figure 2.1 Standard curve of Hexose assay.
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2.9.2.5 Lipopolysaccharide (LPS) detection assay
The Pierce LAL Chromogenic Endotoxin Quantitation kit was used to measure the 
amount of lipopolysaccharide (LPS) in the purified PIA samples.
The kit contains the following reagents: Escherichia coli endotoxin standard, 
lyophilized, reconstituted in 1ml of endotoxin-free water provided with the kit to 
working concentrations of 15-40 EU/ml (one endotoxin unit/mL (EU/mL) equals 
approximately 0.1 ng endotoxin/mL of solution). Limulus Amebocyte Lysate (LAL), 
lyophilized, 2 vials, reconstituted immediately before use with 1.4mL/vial of endotoxin- 
free water. Chromogenic substrate contains ~7mg of lyophilized substrate, 1 vial, 
reconstituted with 6.5ml/vial of endotoxin-free water to yield a final concentration of 
~2mM. The standard stock solutions prepared from the endotoxin standard were with 
final endotoxin concentration (1.0, 0.5, 0.25, 0.1) EU/ml.
All reagents equilibrated to room temperature before use, and the microplate 
equilibrated in a heating block for 10 minutes at 37°C. A 50pL of each standard or 
sample was added in replicate into the microplate well, the plate covered with the lid and 
incubated for 5 minutes at 37°C. Then 50pL of LAL was added to each well, plate 
covered with the lid and gently shake the plate on a plate shaker for 10 seconds. The 
plate incubated at 37°C for 10 minutes. Then lOOpL of substrate solution added to each 
well. The plate covered with lid and gently shakes on a plate mixer for 10 seconds. The 
plate incubated at 37°C for 6  minutes. Then 50pL of stop reagent (25% acetic acid) 
added. The plate gently shakes on a plate mixer for 10 seconds. Then absorbance 
measured at 405-4 lOnm on a microplate reader.
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2.10 Immunological methods
2.10.1 DuoSet Enzyme-linked immunosorbant assays (ELISA) development 
system
Six different human ELISAs were used in this study obtained from R and D system; 
these were specific for Human CXCL8/IL-8 , Human IL-1 p/IL-lF2, Human TNF-a, 
Human IL-10, Human complement component C5a, Human CCL17/TARC. Reagents 
for these ELISAS included:
Capture Antibodies: Mouse anti-human IL-8 , IL-lp, and TNF-a (720jig/ml), IL-10, 
Thymus and activation-regulated chemokine (TARC) and C5a (360pg/ml). These were 
reconstituted in 1ml PBS and diluted to working concentrations of 4pg/ml (in PBS) for 
IL-8 , IL-1 P, and TNF-a, 2pg/ml (in PBS) for IL-10 and TARC and lpg/ml (in PBS) for 
C5a.
Detection Antibodies: the following biotinylated detection antibodies were used in the 
ELISA: goat anti-human IL-8  (3.6pg/ml), goat anti-human IL-ip (36pg/ml), goat anti­
human TNF-a (45pg/ml), goat anti-human IL-10 (27pg/ml), goat anti-human TARC 
(18|ig/ml) and mouse anti-human C5a (360pg/ml). Secondary antibodies were all 
reconstituted in reagent diluents provided by the manufacture.
Standards: The following recombinant human standards used in the ELISAS: 
recombinant human IL-8  (1 lOng/ml), recombinant human IL-ip (75ng/ml), recombinant 
human TNF-a (320ng/ml), recombinant human IL-10 (210ng/ml), recombinant human 
TARC (llOng/ml), and recombinant human C5a (130ng/ml) when reconstituted with 
0.5ml reagent diluent. Standard curves had seven points using 2-fold serial dilutions in 
reagent diluent with a high standard of 2000pg/ml for IL-8  and IL-10, 250pg/ml for IL- 
1 p, and lOOOpg/ml for TNF-a and 2000pg/ml for C5a.
Streptavidin-HRP was diluted 1:200 to the working concentration specified on the vial 
using reagent diluent.
57
General method- Fifty-pl of capture antibody previously diluted to the working 
concentration in PBS was added to wells of a 96-well microtiter plate (ELISA half 
plate). The plate was sealed with parafilm and incubated overnight at room temperature. 
Each well was then washed 3 times with 200pl wash buffer (0.05% Tween 20 in PBS, 
pH 1.2-1 A) and remaining wash buffer was then removed by inverting the plate and 
blotting it against clean paper towels. To each well, 150pl of block buffer (1% BSA, in 
PBS with 0.05% NaN3) was added and the plate incubated at room temperature for a 
minimum of 1 hour. The plate was then washed as before. A 50pl volume of samples 
and standards were then added to appropriate wells, the plate was then covered with 
parafilm and incubated for 2 hours at room temperature. The plate was washed as before 
prior to adding 50pl of the detection antibody to each well. The plate was again covered 
with parafilm and incubated for 2 hours. The plate was washed prior to adding 50pl of 
the working dilution of Streptavidin-HRP to each well. The plate was covered and 
incubated for 20 minutes in the dark, washed and 50pl of Substrate Solution (1- 
component TMB) added to each well and incubated for 20 minutes at room temperature 
in the dark. Finally, 25pl of stop solution (HC1 44ml water + 4ml 37% HC1) was added 
to each well and the optical density at 450nm of each well determined using a microplate 
reader.
2.10.2 RayBio Human inflammation Antibody Array 3
The RayBiotech system which is able to detect the expression of 42 cytokines in 
samples simultaneously was also used to detect specific cytokines in this study. The 
cytokines antibody array 3 map showed in figure 2.2 . Methodology for this system is 
described below.
Blocking and Incubation
Sample from THP-1 cells in RPMI- media were diluted (1:5) with IX Blocking Buffer. 
Serum samples were diluted 1:10 in IX Blocking Buffer. All membranes were placed in 
an eight-well tray (one/well), which was handled using sterile forceps. Membranes were 
inspected for the (-) mark to ensure correct antibodies orientation prior to being 
completely immersed with 2ml IX Blocking Buffer. The preparation was then incubated 
at room temperatures for 30 minutes. After removing Blocking Buffer, membranes were
5 8
incubated with 1ml of samples at room temperature for 1-2 hours. Samples were 
decanted from each container and washed (X3) with 2ml of IX Wash Buffer I for 5 
minutes with shaking. This was followed by 2 washes with 2 ml of IX Wash Buffer II, 
each time for 5 minutes with shaking. The working solution for primary antibody was 
prepared by adding lOOpl of IX blocking buffer to the Biotin-Conjugated Anti- 
Cytokines tubes. The preparation was mixed and transferred to a tube containing 2ml of 
IX blocking buffer. One milliliter of diluted biotin—conjugated antibodies was added to 
each membrane and incubated overnight at 4°C. The membranes were then washed 3 
times with wash buffer I and twice with wash buffer II. A 2ml volume of 1,000 fold 
diluted HRP-conjugated streptavidin (prepared by adding 2pl of HRP-conjugated 
streptavidin concentrate to 1998pl IX Blocking Buffer) was added to each membrane, 
and incubated at room temperature for 2 hours. Membranes were washed 3 times with 
wash buffer I and twice with wash buffer II as before.
Detection
Membranes were drained of excess wash buffer and placed on a clean plastic sheet. 
Detection Buffer (250pl of IX Detection Buffer C and 250pl of IX Detection Buffer D 
for one membrane) was added to the membrane which was then incubated at room 
temperature for 2 minute. Any excess detection reagent was drained off by holding the 
membrane vertically with a forceps and touching the edge against a tissue. The 
membrane was then placed protein side up, on a piece of plastic sheet and covered with 
another plastic sheet.
Signals from the membrane were detected using a chemiluminescence imaging system 
(Gel Doc with Quantity One software).
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2.11 Cell culture
2.11.1 Culture of THP-1 cells
The human Acute Monocytic Leukemia Cell Line, THP-1, was used in this study. Cells 
were cultured in RPMI- supplemented with 10% FBS, 1% penicillin/streptomycin (P/S) 
and 1 % L-Glutamine, and incubated in a 5% C 0 2 incubator at 37°C.
2.11.2 Thawing stocks of frozen THP-1 cells
Frozen stocks were thawed rapidly at 37°C and transferred to a 50ml centrifuge tube 
containing 30 ml of warm RPMI- media with 1% L-glutamine, 10% FBS and 1% P/S. 
The suspension was mixed gently and centrifuged at 350g for 5 minutes. The 
supernatant was decanted and the washing step repeated again to remove cell debris. 
Cell pellet was re-suspended in 15 ml fresh medium and the cells incubated in a 5% C 0 2 
incubator at 37°C in a NUNC cell culture dish.
2.11.3 Sub-culturing of THP-1 cell
THP-1 cells were sub-cultured every 3-4 days by gently lifting cells using a sterile cell 
scraper. Cells were then transferred to a 50ml centrifuge tube and centrifugated at 350g 
for 5 minutes and the supernatant decanted. Cells were resuspended gently by flicking 
the tube before 5ml of fresh media was added to the cell suspension. Cell viability was 
examined by using a Naubeuer Haemocytometer to calculate the number of the viable 
cell. To determine cell viability, lOpl of cell suspension was mixed with lOpl of Trypan 
Blue and added to the haemocytometer before visualising under a light microscope. 
Viable cell concentrations were estimated by multiplying cell counts by 20,000 and the 
dead cell percentage was calculated by counting clear and blue cells. Cells were seeded 
at a density 2-3x105/ml viable cell in each dish with 15 ml of cell culture media and then 
incubated in 5% C 0 2 incubator at 37°C.
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2.11.4 THP-1 cell killing assay
An overnight culture of S. epidermidis 1457 and S. epidermidis 1457-M10 was re­
suspended to an OD595 = 0.1. A 1:1000 dilution (~1 x 104/ml) of these suspensions was 
made into 3% FBS /IMDM. To 1ml volume of these bacterial suspensions 2xl06 THP-1 
monocyte macrophages was added and incubated for 2 hours. Control cultures at time 
zero and those without macrophages were included. At defined time points, interaction 
mixes were diluted 1:1 with 0 .2 % triton and mixed by pipetting to digest macrophages. 
Dilutions were plated onto TSB agar and incubated overnight at 37°C. Colonies were 
counted and the number used to estimate remaining viable bacteria.
2.11.5 Stimulation of THP-1 cells with bacterial products
2.11.5.1 Cytokine expression in response to challenge with S. epidermidis 
culture supernatant
Various dilutions of crude supernatant (1:5000, 1:500, 1:10 and 1:2.5) pl/ml were added 
to 2xl05 THP-1 cells/500pl of RPMI- containing 10% FBS and 1% L-glutamine and 
P/S. Controls included a time zero sample, a sample containing PBS in place of 
supernatant and finally a sample containing phorbol myristate acetate (PMA) instead of 
supernatant. Supernatants were collected at 6  and 24 hours and ELISA performed as 
described in section 2 .1 0 .1.
2.11.5.2 Cytokine expression in response to PIA challenge
Increasing concentrations of PIA extract (0.5, 1.5, 12, 30, 60pg/ml) were added to 2xl05 
THP-1 cells in 500pl RPMI- containing 1% L-glutamine and 1% P/S and different FBS 
concentration (10%, 3%, 1%). Controls were a time zero sample, a sample with sodium 
phosphate buffer or PMA instead of PIA extract. The plates were incubated at 37°C in 
5% CO2 for 6  and 24 hours, before the media was aspirated and centrifuged at 2000rpm 
for 5 minutes. Supernatants were decanted and stored at -20°C until use. Samples were 
analyzed by ELISA as described in section 2.10.1.
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2.11.5.3 Cytokine expression in response to S. epidemidis 1457 biofilm
Biofilms were prepared in a 24 cell culture plate using a modification to the method 
previously outlined in section 2.8.1. After incubation TSB media was removed and the 
biofilm washed three times with PBS. IMDM containing 5xl05 THP-1 cells, 10% FBS 
and 1 % LG was then added to each well prior to addition of increasing concentrations of 
Dispersin B (Disp.B) (0.001, 0.01, 0.1, lpg/ml). Plates were incubated at 37°C and 5% 
CO2 for 6  hours, before the media was aspirated and centrifuged at 2000rpm for 5 
minutes. The supernatant was decanted and kept frozen at -20°C prior to further use. 
Samples were analyzed for cytokine production by ELISA as described in section 
2 . 10. 1.
2.11.5.4 Cytokine expression in response to planktonic S. epidermidis 
bacteria.
Overnight culture of S. epidermidis 1457 and S. epidermidis 1457-M10 were prepared in 
TSB. After incubation, bacterial suspensions with OD6oonm=l were prepared in IMDM. 
A lOjul volume of this suspension was then added to 500pl of IMDM containing 10%. 
FBS and 1% LG and THP-1 at 5xl05/well in a 24 well cell culture plate. PMA (lOOnM) 
was used as a positive control. Cultures were incubated at 37°C with 5% CO2 for 6  
hours. The media was aspirated and centrifuged at 2000rpm for 5 minutes before the 
supernatant was decanted and frozen at -20°C until use. Samples were analyzed for 
cytokine production by ELISA as described in section 2.10.1.
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2.12 Whole blood methods
2.12.1 Whole blood isolation
Whole blood was collected on the day of the experiment from healthy volunters using 
the vacutte blood collection system with sodium heparin (5ml-9ml). Volunteers gave 
their consent and the work is assessed by the local Human Tissue Act committee at 
College of Medicine, Swansea University.
2.12.2 Whole blood killing
One millilter of blood was added to a 1.5ml microcentrifuge tube. A 10pl volume of S. 
epidermidis 1457 or S. epidermidis 1457-M10 was added directly to blood. The bacterial 
dose used was 1:10,000 dilution of OD6oonm=l of an overnight broth in TSB or IMDM. 
Blood with bacteria was incubated with rotation at lOrpm at 37°C for different time 
points (1,2,3,6,and 24 hours) according to the experiment and viable counts assessed 
according to section 2.8.3. Remining whole blood was centrifuged at 12,000rpm for 5 
min and the platelet poor plasma / serum removed and stored at -20°C prior to further 
analysis.
2.12.3 Pretreatment of whole blood with immunsuppresive agents
2.12.3.1 Pretreatment with dexamethasone
One millilitre of whole blood was placed into a 1.5ml microcentrifuge tube before 
adding different dilutions of Dexamethasone (lmg/ml) in 100% ethanol (1:4, 1:2500, 
1:25000) and incubated overnight with rotation at lOrpm at 37°C. On the next day 
bacteria were added to blood as described in section 2.12.2. Whole blood was incubated 
with rotation (lOrpm) at 37°C for 6 hours and then and then viable counts assessed. 
Platelet poor plasma/serum was isolated as described in section 2.12.2.
2.12.3.2 Pretreatment with cytochalasin D
One millilitre of whole blood was placed in 1.5ml microcentrifuge tubes, and incubated 
with increasing concentration of Cytochalasin D (0.2pg/ml, lpg/ml, 3pg/ml) for 15 
minutes. Bacteria were added to blood as described in section 2.12.2. Whole blood was 
incubated with bacteria on rotation (lOrpm) at 37°C for different time points (3, 6,and 24
6 4
hours) according to our experiment and viable counts were then assessed. Platelet poor 
plasma/serum was isolated as described in section 2.12.2.
2.12.4 Whole blood killing with PIA Extract
One millilitre of whole blood was added to a 1.5ml microcentrifuge tube and incubated 
with purified PIA extract and 5. epidermidis 1457-M10 extract at increasing 
concentration (10, 30, and 60pg/ml) for 3 hours before adding S. epidermidis 1457-M10, 
as described in section 2.12.2. Suspensions were incubated with rotation (lOrpm) at 
37°C for 3 hours and viable counts assessed. Platelet poor plasma/serum was isolated as 
described in section 2.12.2.
2.12.5 Whole blood killing with antibody receptor blocking antibodies
One millilitre of whole blood was added to a 1.5ml microcentrifuge tube, and incubated 
the with anti-human CD1 lb, CD18 and CD16 and their Isotype (all at 2.5jag/ml) for 30 
minutes. Then S. epidermidis 1457 and its isogenic mutant S. epidermidis 1457-M10, 
was added as described in section 2.12.2. Suspensions were incubated with rotation 
(lOrpm) at 37°C for 6 hours and viable counts assessed. Platelet poor plasma/serum was 
isolated as described in section 2.12.2.
2.13 Cytospin preparations
Cytospin preparations were used for phagocytosis and immunocytochemistry assays.
2.13.1 Sample preparation: Two hundred microliters of whole blood was added to 
8ml polystyrene tubes and 3ml of RBC lysis buffer added. Samples were incubated for a 
maximum of 30 minutes at 37°C. Tubes were centrifuged at 700g for 5 minutes, the 
supernatant discarded and 1ml of lysis buffer added. Suspensions were mixed and 
centrifuged as before. The supernatant was discarded and lOOpl of PBS added to the 
tube.
2.13.2 Chamber preparation: A microscope slide was put into the cytospin clip and 
a filter card was positioned between the sample container and the slide before securing 
the stack in place. Then 70-120pl of sample was aliquoted to an upright cytochamber
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prior to inserting it into the cytospin machine. Samples were centrifuged at 300rpm for 3 
minutes prior to removing the filter paper and allowing slides to air dry.
2.14 Hemocolor staining procedure for Microscopy
Slides prepared by cytospin were stained to assess phagocytosis. All the staining was 
done in coplin jars by placing air dried slides in fixative (5 seconds), then blotting excess 
fixative on clean tissue paper. Slides were placed in red color reagent (3 seconds), before 
blotting removed of excess stain. Slides were then placed in blue colour reagent (6 
seconds) prior to blotting removal of excess stain. Finally slides were placed in buffer 
solution (twice over 10 seconds) and left to air dry.
2.15 Immunocytochemistry
Cytospin preperations were blocked with 200pl 1% BSA for 1 hour, then washed X3 
with PBS. A 200pl volume of anti-rabbit PIA antiserum (diluted 1:50) was applied, the 
slides covered and after 30 minutes the slides washed X3 with PBS. Slides were then 
stained with fluorescein-conjugated anti-rabbit IgG (Alexa flour 488, diluted 1:100) and 
propidium iodide (PI) (diluted 1:1000) for 30 minutes. Slides were washed X3 wih PBS 
then 25pl of vectashield hardset was added. Preparation was overland with a coverslip 
and left in the fridge to harden.
2.16 Microscopy
2.16.1 Epifluorescent microscopy
Epifluorescent microscopy was used to examine the stained immunocytochemistry slides 
prepared with anti-PIA antibody, anti-Embp antibody and propidium iodide (PI) to 
detect the S. epidermidis biofilm formation in different physiological media and at 
different time points.
66
2.16.2 Confocal Laser Scanning Microscopy (CLSM)
Confocal laser scanning microscopy was used for characterisation of S. epidermidis 
biofilm structure, charactarisation of S. epidermidis biofilm viability and migration of 
macrophages into preformed biofilm.
Four and 8 well chamber slides were used to stain both S. epidermidis 1457 and 5179- 
R1 strains. Then up to 500pl of a 1:100 dilution of an overnight suspension culture of 
each strain was aliquoted into each well of a chamber slides and incubated at 37°C 
overnight.
2.17 Fluorescent staining
Fluorescent assays were done to differentiate between bacteria and matrix in biofilms 
and to assess bacterial viability.
2.17.1 Fluorescent staining of biofilms
Bacterial biofilms were generated as described in section 2.8.1 and the cells were labeled 
by incubating with Syto 9 (20pM) for 60 minutes. The matrix was stained by incubating 
with rhodamine-conjugated wheat germ agglutinin (which binds to N-acetylglucosamine 
residues in PIA) (20pg/ml) for 60 minutes. Excess stain was removed by three gentle 
washes in PBS. Signal was detected using a plate reader or CSLM at excitation/ 
emission wavelengths of 485/498nm for Syto 9 and 555/580nm for rhodamine.
2.17.2 Live / dead cell staining assay
Biofilms were produced as described in section 2.8.1 and syto 9 staining was similar to 
the above with the exception of the last 5 minutes where propidium iodide (300ng/ml) 
was added. Biofilms were washed gently and then visualised using CSLM at excitation / 
emission wavelengths of 485/498nm for Syto 9 and 535/617nm for propidium iodide.
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2.18 Software programs used in this study: 
Table 2.12 Software programs used in this study
Program Version Manufacturer
Image J Image processing program V. 1.45 National Institutes of Health
Axio vision for Fluorescent Microscope V. 4.8 Carl Zeiss
LSM image browser for Laser Scanning 
Microscope
V. 4.2 Carl Zeiss
Quantity One for Gel Doc V4.62 Bio-Rad
Microsoft Office word and power point 2007 Microsoft
Microsoft office Excel 2007 Microsoft
IBM SPSS Statistics 16.0 for 
Windows
IBM
2.19 Data evaluation and statistical analysis
All results were expressed as Mean ± standard error of the mean (SEM). To compare 
groups an ANOVA and T- test was used with p<0.05 being considered significant.
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Chapter 3
Biofilm formation by S. epidermidis 
cultured in different physiological
media
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3.1 Introduction
Biofilm formation is the major virulence factor of S. epidermidis and plays an important 
role in protecting the bacterial cell from the killing effect of antimicrobial agents and the 
immune system (Fey and Olson, 2010). To achieve this, staphylococci limit antibiotic 
diffusion into the biofilm and restrict leukocyte penetration which attenuates the host 
immune response (Mack, Rohde et al., 2006; Kokare, Chakraborty et al., 2009). There 
are three main mechanisms of biofilm formation by S. epidermidis. These include 
production of polysaccharide intercellular adhesin (PIA) through the icaADBC locus 
(Mack, Haeder et al., 1996), production of accumulation associated protein (Aap) which 
is activated by proteolytic cleavage (Rohde, Burdelski et al., 2005) and production of 
extracellular matrix binding protein (Embp) which is an fibronectin-binding protein 
found on cell surface (Christner, Franke et al., 2010).
Recent studies have suggested that the host plays a major role in promoting biofilm 
phenotype in S. epidermidis. For instance, PIA expression and biofilm formation are 
subjected to phase variation induced by the insertion sequence element IS256 which 
reversibly inactivates the ica operon (Ziebuhr, Krimmer et al., 1999; Conlon, 
Humphreys et al., 2004). Aap is activated by a host/bacterial protease enzyme (Rohde, 
Burdelski et al., 2005). Embp biofilms are induced by serum in biofilm negative S. 
epidermidis 1585 (Christner, Franke et al., 2010), which suggests that specific 
physiological conditions may promote the biofilm phenotype.
Studies investigating the nutritional requirements for S. epidermidis biofilm formation 
have confirmed the essential need for glucose which is routinely added to TSB 
(TSB/G+) when generating S. epidermidis biofilms in vitro (Mack, Siemssen et al., 
1992; Dobinsky, Kiel et al., 2003). Defining a physiological medium that supports S. 
epidermidis growth and biofilm formation is essential for PIA production with few 
contaminations, and allows study host-PIA interaction (as addressed in chapter 5 and 6). 
Study investigated host-pathogens interaction, demonstrated an apoptotic changes in 
macrophages cultivated with Staphylococci in TSB medium (Thurlow, Hanke et al., 
2011). The minimal nutritional requirement needed to generate a S. epidermidis biofilm 
has been identified in a chemically defined medium called Hussain-Hastings-White
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modified medium (HHWm) in which basic components were glucose, 18 amino acids, 
two purines and six vitamins (Hussain, Hastings et al., 1991).
Less is known about the effect of physiological media on biofilm formation. The effect 
of cell culture media on S. epidermidis biofilm formation was investigated in this 
chapter. Cell culture media can be more reliable media compare to TSB, as it may reflect 
a more realistic picture of the environment in which S. epidermidis grows biofilm. 
Biofilm assays were performed in five different cell culture media, these were RPMI 
with glutamine (RPMI+), RPMI without glutamine (RPMI-), DMEM, DMEM/F12 and 
IMDM.
RPMI is a basic media that supports the growth of mammalian cells, it contains the 
reducing agent glutathione and high concentrations of the vitamins, inositol and choline, 
along with the vitamins biotin, vitamin B 12 and para-Aminobenzoic acid (PABA) 
(Moore and Woods, 1976; Invitrogen RPMI, 2013). Two RPMI media were used so that 
the effect of glutamine (+/- Glutamine) on biofilm formation could be studied.
DMEM is a basal medium for mammalian cell culture which contains a high 
concentration of amino acids and vitamins. Also used was DMEM/F12 which contains a 
1:1 mixture of DMEM and Ham's F-12 Nutrient Mixture (contains ingredients not found 
in other basal media; zinc, putrescine, hypoxanthine, and thymidine) (Dulbecco and 
Freeman, 1959; Rutzky and Pumper, 1974; Invitrogen DMEM, 2013). IMDM is a highly 
enriched media modified from DMEM media, lacking iron, and replaced by potassium 
nitrate and sodium selenite (Iscove and Melchers, 1978; Invitrogen IMDM, 2013).
In this study, eight strains of S. epidermidis were used to investigate biofilm formation 
under different physiological media, these were PIA positive S. epidermidis 1457 from 
central venous catheter infection and its isogenic mutant S. epidermidis 1457-M10 ( non 
biofilm forming) that was produced by insertion of transposon Tn977 at nucleotide 931 
in the icaAgene of the icaADBCgcne locus, in addition to two other PIA forming biofilm 
5. epidermidis 9142 and S. epidermidis 8400 which isolated from central venous catheter 
infection (Mack, Siemssen et al., 1992). Staphylococcus epidermidis 1457 was originally 
used to determine PIA structure through analysis of biofilm obtained by 1457 grown in 
TSB (Mack, Davies et al., 2009). Biofilm negative S. epidermidis 5179 ( non Aap 
forming) isolate from CSF-shunt infection and biofilm positive S. epidermidis 5179-R1
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(Aap forming biofilm) subpopulation of S. epidermidis 5179 also been used (Mack, 
Siemssen et al., 1992). In addition to wild type S. epidermidis 1585 which is a biofilm 
negative strain isolated from blood of a patient with an infected catheter, and an Embp 
positive biofilm forming 5. epidermidis 1585-RA generated by culture through multiple 
passages (Christner, Franke et al. 2010).
In this chapter:
• The ability of specific cell culture media to support biofilm formation was 
studied.
• Nutritional differences between each biofilm mechanism were identified.
• The effect of human and bovine serum on biofilm formation was investigated.
3.2 Methods
To assess bacterial growth, an overnight (18h) pre-culture of S. epidermidis in TSB was 
diluted 1:100 and grown in microcentrifuge tubes for 18h at 37°C, with different 
concentrations of FBS and pooled human serum (PS) (0.1%, 0.3%, 1%, 3%, and 10%) in 
TSB, RPMI+, RPMI-, DMEM, DMEM/F12 and IMDM, the subsequent growth assessed 
by reading absorbance at OD6oonm. Each experiment was undertaken three times.
To assess serum effects on biofilm formation in different media, biofilm assays were 
undertaken as described before (section 2.8.1) in 96 well microtitre plates with different 
serum concentration (0.1%, 0.3%, 1%, 3%, and 10%) and without serum, by adding 
200pl per well of a 1:100 dilution of pre-culture to TSB/G+, and different cell culture 
media including IMDM, DMEM, DMEM/F12, RPMI- and RPMI+. Each experiment 
was performed three times
The inhibitory effect of serum on biofilm formation further investigated by fractionating 
serum samples (FBS and PS) using amicon centrifugation to generate samples with a 
defined molecular weight ranges. Then the effect of these fractions on biofilm formation 
assess by performing biofilm assay (for each defined molecular weight ranges) as 
described in section 2.8.1 in 96 well microtitre plates with different serum concentration 
(0.1%, 0.3%, 1%, 3%, and 10%) and without serum. All experiments were 
performed independently 3 times.
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Experiments were undertaken to assess the effect that pre-coating the wells of the 
microtiter plate with serum had on subsequent biofilm formation. In these studies wells 
were pre-coated overnight with 200pl of 10% FBS or PS at 37°C. After this period the 
coating solution was removed and the wells inoculated with S. epidermidis as previously 
described (section 2.8.1). After about 18 hours incubation, biofilms were washed X3 
with PBS and fixed with Bouin's fixative, left to air dry, stained with crystal violet and 
the biofilm determined at OD57onm, the experiment was performed three times. 
Immunocytochemistry (ICC) performed to identify Embp expression in Embp biofilm 
positive S. epidermidis 1585-RA and biofilm negative S. epidermidis 1585 cultured in 
cell cultured media. Microscope slide was prepared as in section (2.13.2) using lOOpl of 
sample from S. epidermidis 1585-RA and S. epidermidis 1585 incubated for 18h in cell 
culture media. Cytospin preperations were blocked with 200pl 1% BSA for 1 hour, then 
washed X3 with PBS. A 200pl volume of anti- Embp specific abbsorbed antiserum 
(diluted 1:50) was applied, the slides covered and after 30 minutes the slides washed X3 
with PBS. Slides were then stained with fluorescein-conjugated anti-rabbit IgG (Alexa 
flour 488, diluted 1:100) for 30 minutes. Slides were washed X3 wih PBS then 25pl of 
vectashield hardset was added. Preparation was overland with a coverslip and left in the 
fridge to harden. Slides examined using epifluorecent microscopy.
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Results
3.3 Screening of cell culture media supporting PIA dependent biofilm 
formation
In order to investigate the effect of cell culture media on S. epidermidis biofilm 
formation, biofilm assays were performed in five different cell culture media with three 
strains of S. epidermidis that produce PIA dependent biofilms including S. epidermidis 
1457, 8400 and 9142. The cell culture media chosen were RPMI+, RPMI-, DMEM, 
DMEM/F12 and IMDM.
All PIA producing S. epidermidis generated large quantities of biofilm in TSB/G+ as 
determined by absorbance measurements (Figure 3.1). For cell culture media, it was 
found that S. epidermidis biofilm formation was specific to certain media. DMEM/F12 
and IMDM were the best cell culture media in supporting biofilm formation by S. 
epidermidis 1457, (P<0.05) in comparison to other media. There was an advantage of 
growing S. epidermidis 1457 in RPMI without glutamine (RPMI-); as removing 
glutamine enhanced biofilm formation in comparison to RPMI with GlutaMax (RPMI+). 
Cell culture media did not support high level of biofilm formation by both S. epidermidis 
8400 and S. epidermidis 9142 (Figure 3.1).
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. I T  I  5. ep ide rm id is  9142^, ☆
I  l  L L
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TSB PBS RPMI + RPMI- DMEM DMEM/F12 IMDM
media
Figure 3.1 Screening of cell culture media supporting PIA dependent biofilm 
formation. The three PIA forming biofilm strains of S. epidermidis used were 1457, 
8400 and 9142. These strains were cultured for 18h in five different cell culture media, 
namely RPMI+, RPMI-, DMEM, DMEM/F12 and IMDM. The columns represent the 
mean o f three independent experiments. Stars indicate significant difference within 
groups *P<0.05.
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3.4 Screening of cell culture media supporting Aap and Embp 
dependent biofilm formation
In order to investigate the effect of the five cell culture media previously mentioned on 
Aap and Embp dependent biofilms, biofilm assays were performed using S. epiderm idis  
5179-R1 (Aap dependent) and S. epiderm idis  1585-RA (Embp dependent).
In TSB/G+ S. ep iderm idis  5179-R1 formed greater quantities of biofilm in comparison 
to S. epiderm idis  1585-RA. RPMI with GlutaMax (RPMI+) was the best cell culture 
media to support biofilm formation by S. epiderm idis  5179-R1. RPMI without L- 
glutamine (RPMI-) and IMDM media also supported biofilm formation by S. 
epiderm idis  5179-R1. but to a lesser extent. S. epiderm idis  1585-RA formed weaker 
biofilms, RPMI+, IMDM and DMEM/F12 media were also able to support biofilm 
formation (Figure 3.2).
5179-Rl (Aap dependent) 
1585-RA (Embp dependent)
TSB RPMI + RPMI- DMEM DMEM/F12 IMDM
m e d ia
Figure 3.2 Screening of cell culture media supporting Aap and Embp dependent 
biofilm formation. S. ep iderm idis  5179-Rl (Aap dependent) and S. epiderm idis 1585- 
RA (Embp dependent) were cultured for 18h in five different cell culture media namely, 
RPMI+, RPMI-, DMEM, DMEM/F12 and IMDM. The results represent mean of three 
independent experiments.
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3.5 Screening of cell culture media inducing Embp biofilm formation in 
biofilm negative S. epidermidis 1585
To explore the ability of cell culture media to induce Embp biofilm formation in biofilm 
negative S. epidermidis 1585, biofilm assays were performed with TSB and also the five 
different cell culture media (RPMI+, RPMI-, DMEM, DMEM/F12 and IMDM).
RPMI+ induced biofilm formation by S. epidermidis 1585 (P<0.05) with an optical 
density reading of 0.56 followed by DMEM and IMDM with readings of 0.41 and 0.31 
respectively (Figure 3.3). Importantly TSB did not induce biofilm formation by this 
strain.
0.8
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Q 0.4 -
TSB RPMI + RPMI- DMEM DMEM/F12 IMDM
m e d ia
Figure 3.3 Screening of cell culture media inducing Embp biofilm formation in 
biofilm negative S. epidermidis strain 1585. The incubation was for 18 hours. The 
results represent mean of three independent experiments. Star indicate significant 
difference within groups *P<0.05.
To further investigate the Embp expression and confirm the Embp biofilm expression by 
biofilm negative S. epidermidis 1585 grown in cell culture media, an 
Immunocytochemistry (ICC) undertaken for both Embp biofilm positive S. epidermidis 
1585-RA and Embp biofilm negative S. epidermidis 1585, using Embp specific absorbed 
antiserum for Embp detection.
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ICC demonstrated Embp expression in S. epiderm idis  1585 cultured in DMEM and 
RPMI+ (Figure 3.4 C and D) compared to Embp positive S. epiderm idis 1585-RA 
(Figure 3.4 A and B).
c
%
D
%
Figure 3.4 Immunofluorescence detection of Embp expression in S. epidermidis 
1585-RA and S. epidermidis 1585 using Embp -specific absorbed antiserum.
Immunocytochemistry (ICC) demonstrated Embp expression in Embp biofilm negative 
S. epiderm idis  1585 grown in cell culture media compared to Embp positive S. 
epiderm idis 1585-RA. A. S. epiderm idis  1585-RA in TSB, B. S. epiderm idis  1585-RA in 
RPMI+, C. S. epiderm idis 1585 in DMEM, D. S. epiderm idis  1585 in RPMI+.
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Christner et al (Christner, Franke et al., 2010) showed that goat serum could induce 
biofilm formation in biofilm negative S. epidermidis 1585. Biofilm assays were carried 
out using three different goat serum concentrations (50%, 60%, 70%) in TSB/G+, and 
compared to biofilm formation in IMDM, DEME and RPMI+ which were the media 
provoke biofilm formation in this negative strain.
Growth o f S. epidermidis 1585 under different concentrations of goat serum (50%, 60%, 
and 70%) was shown not to induce biofilm formation after both 24h and 48h compared 
to the culture in IMDM, DMEM and RPMI+ which significantly induced biofilm 
formation ( P<0.05) (Figure 3.5).
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0.6
0.4
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TSB 50%G.S. 60%G.S. 70%G.S IMDM DMEM RPMI +
m edia
Figure 3.5 Investigating cell culture media ability to induce biofilm formation in S. 
epidermidis 1585 in comparison to goat serum in 24 and 48 hours. Results represent 
the data from three independent experiments. Stars indicate significant difference 
between cell culture media and goat serum *P<0.05.
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3.6 Effect of mixing cell culture media on biofilm formation
To investigate a universal culture media supportive of biofilm formation by all S. 
epidermidis strains (with different accumulation mechanisms) a mixed media containing 
components that supported good biofilm formation by each strain was prepared. This 
mix contained DMEM/F12 which was the best at supporting biofilm formation by S. 
epidermidis 1457, and RPMI+ was also included as it was the best media to support 
biofilm formation of 5. epidermidis 5179-R1.
Combining DMEM/F12 and RPMI+ cell culture media in a 1:1 ratio lead to reduced 
biofilm formation by both S. epidermidis 1457 and S. epidermidis 5179-R1 strains in 
compared to DMEM/F12 and RPMI+ alone. Furthermore control samples diluted in 
PBS gave similar response to the original media (Figure 3.6).
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TSB
S. ep iderm id is  1457 ( PIA dependent)
S. ep iderm id is  5179-R1 ( Aap dependent)
DMEM/F12 RPMI + MIX DMEM/F12+PBS RPMI+PBS
m edia
Figure 3.6 Effect of mixing cell culture media DMEM/F12 and RPMI+ on biofilm 
formation. The figure shows the relative biofilm formation of both S. epidermidis 1457 
(PIA dependent) and S. epidermidis 5179-R 1 (Aap dependent) in separate culture media 
as well as a mixed preparation. The 1:1 mix of DMEM/F12 and RPMI+ was found to 
generate lower level of biofilm by each of these strains compared with the medium 
previously identified as giving best biofilm formation for strains. Results represent the 
data from three independent experiments.
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3.7 The effect of serum on growth and biofilm formation of S. 
epidermidis 1457 and S. epidermidis 5179-R1
To study the effect of FBS and human serum on the growth and biofilm formation of S. 
epiderm idis  1457 and S. epiderm idis  5179-R1, pooled serum (PS) was generated from 7 
different human sera and added to TSB, IMDM and RPMI- media and incubated for 18 
hours. Serum concentrations used were (0.1%, 0.3%, 1%, 3%, and 10%).
Adding FBS and PS had no effect on the growth of S. epiderm idis  1457 and S. 
epiderm idis  5 179-R1 in any of the three media (Figure 3.7 A and B ).
Regarding effects o f FBS on biofilm formation, S. epiderm idis  1457 grown in TSB, 
IMDM or RPMI-, showed a dose dependent decrease with maximum effect at 10% 
serum. For PS the dose dependent inhibitory effect was more powerful, resulting in 
complete inhibition of biofilm formation at 10% serum in TSB, RPMI- and IMDM 
(Figure 3.7A).
In S. epiderm idis  5179-R1, both FBS and PS had a powerful inhibitory effect on the 
biofilm formation especially in cell culture media. In TSB 1-10% scrum inhibited 
biofilm formation, while adding 0.1% FBS or PS to RPMI- and IMDM completely 
prevented biofilm formation (Figure 3.7 B).
■  TSB  F BS/B  I T S B P S / B  ■  R P M I -  F B S /B  ■ R P M I - P S / B  ■  I M D M  FB S /B  ■  I M D M  P S / B
♦  T S B F B S / G  A  TS B P S / G  X R P M I - F B S / G  ♦  R P M I - P S / G  - I M D M F B S / G  O I M D M  P S / G
2.4 r 1.2
cont. 0.1% 0.3% 1% 3% 10%
se ru m  co n ce n tra t io n  % (v/v) in cu ltu re  m ed iu m  /S. epidermidis 1457
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cont. 0.1% 0.3% 1% 3% 10%
se rum  c o n cen tra t io n  % (v/v) in cu ltu re  m ed iu m  /S . epidermidis 5179-R1
F igure 3.7 Effect o f  FBS and PS on the grow th and biofilm  form ation o f S.
epidermidis. A. S. epiderm idis  1457 (PIA dependent) B. S. epiderm idis  5179-R1 (Aap 
dependent). The markers on the top of graph represent the effect of different 
concentration of both FBS and PS (0.1%, 0.3%, 1%, 3%, and 10%) on the growth (G) of 
S. epiderm idis  1457 and S. epiderm idis  5179-R1 in three different media namely, TSB, 
RPMI- and IMDM. The columns represent the effect of different concentration of both 
FBS and PS (0.1%, 0.3%, 1%, 3%, and 10%) on the biofilm formation (B) of S. 
epiderm idis  1457 and S. epiderm idis  5179-R1 in three different media namely, TSB,
RPMI- and IMDM. Results represent the data from 3 independent experiments. Stars
indicate significant difference between control and different serum concentrations 
* P<0.05. FBS/B; biofilm formation with presence of fetal bovine serum in media, PS/B; 
biofilm formation with presence of pooled human serum in media, FBS/G; growth with 
presence of fetal bovine serum in media, PS/G; growth with presence of pooled human 
serum in media.
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3.8 The effect of serum on biofilm formation by S. epidermidis 1585-RA 
and 1585
The effect of FBS and PS on biofilm formation by Embp biofilm positive S. epidermidis 
1585-RA, and biofilm negative S. epidermidis 1585 was also assessed. Increasing 
concentrations of scrum were added to TSB and the cell culture media; RPMI+, RPMI-, 
DMEM, DMEM/F12 and IMDM, prior to biofilm assays.
For 5. epidermidis 1585-RA, adding FBS and PS scrum reduced biofilm formation in 
TSB, RPMI-t- and IMDM (Figure 3.8 A and B). For biofilm negative S. epidermidis 
1585 adding serum did not induce biofilm formation in TSB. However serum did reduce 
the biofilm induced by RPMI+, DMEM and IMDM and this was statistically significant 
P<0.05 (Figure 3.8 C and D).
A 1 g Serum concentration%
1.6
1.4
E 1-2  c
■ cont. ■ 0.1% 0.3% ■ 1% B3% ■ 10%
0.8Q
O 0.6
0.4
0.2
0
TSB RPMI + RPMI- DMEM DMEM/F12 IMDM
M edia with FBS/ S. epidermidis 1585-RA
Serum concentration %
TSB RPMI+ RPMI- DMEM DMEM/F12 IMDM
M edia  with  PS/ S. epidermidis 1585-RA
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Figure 3.8 Serum  effect on biofilm  form ation  by S. epidermidis 1585-RA and S. 
epidermidis 1585. A. S. epidermidis 1585-RA biofilm formation with FBS, B. S. 
epidermidis 1585-RA biofilm formation with PS, C. S. epidermidis 1585 biofilm 
formation with FBS, D. S. epidermidis 1585 biofilm formation with PS. The columns 
represent the effect of different concentration of both FBS and PS (0.1%, 0.3%, 1%, 3%, 
and 10%) on the biofilm formation of S. epidermidis 1585-RA (Embp dependent) and S. 
epidermidis 1585 (biofilm negative) in different media namely, TSB, RPMI+, RPMI-, 
DMEM, DMEM/F12 and IMDM. Results represent the data from 3 independent 
experiments. Stars indicate significant difference between control and different scrum
85
concentrations * P<0.05. Media with FBS; biofilm formation with presence of fetal 
bovine serum in culture media, media with PS; biofilm formation with presence of 
pooled human serum in culture media, control is biofilm formation in serum free 
medium.
3.9 The effect of coating microtiter plate wells with serum on biofilm 
formation by S. epidermidis 1457, 5179-R1 and 1585-RA
The effect of serum coating the microtiter plate wells on subsequent biofilm formation 
by S. epidermidis 1457, 5179-R1 and 1585-RA, was performed in 96 well plates whose 
wells were coated overnight with 10% PS and FBS. The culture media used for biofilm 
formation were TSB, RPMI+, RPMI- and IMDM. After incubation the biofilm was 
assessed by staining with crystal violet and the measuring OD570.
For S. epidermidis 1457, pre-coating wells with FBS resulted in slight reduction in 
biofilm formation in all media tested. Coating with PS had no effect on biofilm 
formation in all the three media. For S. epidermidis 5179-R1, pre-coating wells with 
FBS or PS completely inhibited biofilm formation in all the three media and this was 
statistically significant, P< 0.01 (Figure 3.9 A). Pre-coating wells with FBS significantly 
reduced biofilm formation by S. epidermidis 1585-RA in TSB, and prevented biofilm 
formation in IMDM and RPMI+ media. Pre-coating wells with PS inhibited biofilm 
formation completely in all media (Figure 3.9 B).
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Figure 3.9 Effects of pre-coating microtitre plate wells with serum on S. epidermidis 
biofilm formation. A. S. epidermidis 1457 and 5. epidermidis 5179-R1 cultured in 
TSB, RPMI- and IMDM. B. S. epidermidis 1585-RA cultured in TSB, RPMI+ and 
IMDM. The figure shows the effect of pre-coating microtitcr plate wells with pooled 
human scrum (PS) and fetal bovine serum (FBS) on biofilm formation of S. epidermidis 
1457 (PIA dependent), S. epidermdis 5179-R1 (Aap dependent) and S. epidermidis 
1585-RA (Embp dependent). Results represent the data from 3 independent experiments. 
Cont.; control which represent biofilm formation in non serum pre-coated microititre 
plate wells. Stars indicate significant difference between different serum concentrations 
**P<0.01, *P<0.05.
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3.10 The effect of molecular weight (MW) size fractions of FBS and PS 
on biofilm formation by S. epidermidis strains
The effect of different fractionated serum samples on biofilm formation was studied to 
determine whether the molecular weight of serum used was an important factor in 
affecting biofilm formation.
Both FBS and PS were fractionated into four groups: fractions above 30000 kDa, 
fractions between 30000-10000 kDa, fractions between 10000-3000kDa and fractions 
below 3000kDa. Biofilm assays were performed with different fractions of serum to 
characterise the size (according to their MW) of the biofilm inhibitory factors.
3.10.1 The effect of molecular weight (MW) size fractions of FBS on S. 
epidermidis biofilm formation
Biofilm assays for S. epidermidis 1457 and S. epidermidis 5179-R1 were performed with 
different fractions of FBS. For fractions with MW above 30000kDa, the effect on S. 
epidermidis 1457 biofilm was limited when added to TSB, while for IMDM and RPMI- 
there was a trend toward a dose dependent decrease in biofilm formation until 3-10% 
serum.
Complete inhibition of biofilm formation was observed for S. epidermidis 5179-R1 with 
serum preventing biofilm formation in all media even with lowest concentrations of 
serum except for 0.1% TSB (Figure 3.10 A). It appears that the major inhibitory effect 
of serum lay in fractions with MW above 30000kDa and was consistent with earlier 
findings with FBS and PS on biofilm formation (section 3.5).
For serum fractions with MW between 30000-lOOOOkDa, 10000-3000 kDa and below 
3000 kDa, there were mild or no effects on S. epidermidis 1457 biofilm formation in all 
three media. For S. epidermidis 5179-R1 there was no or limited effects when added to 
TSB and IMDM. In RPMI-, the serum actually induced biofilm formation and this effect 
increased with increasing the serum concentration 0.3-10% (P<0.05) (Figure 3.10 B,C 
and D).
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Figure 3.10 The effect of different molecular weight fractions of FBS on biofilm 
formation by S. epidermidis 1457 and S. epidermidis 5179-R1. A. FBS fractions with 
MW > 3000()kDa. B. FBS fractions with MW between 30000- lOOOOkDa. C. FBS 
fractions with MW between 10000-3000kDa. D. FBS fractions with MW < 3000kDa. 
Three different media TSB, IMDM and RPMI- used to cultured S. epidermidis 1457 
(PIA dependent) and S. epidermidis 5179-R1 ( Aap dependent) and the effect of 
different molecular weight fractions of FBS on biofilm formation assessed. The fraction
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> 30,000 kDa had powerful inhibitory effect compared to other frctions. Results 
represent the data from 3 independent experiments. Stars indicate significant difference 
between control and different serum concentrations **P<0.01, *P<0.05. Cont. is control 
medium used to cultured S. epidermidis without serum, FBS id fetal bovine serum.
For S. epidermidis 1585-RA and S. epidermidis 1585, biofilm assays were performed 
with different fractions of FBS in TSB, IMDM and RPMI+ (1585-RA) and IMDM, 
DMEM and RPMI+ (1585) (Figure 3.11 A-D). For fractions with MW above 30000kDa, 
inhibitory effects on biofilm formation in TSB occurred with serum concentration 
>0.3%. For S. epidermidis 1585-RA, whilst in IMDM and RPMI- the serum effect was 
limited (Figure 3.11 A). For S. epidermidis 1585 all concentrations of FBS prevented 
biofilm formation in all media (Figure 3.11 A). For all other FBS fractions, FBS had no 
effect on biofilm formation for both S. epidermidis 1585-RA and S. epidermidis 1585 
(Figure 3.11 B-D).
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Figure 3.11 The effect of different molecular weight fractions of FBS on biofilm 
formation in 1585-RA and 1585 S. epidermidis strains. A. FBS fractions with MW 
above 3()()()()kDa. B. FBS fractions with MW between 30000-1 OOOOkDa. C. FBS 
fractions with MW between 10000-3000kDa. D. FBS fractions with MW below 
3000kDa. Three different media TSB, IMDM and RPMI- used to cultured S. epidermidis 
1585-RA (Embp dependent) and S. epidermidis 1585 ( biofilm negative). The fraction >
30,000 kDa had a powerful inhibitory effect com pared to other fractions. Results 
represent the data from 3 independent experiments. Cont. is control medium used to 
cultured S. epidermidis without serum, FBS is fetal bovine serum.
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3.10.2 The effect of different molecular weight (MW) fractions of PS on 
S. epidermidis biofilm formation
Biofilm assays of S. epidermidis 1457 and S. epidermidis 5179-R1 incubated with MW 
fractions of PS above 30000kDa in TSB led to greater than 50% biofilm reduction for S. 
epidermidis 1457. In IMDM and RPMI- concentrations of PS >1% prevented biofilm 
formation (P<0.05). For S. epidermidis 5179-R1 adding PS prevented biofilm formation 
in all three media at PS >0.1% and these effects were statistically significant P<0.05 
(Figure 3.12 A).
PS fractions with MW between 30000- lOOOOkDa, 10000-3000kDa and below 3000kDa 
had no significant effect on 1457 biofilm formation in TSB, IMDM and RPMI- (Figure 
3.12 B,C,D). For S. epidermidis 5179-R1, adding PS fractions with MW between 30000- 
lOOOOkDa had no effect on biofilm formation in TSB and IMDM, but decreased biofilm 
formation in RPMI- when PS >0.3% (Figure 3.12B). For the PS fractions with MW 
between 10000-3000kDa, no effect on 5179-R1 biofilm formation was evident in TSB. 
Increased biofilm formation occurred in IMDM and no biofilm formation was evident in 
RPMI- (P<0.05) (Figure 3.12 C). Finally, adding PS fractions with MW below 3000kDa 
had no effect on biofilm formation of S. epidermidis 5179-R1 in TSB and IMDM, but 
still prevented biofilm formation in RPMI- (P<0.05) (Figure 3.12 D).
PS had a significantly higher inhibitory effect on biofilm formation compared with FBS. 
The inhibitory effect of PS on biofilm formation in S. epidermidis 1457 was due to 
serum components present in fractions above 30000kDa, whilst in 5179-R1 the effect 
was limited in TSB and IMDM. In contrast, in RPMI-, PS inhibited biofilm formation 
unlike FBS which induced biofilm.
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Figure 3.12 The effect of different molecular weight fractions of PS on biofilm 
formation in S. epidermidis 1457 and S. epidermidis 5179-R1. A. PS fractions with 
MW above 30000kDa. B. PS fractions with MW between 30000-1 OOOOkDa. C. PS 
fractions with MW between I0000-3000kDa. D. PS fractions with MW below 3000kDa. 
Three different media TSB, IMDM and RPMI- used to cultured S. epiderm idis  1457 
(PIA dependent) and 5. epiderm idis  5179-R1 (Aap dependent). The fraction > 30,000
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kDa had a powerful inhibitory effect compared to other fractions. Results represent the 
data from 3 independent experiments. Stars indicate significant difference between 
control and different serum concentrations *P<0.05. Cont. is control medium used to 
culture S. epidermidis without serum, PS is pooled human serum.
Biofilm assays were undertaken with S. epidermidis 1585-RA and S. epidermidis 1585 
using culture media to which different MW fractions of PS had been added. Using PS > 
30,000kDa and at concentrations > 0.3% in TSB, biofilm inhibition was evident with S. 
epidermidis 1585-RA. For this strain, the addition of this fraction of PS completely 
inhibited biofilm formation in the other test media. For S. epidermidis 1585 adding PS 
prevented biofilm formation in all the three media (Figure 3.13A).
Adding PS fractions between 30000-lOOOOkDa had no effect on biofilm formation of 
1585-RA in the three media; whilst for S. epidermidis 1585, PS prevented biofilm 
formation when added to DMEM, with no effect on biofilm formation in IMDM and 
RPMI+ (Figure 3.13B).
PS fractions between 10000-3000kDa and < 3000kDa, in TSB, inhibited S. epidermidis 
1585-RA biofilm at 10%, but had no effect on biofilm formation in IMDM and RPMI+. 
In the case of S. epidermidis 1585, PS had no effect on biofilm formation in IMDM and 
RPMI+, but prevented biofilm formation in DMEM (Figure 3.13 C and D).
In summary, PS had more potent inhibitory effect on biofilm formation compared with 
FBS on S. epidermidis 1585-RA and S. epidermidis 1585. The inhibitory effect of PS on 
biofilm formation by S. epidermidis 1585-RA and S. epidermidis 1585 was due to serum 
components present in fractions above 30000kDa. For other fractions the inhibitory 
effect on S. epidermidis 1585 was observed in DMEM only.
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Figure 3.13 The effect of different molecular weight fractions of PS on biofilm 
formation in S. epidermidis 1585-RA and S. epidermidis 1585. A. PS fractions with 
MW above 3()00()kDa. B. PS fractions with MW between 30000-1 OOOOkDa. C. PS 
fractions with MW between 10000-3000kDa. D. PS fractions with MW below 3000kDa. 
Four different media TSB, IMDM, DMEM and RPMI+ used to culture S. epidermidis 
1585-RA (Embp dependent) and S. epidermidis 1585 (biofilm negative). The fraction >
30,000 kDa had a powerful inhibitory effect on biofilm formation compared with other 
fractions. Results represent the data from 3 independent experiments. Cont. is control 
medium used to culture S. epidermidis without serum, PS is pooled human serum.
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3.11 Discussion
The purpose of the present study was to determine the significance of the growth 
conditions on the growth and biofilm formation of different S. epidermidis strains with 
different mechanisms of biofilm accumulation. The ability of specific cell culture media 
to support biofilm formation was investigated, and a difference in the nutritional 
requirement needed for biofilm formation between different S. epidermidis strains with 
different mechanism of biofilm accumulation was identified. In addition, serum effect 
(human and bovine) on biofilm formation was studied.
This study demonstrated that cell culture media can support the growth and biofilm 
formation of S. epidermidis strains exhibiting different mechanisms of biofilm formation 
(PIA, Aap and Embp). This effect could be due to the effect of specific nutrients in these 
media that regulate PIA, Aap and Embp expression with the resultant formations of 
biofilm. Dobinsky et al (Dobinsky, Kiel et al., 2003) showed that glucose was essential 
for PIA synthesis and biofilm formation and in this study glucose was a component in all 
cell culture media studied. In addition, all cell culture media used contained the 
inorganic salts magnesium (Mg) and calcium (Ca), which are important for biofilm 
formation according to Ozerdem et al who demonstrated a significant increase in biofilm 
formation by adding Mg and Ca to TSB (Ozerdem Akpolat, Elci et al., 2003).
There was a difference in biofilm formation between RPMI + and RPMI- suggesting that 
glutamine has differential effects on biofilm growth by S. epidermidis. Thus glutamine 
induces biofilm development in strains like S. epidermidis 1585-RA and S. epidermidis 
1585 and appears non-essential for biofilm development in S. epidermidis 5179-R1 and 
is inhibitory for S. epidermidis 1457. This is interesting as to the author s knowledge this 
is the first report of a specific nutrient having differential effects on specific biofilm 
mechanisms. L-glutamine is an important precursor for peptide and protein synthesis, 
amino sugar synthesis, purine and pyrimidine for nucleic acid and nucleotide synthesis, 
(Matthews and Anderson, 2002; Forchhammer, 2007). The metabolic effect of 
glutamine on PIA synthesis was partly demonstrated by Vuong et al as factors able to 
repress tricarboxylic acid (TCA) cycle activity induced PIA production (Vuong, Kidder 
et al., 2005). Furthermore, activation of TCA by inactivation of the glutamine permease 
gene (glriP) (which prevents glutamine transport from the media to the cell) led to
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decreased PIA synthesis and biofilm accumulation (Zhu, Xiong et al., 2009). The 
importance of glutamine to cell survival and proliferation in vitro was described by 
Eagle et al (Eagle, Oyama et al., 1956) who developed the first chemically defined 
synthetic medium that contained glucose, 19 essential and nonessential amino acids and 
a high concentration of glutamine.
In addition, RPMI media contains glutathione in a reduced form which is an essential 
element in DNA synthesis, protein synthesis, and enzyme activation, and also acts as an 
antioxidant (Moore and Woods, 1976; Invitrogen RPMI, 2013). Indeed adding 
glutathione to cell culture media enhances cell growth and proliferation (Ozawa, Nagai 
et al., 2006).
IMDM was the media that best supported the growth and biofilm formation of S. 
epidemidis strains with different mechanisms of biofilm formation including S. 
epidermidis 1457, S. epidermidis 5179-R1, and S. epidermidis 1585-RA. Furthermore 
this medium was also able to induce biofilm formation in the biofilm negative S. 
epidermidis 1585. IMDM is a highly enriched medium modified from DMEM. The 
positive effect of IMDM on biofilm formation may be due to presence of sodium 
pyruvate which is known to act as a source of energy and prevent hydrogen peroxide 
accumulating in the medium. IMDM also contains selenium which is an essential trace 
element for cell growth and development and functions as an antioxidant. Furthermore, 
IMDM lacks iron supplementation which could induce biofilm formation (Johnson, 
Cockayne et al., 2005; Johnson, Cockayne et al., 2008; Invitrogen IMDM, 2013). Iron 
plays an important role in all aspects of cell growth, proliferation and differentiation in 
bacteria (Comelis and Andrews, 2010). Interestingly, innate immunity resists bacterial 
infection by promoting an iron deprived state in blood and tissues leading to inhibition 
of pathogen growth (Symeonidis and Marangos, 2012). The growth and biofilm 
formation of S. epidermidis under iron deprived condition could be a survival 
mechanism, which explains the ability of S. epidermidis to withstand unsuitable 
environmental conditions and cause persistent and chronic infections.
This research was also able to identify culture conditions that promoted biofilm 
production in the biofilm negative strain S. epidermidis 1585. Thus biofilm production 
and Embp expression was demonstrated in IMDM, RPMI+ and DMEM, which may be
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due to the lack of iron. This finding correlates with those of Deighton et al who found 
that stress conditions (like iron depletion) can induce biofilm formation in biofilm 
negative strains (a situation which is present in IMDM) or provoke biofilm formation 
under low iron conditions (Deighton and Borland, 1993; Baldassarri, Bertuccini et al., 
2001; Vuong, Kidder et al., 2005). Furthermore, these conditions could induce 
phenotypic variation which convert normal skin flora to pathogenic microorganisms 
upon entering the host and the low iron environment.
Biofilm induction in S. epidermidis 1585 was examined using cell culture media and 
serum. Previous work by Christner et al (Christner, Franke et al., 2010) showed that 
biofilm could be induced in this particular strain by goat serum although this could not 
be reproduced in this present study using three different serum concentration (50%, 
60%, and 70%). The possible reason for this could be due to the different sources of goat 
serum (Difco and Invitrogen). However, cell culture media including RPMI+, IMDM 
and DMEM induced biofilm formation by S. epidermidis 1585, which could be due to 
glutamine, as all the three media contain glutamine. The observed biofilm formation in 
selected media could indicate the important of certain amino acids for recognised 
mechanisms of S. epidermidis biofilm formation.
Amino acid catabolism is important for staphylococcal biofilm formation (Resch, 
Rosenstein et al., 2005; Resch, Leicht et al., 2006). Bacteria have established 
mechanisms for the selective transport of amino acids into the cytosol. This allows 
acquisition of the necessary amino acids from the local environment (Beenken, Dunman 
et al., 2004; Horsburgh, Wiltshire et al., 2004). The metabolic requirement of 5. aureus 
growing as a biofilm differs from that of planktonic growth. In a biofilm 5. aureus 
selectively utilises certain amino acids compared to planktonic cells (Zhu, Weiss et al., 
2007). The ability of staphylococci to use amino acids present in the host environment 
during infection is an important factor contributing to growth and pathogenesis 
(Horsburgh, Wiltshire et al., 2004). These finding suggest that different nutritional 
requirement are needed for different S. epidermidis strains to induce biofilm formation 
in vitro. The cell culture media used and resulting biofilm formation summarized in 
Table 3.1.
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Table 3.1 Biofilm formation by S. epidermidis strains cultured in different cell 
culture media.
Culture medium and resulting biofilm formation
Biofilm dependent 
mechanism/strain
TSB RPMI+ RPMI- DMEM DEMEM/F12 IMDM
PIA/ S. epidermidis 
1457
+  +  +  * + + +  * + + + + + + +  *
PIA/ S. epidermidis 
8400
+  +  + + + + + +
PIA/ 5. epidermidis 
9142
+  +  + + + + + +
Embp/ 5. epidermidis 
1585-RA
+  +  * + * * * * +  *
Aap/ S. epidermidis 
5179-R1
+  +  +  * + + +  * +  *
S. epidermidis 1585 - + + - + - +
Addition of whole fetal bovine serum * or whole human serum reduced biofilm 
development; +++, sunstantial biofilm formation, ++, moderate biofilm formation, +, 
limited biofilm formation, -, no biofilm formation.
S. epidermidis is part of the normal skin flora, however when entering the human host it 
develops a pathogenic phenotype. This study hypothesizes that there are certain factors 
in host blood or tissues which modify this transformation. To explore this theory, serum 
was added to TSB and cell culture media and examined the effect of this on growth and 
biofilm formation.
FBS and PS (0.1-10%) had no effect on S. epidermidis growth, although inhibition of 
biofilm formation was evident. Interestingly, the test strains had different sensitivities to 
serum, with PIA dependent biofilm accumulation being less sensitive to that of Aap and 
Embp dependent biofilm development.
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Patel et al demonstrated that the presence of adsorbed serum proteins suppresses the 
initial adhesion of S. epidermidis (Patel, Ebert et al., 2007) and Liu et al demonstrated an 
inhibitory effect of FBS coated surface on bacterial adhesion (Liu, Strauss et al., 2008) 
which supports findings from this study. In contrast, the presence of 20% serum 
increased bacterial adhesion and aggregation on both anionic and cationic charged 
surfaces (MacKintosh, Patel et al., 2006).
The presence of PS in the media appeared to have a more potent inhibitory effect on 
biofilm formation than FBS, especially for Aap biofilm dependent strains. These finding 
correlate with those of Abraham and Jefferson (Abraham and Jefferson, 2010) who 
demonstrated that 50% FBS prevented S. aureus biofilm formation, whilst only 10% 
human serum was needed. Others have suggested the importance of certain human 
serum proteins such as apo-transferrin, which had an inhibitory effect on bacterial 
adhesion and biofilm formation in S. aureus and S. epidermidis (Ardehali, Shi et al., 
2002; Ardehali, Shi et al., 2003).
To study the influence of adhesion on biofilm formation, this research examined S. 
epidermidis biofilm development on polystyrene surface pre-coated with serum. Coating 
had no effect on S. epidermidis 1457 biofilm formation, whilst it prevented biofilm 
formation by the protein dependent biofilm of S. epidermidis 5179-R1 and S. 
epidermidis 1585-RA and the biofilm negative S. epidermidis 1585 (induced). This may 
indicate a variation in surface requirement to achieve primary adhesion between 
carbohydrate mediated biofilm and protein mediated biofilm formation. The influence of 
a conditioning film has generated variable result regarding biofilm development. For 
instance, Pihl et al (Pihl, Arvidsson et al., 2013) showed that S. epidermidis adherence to 
10% serum-coated peritoneal catheters was four times greater than to uncoated ones. 
Furthermore, growing Candida spp on surfaces coated with serum showed that biofilm 
formation increased with increasing serum concentration (Nikawa, Nishimura et al., 
2000). Others have suggested that adsorption with 20% serum inhibits the initial stages 
of adhesion, but within 24 hours incubation, a mature biofilm developed that did not 
differ from biofilm formed on non-adsorbed surfaces (Patel, Ebert et al., 2007). It was 
therefore assumed that in the case of Aap and Embp dependent biofilm, the coating 
serum completely prohibited primary attachment as within 24h a measurable biofilm
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was still not evident. This is similar to studies with Pseudomonas aeruginosa biofilm 
formation where pre-coating with adult bovine serum and bovine serum albumin has 
been shown to be inhibitory (Hammond, Dertien et al., 2010).
To further investigate the effect of serum on biofilm formation, the FBS and PS was 
fractionated according to MW using Amicon Ultra centrifugal filter units. It was found 
that the serum inhibitory effect observed in whole serum was present in the serum 
fractions with MW above 30000kDa. PS fractions had greater inhibitory effects 
compared to equivalent FBS fractions. This effect may be attributed to albumins, 
transferrin, immunoglobulins and lipoproteins (Tirumalai, Chan et al., 2003) which are 
the major serum proteins with MW above 30000kDa. It seems that the factors in serum 
fractions above 30000kDa are highly efficient at inhibiting biofilm formation as all 
dilutions (0.1-10%) of this fraction inhibited biofilm formation. This may be due to 
blocking effect of the proteins in these fractions that interfere with adhesive capability of 
different S. epidermidis adhesins.
There are many surface proteins that can initiate primary attachment of S. epidermidis to 
surfaces and promote adhesion including Staphylococcus surface proteins SSP-I and 
SSP-II (Veenstra, Cremers et al., 1996), extracellular matrix binding proteins like 
Autolysin AtlE, fibronectin binding protein (Embp) (McCann, Gilmore et al., 2008), 
fibrinogen binding (Fbe) (Nilsson, Frykberg et al., 1998), collagen binding protein 
(GehD) (Bowden, Visai et al., 2002), and the cell surface associated proteins, Sdrf, SdrG 
and SdrH (McCrea, Hartford et al., 2000).
This present study also demonstrated biofilm induction under certain conditions. In S. 
epidermidis 5179-R1, FBS fractions below 30000kDa in RPMI- stimulated biofilm 
formation (the opposite effect was found in the same fractions of PS). This might be due 
to the Tack of glutamine’ which is unmasked when the inhibitory effect of high MW 
fractions is removed. Our FBS data contrasts, whilst the PS data concurs with findings 
of Abraham and Jefferson (Abraham and Jefferson, 2010), where an inhibitory effect on 
S. aureus biofilm formation was identified with serum fractions below 3000kDa. The 
effects of serum on biofilm formation suggested that there are host factors responsible 
for both inducing and inhibiting biofilm formation confirming the importance of the host 
in the final biofilm response Figure 3.14.
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Chapter 4
Purification of PIA produced by S. 
epidermidis biofilms cultured on 
different substrates and growth media
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4.1 Introduction
PIA purification was first described by Mack et al in 1994 (Mack, Nedelmann et al., 
1994) when S. epidermidis was grown in TSB, the supernatants recovered, dialyzed, and 
chromatography used to separate PIA fractions. However difficulties exist in using PIA 
purified by this method for study of host pathogens interactions. These difficulties 
include the fact that i) TSB is not sufficient to support human cells in culture, as TSB 
induced apoptosis in immune cells (Thurlow, Hanke et al., 2011; Hanke and Kielian, 
2012); ii) TSB could be contaminated with lipopolysaccharide (LPS) which could 
interfere with interpretation of results, as macrophages can be activated by LPS 
concentrations as low as 15pg/ml (Wakelin, Sabroe et al., 2006); iii) Purified PLA could 
be contaminated with TSB media components; iv) PIA is lost during the dialyses 
process.
Defining a physiological medium that supports both bacterial and human cells and 
allows for PIA production with few contamination so that their interaction may be 
studied was partly addressed in chapter 3. Thus, identifying cell culture media that 
supports the growth and biofilm formation of different strains of S. epidermidis, in 
Chapter 3 will inform the larger scale production of purified PIA in this chapter (Figure 
4.5) and will be used to allow study of host pathogens interactions (Chapter 5 and 6). 
The importance of medium and atmosphere for Staphylococcus biofilm formation was 
addressed in previous studies. Hussain et al. found that biofilm formation of S. 
epidermidis cultured in a chemically defined medium called Hussain-Hastings-White 
modified medium (HHW) with 5% C02 unaffected compared to S. epidermidis cultured 
under same condition in TSB were biofilm formation prohibited (Hussain, Wilcox et al. 
1992). Similar effect was confirmed by Stepanovic et al. who found that incubation in 
C02 rich environment significantly reduce biofilm formation by both S. aureus and S. 
epidermidis (Stepanovic, Djukic et al., 2003).
In this chapter:
• PIA was purified on a large scale (milligrams) for cell culture studies.
• Purification methods from planktonic bacteria and from adherent biofilms were 
compared.
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4.2 Methods
This present study modified a previously described methodology, referred from here on 
in as the (Mack Method). This method was modified by using IMDM instead of 
TSB/G+ to culture S. epidermidis 1457. Initially, S. epidermidis 1457 cultured into 6 
glass beakers, a negative control culture of the biofilm negative S. epidermidis 1457-10 
was similarly prepared. The biofilms obtained from culturing S. epidermidis 1457 in 
IMDM in glass beakers was weak and small in amount (Figure 4.1) and the amount of 
PIA was low in compare to Mack method as will show in 4.3. Thus, cell culture plates 
used as opposed to glass beakers. This was undertaken in order to try and increase PIA 
yield. The PIA purification using IMDM in cell culture plates is described in the 
materials and methods (section 2.9.1). In brief, on day 1, 5ml of IMDM was inoculated 
with S. epidermidis 1457 and incubated overnight at 37°C (Pre-culture). Twenty ml of 
IMDM was added to NUNC cell culture plates followed by 200pl of the pre-culture. 
This preparation was incubated for 48 hours without shaking at 37“C. After 72 hours the 
biofilms were scraped from the plates using a sterile cell scraper and the purified 
extracts were applied directly to Q-Sepharose columns without the need for a dialysis 
step (preventing potential PIA loss in this process). Then, 15 consecutive 2ml fractions 
were collected. Confirmatory assays for PIA included ELISA, Hcxosamine assay, 
Coagglutination assay and Hcxose assay and were done on all the 15 fractions and the 
pooled fractions (tubes 1-2, 3-7, 8-10 and 11-15) pooled together as described in section
2.9.2 (Mack, Ncdclmann et al., 1994; Mack, Bartscht et al., 2001).
A B
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Figure 4.1 PIA purification from biofilm cultured in IMDM in a glass beakers.
A. Biofilm formation of 1457 S. epidermidis cultured in IMDM B. Biofilm negative S. 
epidermidis I457-M 10 cultured in IMDM.
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Results
4.3 Comparison of PIA preparation by the Mack and IMDM methods
To compare PIA production from the Mack and IMDM methods, several confirmatory 
assays were performed on pooled extracts from six glass beakers cultures. Two isolates 
was cultured either in TSB (Mack method) or IMDM and there were S. epidermidis 
1457 (PIA dependent) and a negative control NC of S. epidermidis 1457-M10. 
Fractions obtained from chromatography (section 2.9.1) were pooled as following: 
fractions 1-2, fractions 3-7, fractions 8-10 and fractions 11-15 together.
A total Hexosamine assay was undertaken as described previously in the materials and 
methods (section 2.9.2.3) to estimate the amount of PIA produced. The amount of PIA 
in purified extracts obtained by Mack method was more than that obtained by growing S. 
epidermidis 1457 in IMDM in glass beakers (Table 4.1). Purity of the pooled fractions 
was restricted to one pooled fraction in extracts isolated from IMDM, whereas, 
hexosamine sugars could be detected in other pooled fractions isolated from TSB. In 
addition, biofilms produced by IMDM were noticeably weaker, detaching easily from 
the surface of the beaker as in Figure 4.1 A.
An optimized PIA ELISA (section 2.9.2.1.2) was used to detect the antigenic presence 
of the PIA molecule. Pooled PIA fractions and the NC extract from the IMDM method 
were assayed by ELISA (1:20, 1:100 and 1:500 dilutions) together with the pooled 
fractions of PIA (tubes 3-7), and pooled fractions of NC (tubes 3-7) prepared by the 
Mack method (1:500 dilution) (Table 4.2). The optimized PIA ELISA confirmed the 
presence of PIA in extracts isolated by both methods and alluded to higher levels 
generated by the Mack method (Table 4.2).
Hexose sugar was quantified in the purified PIA extract by a Hexose assay (section 
2.9.2.4 ) with a robust standard curve. This assay confirmed the absence of hexose in all 
samples tested.
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Table 4.1 Hexosamine assay of PIA fractions obtained by Mack and IMDM 
method.
Pooled
fractions
1457-TSB
PI
1457- TSB 
P2
NC- TSB 1457-IMDM NC-IMDM
1-2 1 pg/ml 21 pg/ml Opg/ml 0 pg/ml Opg/ml
3-7* 224 pg/ml 156 pg/ml Opg/ml 131 pg/ml Opg/ml
8-10 21 pg/ml 42 pg/ml Opg/ml 0 pg/ml Opg/ml
11-15 22 pg/ml 24 pg/ml Opg/ml 0 pg/ml Opg/ml
PI, preparation one; P2, preparation two; NC, negative control. * The pooled fractions
should contains PIA.
Table 4.2 PIA ELISA of the pooled fractions of PIA prepared by Mack and IMDM 
method
PIA extract/nm NC extract/nm
1:20 1:100 1:500 1:20 1:100 1:500
IMDM 1-2 0.144 0.108 0.119 0.32 0.112 0.114
IMDM 3-7 0.803 0.438 0.202 0.209 0.204 0.246
IMDM 8-10 0.22 0.139 0.121 0.243 0.166 0.133
IMDM 11-15 0.209 0.174 0.152 0.251 0.171 0.131
TSB 3-7 0.768 0.118
The numbers represent the absorbance value at OD=450nm.
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4.4 Up-scaling of PIA preparation using adherent biofilms produced in 
IMDM using cell culture plates
IMDM cell culture media supported S. epidermidis 1457 biofilm formation, however it 
was reasoned that glass was not the optimum surface for biofilm formation. Indeed 
biofilm assays are routinely done in NUNC 96 well cell culture plates. An approach was 
used involving the inoculation o f a NUNC 90mm cell culture plate with an S. 
epidermidis 1457 pre-culture grown in IMDM. Robust biofilms could be seen at 24 and 
48 hours following inoculation.
To quantify the amount o f PIA purified from S. epidermidis 1457 grown in IMDM using 
6 and 24 cell culture plates, hexosamine assays were carried out as described in 
materials and methods (section 2.9.2.3) for all the purified fractions 1-15 (Figure 4.2). 
There was a large increase in the amount of PIA obtained from 24 cell culture plates in 
comparison to the amount of PIA obtained from 6 cell culture plates. Critically for both 
preparations, PIA as determined by hexosamine was highest in fractions 3-7. In both 
preparations fraction 3 resulted in peak PIA output of 1187 pg/ml (from 24 plates) and 
2()()pg/ml (from 6 plates) of PIA respectively (Figure 4.2).
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Figure 4.2 Hexosamine assays of PIA fractions obtained by the IMDM method 
using 6 and 24 cell culture plates. Assay carried out on all 15 fractions for both 6 and 
24 plates preparations.
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After confirming the amount of PIA in all purified fractions obtained from growing S. 
epidermidis 1457 in 6 and 24 cell culture plates with IMDM, the PIA fractions were 
pooled together (1-2, 3-7, and 8-15) and the Hexosamine assay repeated. In the pooled 
fraction of tubes 3-7 which contained the majority of Hexosamine, the PIA increased 
from 103pg/ml in 6 plates to 603pg/ml in preparation 1 (PI) of 24 plates and 1065pg/ml 
in preparation 2 (P2) of 24 plates .
To determine antigenic presence of PIA the optimized ELISA was used as previously 
described. The optimized PIA ELISA confirmed the presence of PIA in extracts isolated 
by both methods, PIA levels were higher in fractions obtained from 24 cell culture plates 
in comparison with PIA obtained from 6 cell culture plates, and higher levels were 
detected in pooled fractions 3-7 as shown in table 4.3
Table 4.3 PIA ELISA of pooled fractions obtained by IMDM method
Pooled fractions 6 plates/nm 24 plates/nm
1-2 0.12 0.38
3-7 2.57 2.36
8-10 1.83 1.63
11-15 1.36 0.37
The numbers represent the absorbance value at OD=450nm.
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To further quantify the presence of functional PIA, a coagglutination assay (section 
2.9.2.2) was performed on pooled fractions (3-7) obtained from 6 and 24 plates 
preparations. Furthermore, extracts from biofilm negative S. epidermidis 1457-M10 and 
PBS were used as negative controls. PIA fractions from the 6 plate preparation had 
minimum active concentrations at 1/2 dilutions, whilst fractions from 24 plate 
preparations had minimum active concentrations at 1/502. Similar fractions from S. 
epidermidis 1457-M10 (NC) showed no activity in this assay (Table 4.4).
Table 4.4 Coagglutination assay for PIA detection
Neat 1/2 1/4 1/8 1/16 1/32 1/64 1/128 1/256 1/502 1/1024
6 PIA + + - - - - - - - - -
24 PIA + + + + + + + + + + -
24 PIA + + + + + + + + + + -
NC - - - - - - - - - - -
PBS - - - - - - - - - - -
PIA, polysaccharide intercellular adhesin; NC, negative control; PBS, phosphate 
buffered saline; neat, used samples without any dilution; +, coagglutination 
detected; -, absence of coagglutination.
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4.5 Lipopolysaccharide (LPS) detection assay
The LAL Chromogenic Endotoxin Quantitation Kit (section 2.9.3) was used to measure 
the amount of LPS in our purified PIA samples. The assay produced a robust standard 
curve (Figure 4.3) and reading were negative in all the purified samples obtained by 
IMDM methods, involving both samples obtained from biofilm forming S. epidermidis 
1457 and samples obtained from biofilm negative S. epidermidis 1457-M10 which was 
used as negative controls.
1.2
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0
y = 0 .99989x  + 0 .00005  
R2 = 0 .96072
0.2 0 .4 0.6 0.8
EU/ml
1.2
Figure 4.3 Standard curve of LPS detection assay.
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4.6 Confirmation of improved IMDM method
To compare material input and PIA output between the methods modified within this 
chapter an assessment of the volume of starting culture, the surface, including its area 
and the constituent material, and the final yield of PIA within the purified sample was 
done (Table 4.5). In moving from 6 beakers to 6 tissue culture plates, the total volume of 
starting culture was decreased 12-fold, despite the surface area and bacterial yield 
remaining equal. Furthermore a 4-fold increase in the number of tissue culture plates 
resulted in a 6-10-fold increase in yield, but with 3-fold less starting culture from the 
original Mack method (Table 4.5).
Table 4.5 Comparison of modified PIA preparation methods
Method Surface Material Volume (ml)
Surface area
„_2cm
PIA
(ue)
PIA
/18ml
Mack / PI 6 Beaker-Glass 6 x 300 = 1800 6 x 55 = 330 224 4 mg
Mack/P2 6 Beaker-Glass 6 x 300 = 1800 6 x 55 = 330 156 2.8mg
IMDM 6 Beaker-Glass 6 x 3 0 0 =  1800 6 x 55 = 330 131 2.35mg
IMDM 6 NUNC-TC dish 6 x 2 5  = 150 6 x 55 = 330 103 1.85 mg
EMDM/P1 24 NUNC-TC dish 24 x 25 = 600 24x55  = 1320 603 10 mg
IMDM/P2 24 NUNC-TC dish 24 x 25 = 600 24x55  = 1320 1065 19 mg
PI, preparation one; P2, preparation two.
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4.7 Discussion
Production of polysaccharide intercellular adhesin (PIA) is a major mechanism of S. 
epidermidis biofilm formation (Mack, Riedewald et al., 1999; Rohde, Frankenberger et 
al., 2010; Spiliopoulou, Krevvata et al., 2012), and plays an important role in bacterial 
primary adhesion to a surface and subsequent intercellular adhesion within the biofilm 
(Vuong, Voyich et al., 2004). PIA is considered a major virulence factor of S. 
epidermidis (Rupp, Ulphani et al., 1999) that helps S. epidermidis evade the immune 
system (Vuong, Voyich et al., 2004).
The ability to grow S. epidermidis biofilm and isolate purify PIA without any cross 
contamination from the culture medium is essential in order to study PIA composition 
and determine its biological effect on various aspects of the immune system. TSB has 
previously been the medium of choice to culture S. epidermidis biofilms (Christensen, 
Simpson et al., 1982), with the resultant biofilm undergoing a complex purification 
process to get a highly purified PIA without contamination from medium components. 
Studies carried out by Tojo et al and Ludwicka et al (Ludwicka, Uhlenbruck et al., 1984; 
Tojo, Yamashita et al., 1988) used a complex medium to grow biofilms and a 
complicated procedure for PIA purification in which contamination could not be 
excluded. Others developed a chemically defined medium that induced biofilm 
formation, in which different combinations of amino acids, vitamins and glucose 
produced biofilm by S. epidermidis (Hussain, Hastings et al. 1991).
To study PIA properties and its subsequent effects on the host, it was necessary to obtain 
an efficient method to purify PIA. Previously, Mack et al developed a purification 
process (Mack, Nedelmann et al., 1994) in which they used a TSB/G+ medium to 
culture S. epidermidis 1457 biofilm and used chromatography for the purification 
process. This method was modified by Gerke et al who extracted PIA attached to 
bacterial cell surfaces by boiling in 0.5M EDTA buffer (ethylene-diamine-tetraacetic 
acid) for 5 min at 100°C (Gerke, Kraft et al., 1998). Further modifications from Vuong 
and Otto (Vuong and Otto, 2008) involved boiling and dialysis of PIA extract, followed 
by enzyme digestion steps including treatment with DNase, RNase, Lysostaphin, 
Lysozyme and proteinase K before chromatography.
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The disadvantage of these methods have been; i) the use of TSB as the growth medium 
may lead to PIA contamination; ii) the potential loss of PIA in the dialysis step. Due to 
these limitations the need for a highly purified PIA without contamination to asses host / 
PIA interaction, this study modified the protocol developed by Mack by replacing 
TSB/G+ with IMDM which supported biofilm formation to a similar extent to TSB 
(Chapter 3, Figure 3.1).
S. epidermidis 1457 grown in glass beakers using IMDM produced detectable PIA but 
the amount was much less compared to Mack et al, although purity appeared 
concentrated in discrete fractions. The reduced yield under these circumstances was not 
surprising considering the major roles of growth media (as shown in Chapter 3) and 
(Deighton and Balkau 1990) and surface substrate play in biofilm formation (Bos, van 
der Mei et al. 1999; Patel, Ebert et al. 2003; MacKintosh, Patel et al. 2006).
Staphylococcus epidermidis is a major cause of device related infection, in which 
biofilm formation is the main virulence factor (O'Gara and Humphreys, 2001). Bacterial 
adherence and biofilm formation of S. epidermidis can be affected by the type of the 
biomaterials and their chemical and physical surface properties (Patel, Ebert et al., 
2007). Bacterial adherence and biofilm formation to intraocular lenses are increased 
when the lenses are made from polymethyl methacrylate as bacteria have greater avidity 
for the irregular surface of these lens type (Pinna, Zanetti et al., 2000; Kodjikian, Roques 
et al., 2006).
Surface properties play an important role in biofilm formation and subsequent 
development of catheter associated urinary tract infections. The use of antiseptic- coated 
silver oxide urinary catheters reduces bacterial colonization and biofilm formation 
(Schumm and Lam, 2008) compared with antiseptic-coated silver alloy catheters and 
standard polytetrafluoroethylene coated catheters (Pickard, Lam et al., 2012).
In this study it was hypothesised that the presence of a suitable surface would enhance 
primary bacterial attachment, which is essential for subsequent biofilm formation in 
IMDM (Chapter 3). Thus inoculating S. epidermidis 1457 into cell culture plates 
overcame this inhibitory effect (in beakers) and supported primary attachment, which
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consequently led to formation of a larger quantities o f biofilm. Furthermore, increasing 
the surface area 4X (6 to 24 plates) increased the amount of PIA obtained by 6-10 folds 
(lOOpg/ml from 6 plates to 600-1000pg/m l in 24 plates). These simple findings 
demonstrate that increasing the adherent surface area available to bacteria is a key point 
in obtaining significantly increased biofilm biomass, which ultimately leads to dramatic 
increases in the amount of PIA purified (Figure 4.4).
Staphylococcus epidermidis 1457 
IMDM + Surface
f
*
Biofilm Accumulation 
*  
PIA on large scale
Figure 4.4 Biofilm formation by S. epidermidis 1457 in IMDM using cell culture 
plates.
Finally, bacterial lipopolysaccharides (LPS) are a component of the Gram-negative 
bacteria cell wall and as such are considered major virulence factors (Fujihara, Muroi et 
al., 2003). LPS activates macrophages through Toll - lik e  receptor 4 (TLR4), which 
produces a variety of inflammatory cytokines (Heumann and Roger, 2002). The 
ubiquitous nature of LPS results in cell culture contamination and increased background 
levels during in vitro experiments (W akclin, Sabroc et al., 2006). Removing LPS can 
prove difficult and use of TLR-4 deficient cells is not always practical, thus in these 
studies the confirmatory results that our PIA preparations contain <15pg/ml LPS is
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particularly encouraging. PIA produced by this method will be used in the host pathogen 
interaction experiments described in Chapter 5 and 6.
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Chapter 5
The effect of soluble, cell- associated 
and biofilm- associated PIA on THP-1 
cells: importance of tethering for 
cytokine production
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5.1Introduction
PIA is major virulence factor of 5. epidermidis and essential for its pathogenesis 
(Nedelmann, Sabottke et al., 1998; Rupp, Ulphani et al., 1999). PIA is a linear p 1,6- N- 
acetylglucosamine containing positive charges due to deacetylated amino groups and 
negative charges due to O-succinoyl ester residues (Heilmann, Schweitzer et al., 1996; 
Mack, Fischer et al., 1996), PIA is produced by ica locus, which is composed of the 
operon encoding icaADBC-membrane bound enzyme complex (Vuong, Kocianova et 
al., 2004; Cerca, Jefferson et al., 2007).
PIA has dramatic effects on the innate immune system when tested during in vitro 
assays. Indeed, PIA has been shown to protect planktonic wild-type S. epidermidis from 
the killing effects of neurophils and antimicrobial peptides to a greater extent than its 
PIA negative mutant (Vuong, Kocianova et al., 2004; Vuong, Voyich et al., 2004). 
Kristian et al (Kristian, Birkenstock et al., 2008) demonstrated that PIA dependent 
biofilms protected S. epidermidis from killing by neutrophils through increasing C3 
complement secretion and prevention of C3b and IgG deposition on the bacterial cell 
surface. PIA expressing biofilm positive S. epidermidis were protected from 
phagocytosis by macrophages compared to their isogenic deficient mutants through 
diminished activation of the inflammatory response by a mechanism involving reduced 
NF-kB activation and IL-ip production (Schommer, Christner et al., 2011). Leid et al 
(Leid, Shirtliff et al., 2002) demonstrated that leukocytes could penetrate PIA biofilm, 
but were unable to engulf bacteria inside biofilm compared to their planktonic 
counterparts. This finding suggests that there are mechanisms other than biofilm matrix 
that serve to discourage phagocytosis. In contrast, Wagner et al found that 
Polymorphonuclear leukocytes (PMN) were unable to penetrate biofilm and whilst 
‘paralysed’ retained the ability to produce antimicrobial superoxides (Wagner, Kaksa et 
al., 2004).
The studies in this chapter investigate the effect of PIA on the immune system have used 
the purified PIA molecule (generated in chapter 4), PIA positive S. epidermidis and their 
negative controls in both planktonic and mature biofilm models. Little is known about 
the effect of purified PIA, cell associated PIA and biofilm associated PIA on isolated 
cells in vitro. For that PIA effect on cytokine release (IL-8, IL-10 and TNF-a) was
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studied. IL-8 and TNF-a are pro-inflammatory cytokines release by PMN cells rapidly 
after exposure to infectious agent (Baggiolini and Clark-Lewis, 1992), IL-8 is a 
powerful chemotactic, attract neutrophils to the site of infection (Desbaillets, Diserens 
et al., 1997), whilst IL-10 is anti-inflammatory cytokines inhibit IL-8 and TNF-a release 
from macrophages (Cassatella, Meda et al., 1993). Furthermore, the traditional 
microbiology approache of using biofilm positive wild type S. epidermidis with an 
isogenic biofilm negative mutant often results in two dramatically different phenotypes 
that become difficult to compare due to their different forms. Recent studies 
demonstrated that PIA dependent biofilms can be disrupted by the enzyme dispersinB 
(DspB) which is a beta-l,6-N-Acetylglucosaminidase, originally identified in 
Actinobacillus actinomycetemcomitans (Kaplan, Ragunath et al., 2004; Ramasubbu, 
Thomas et al., 2005; Chaignon, Sadovskaya et al., 2007). DispB has the ability to digest 
PIA, removing the biofilm matrix and exposing biofilm bacteria to the host immune 
system and antibiotics (Venketaraman, Lin et al., 2008; Arciola, 2009; Kaplan, 2009).
In this chapter the studies undertaken were to:
• Investigate the influence of different forms of PIA on the immune response
• Model biofilm structure and leukocyte sedimentation
• Use Dsp.B to examine biofilm associated PIA effects
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5.2 Methods
THP-1 cells were added to planktonically grown S. epidermidis 1457, preformed S. 
epidermidis 1457 biofilm or purified PIA to assess THP-1 effects on bacterial viability 
(section 2.11.4) and cytokines profiles ( section 2.11.5) through using ELISA.
For killing assays, bacterial suspensions of S. epidermidis 1457 and S. epidermidis 1457- 
M10 were incubated with THP-1 monocytes for 2 hours. Control cultures at zero time 
and without macrophages were also included. Bacterial viability was assessed through 
enumerating colony forming unit as described in section 2.8.3. For cytokine production 
assays, samples from THP-1 cells incubated with planktonic S. epidermidis 1457 and S. 
epidermidis 1457-M10 for 6 hours, were tested for expression of IL-8, TNF-a and IL-10 
using an ELISA kit as described in section 2.10.1.
For crude lysate effect, different concentration of crude supernatant prepared as in 
section 2.8.4 (1, 10, 50, 200) pl/ml added to 2X105 THP-1 cells / 500pl of RPMI- made 
with 10%FBS and 1% L-glutamine and P/S. Control culture at zero time with PBS and 
PMA were included. Supernatant were collected at two time points, 6 and 24 hours, and 
an IL-8 ELISA was done for the samples as mentioned previously.
With regards to the effect of purified PIA on THP-1 cells, 60pg/ml of PIA and an 
equivalent volume of PIA- extract (as a negative control; NC) was incubated with THP- 
1 cells for 6 and 24 hours. IL-8 was then quantified by ELISA. THP-1 cells with and 
without Phorbol myristate acetate (PMA) was used as the controls (to assess cytokines 
production in PMA treated THP-1 cells).
For characterization of S. epidermidis 1457 biofilm structure, S. epidermidis 1457 was 
stained with SYT09 (green) and the bacterial PIA matrix stained with 
tetramethylrhodamine conjugate of Wheat Germ Agglutinin (WGA, orange) (as in 
section 2.17.1). A 4 and 8 chamber slide was used to incubate S. epidermidis for 24 
hours and 48 hours. The biofilm was then stained with SYT09 and WGA fluorescent 
stain for 60 minutes. CLSM was then used to image the biofilm.
To examine the ability of THP-1 cells to penetrate S. epidermidis 1457 biofilm, THP-1 
cells were added to preformed biofilm and migration assessed at three different time 
intervals (0-1, 1-2, 2-3 hours). S. epidermidis 1457 expressing green fluorescent protein 
(GFP) (Franke, Dobinsky et al. 2007) was also used along with THP-1 cells stained with
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Cell Mask. CLSM was again used to investigate the penetration of leukocytes into the 
biofilm.
Results 
5.3 The effect of cell associated PIA on THP-1 cells.
To investigate the effect of cell-associated PIA on THP-1 cells, planktonic S. 
epidermidis 1457 (biofilm/PIApositive) and 1457-M10 (biofilm/PIA negative) were 
both used to challenge THP-1 cells and functional killing of bacteria, phagocytosis and 
cytokine production then analysed.
Leukocyte killing assays showed that THP-1 monocytes had no significant effect on the 
growth or killing o f either S. epidermidis 1457 or 1457-M10 after two hours, with both 
strains growing over the course of the assay (Figure 5.1). Phagocytosis assays confirmed 
there was no difference in the number of THP-1 cells containing S. epidermidis 1457 
(1.25+ 0.3%) bacteria/cell+/-SD and S. epidermidis 1457-M10 (0.5+ 0%) bacteria/ccll+/- 
SD of three independent experiments.
Figure 5.1. Effect of THP-1 leukocytes on bacterial viability. t=0 represents control 
culture at the start of the experiment, bacteria alone represents control culture after two 
hours without macrophages, THP-1 + bacteria is the combination of THP-1 cells and 
bacteria after two hours. Results represent data from 3 independent experiments.
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Cytokine ELISA assays showed that planktonic S. epidermidis 1457 and S. epidermidis 
1457-M10 induced IL-8 release by THP-1 cells after 6 hours. Specifically, IL-8 release 
in response to S. epidermidis 1457 was nearly double the amount induced by S. 
epidermidis 1457-M10 bacteria and was statistically significant P<0.05 (Figure 5.2). 
Furthermore, adding planktonically grown S. epidermidis 1457 to THP-1 cells promoted 
TN F-a release com pared with S. epidermidis 1457-M10 and this was statistically 
significant P< 0.05 (Figure 5.3).
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Figure. 5.2 Effect of cell associated PIA on IL-8 release from THP-1 cells.
Comparison between S. epidermidis 1457 (PIA/biofilm) positive and S. epidermidis 
1457-M10 (PIA/biofilm) negative. Results represent data from 3 independent 
experiments. Star indicates significant difference P< 0.05.
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Figure. 5.3 Effect of cell associated PIA on TNF-« release from THP-1 cells.
Comparison between S. epidermidis 1457 (PIA/biofilm positive) and S. epidermidis 
1457-M10 (PIA/biofilm) negative. Results represent data from 3 independent 
experiments. Star indicates significant difference P< 0.05.
In contrast, IL-10 release from THP-1 cells in response to S. epidermidis 1457 and S. 
epidermidis 1457-M10 showed no difference between each other or control THP-1 cells
(Figure 5.4).
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Figure. 5.4 Effect of cell associated PIA on IL-10 release from THP-1 cells.
Comparison between 1457 (PIA/biofilm ) positive and 1457-M 10 (PIA/biofilm) 
negative. Results represent data from 3 independent experiments.
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5.4 The effect of soluble PIA on THP-1 cells
To investigate the effect of soluble PIA on THP-1 cells, crude lysate prepared from S. 
epidermidis 1457 (biofilm/PIA positive) and S. epidermidis 1457-M 10 (biofilm/PIA 
negative), and purified PIA obtained by the IMDM method (Chapter 4) were used to 
examine their effects on cytokine production by THP-1 cells after 6 hours.
Cytokine assays showed that crude extracts induced IL-8 release from THP-1 cells, in a 
dose dependent manner (1:500, 1:50, 1:10, and 1:2.5 dilutions). IL-8 released in 
response to S. epidermidis 1457 crude lysate was higher than that induced by S. 
epidermidis 1457-M 10 (Figure 5.5A). IL-8 production was 350pg/ml and 236pg/ml for 
S. epidermidis 1457 and S. epidermidis 1457-M10, respectively. Increasing the 
incubation time to 24 hours, increased IL-8 levels further, and at the highest dose of 
crude lysate IL-8 a peak level was achieved of 640pg/ml and 51 Opg/ml for S. 
epidermidis 1457 and S. epidermidis 1457-M10, respectively (Figure 5.5 B).
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Figure 5.5 IL-8 cytokine release by THP-1 cells in response to dilution of S. 
epidermidis 1457 and S. epidermidis 1457-M10 crude lysate. A. IL-8 release in 6 
hours, B. IL-8 release in 24 hours. Results represent data from 3 independent 
experiments. PBS is phosphate buffered saline, used as negative control. PMA is 
phorbol myristate acetate, used as positive control.
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To improve the specificity of these experiments the purified PI A (60pg/m l) produced in 
Chapter 4 was used. This PA had previously been shown to be biologically active by the 
co-agglutination assay (Figure 4.4).
Adding purified PIA to THP-1 cells did not induce IL-8 secretion after both 6 and 24 
hours incubation, despite significant IL-8 release following stimulation with PMA and 
LPS (Figure 5.6).
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Figure 5.6 IL-8 cytokines release in THP-1 cell line in response to purified PIA 
extract. IL-8 ELISA preformed at 6 and 24 hours to estimate IL-8 release in response to 
different stimuli. The results shown are representative of three independent experiments. 
C, THP-1 cells only. PMA, phorbol myristate acetate, used as positive control. PIA, 
polysaccharide intercellular adhesin (purified) from S. epidermidis 1457. NC, extract 
from (PIA/biofilm) negative S. epidermidis 1457-M10. LPS, lipopolysaccharide, used as 
positive control.
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5.5 Structure of S. epidermidis biofilm associated PIA as determined by 
confocal laser scanning microscopy
To investigate the effect of biofilm associated PIA on THP-1 monocytes, the temporal 
changes taking place when moncytes were added to S. epidermidis biofilms had to be 
determined. These experiments served to inform later experiments on cytokine 
production.
Confocal scanning laser microscopy (CLSM) was used to define biofilm structure and 
follow the time course of monocytes penetration.
Confocal microscopy images revealed good staining of bacteria using SYT09 (Green), 
whilst WGA (Orange) stained the PIA matrix surrounding and covering the bacteria 
(Figure 5.7A). Staphylococcus epidermidis 1457 formed robust biofilms (Figure 5.7 B- 
C) where bacterial microcolonies were embedded in extracellular PIA. Black areas 
devoid of stain were also observed. Staphylococcus epidermidis 1457 was present in 
high densities close/bound to the substratum and were embedded in the extracellular 
polymeric substance (EPS) of biofilm. Thus, moving from the bottom to the top of the 
biofilm, the numbers of bacteria gradually decrease with increasing amounts of EPS 
becoming evident (Figure 5.7B). This pattern was enhanced after 48 hours due to further 
production of EPS/PLA with a resulting increase in the thickness of biofilm (Figure 
5.7C).
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Figure 5.7 Characterisation of Staphylococcus epidermidis 1457 biofilm structure.
Biofilm growth was viewed by CLSM, the green colour represents the S. epidermidis 
1457 bacteria, and the orange colour represents the PIA matrix. A. Bacteria embedded 
in PIA matrix; B. Biofilm formation in 24 hours; C. Biofilm formation in 48 hours. The 
depth of the biofilm is indicated in the panels of 5.7b and 5.7c.
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For characterisation of S. epidermidis 1457 biofilm viability, the live/dead ratio of cells 
in the biofilm was assessed by Syto 9 and Propidium Iodide (PI) fluorescent stain. Using 
CLSM , live / dead staining revealed that under normal conditions (nutrient, temperature 
and suitable environmental condition), over 90% of the cells in the normal biofilm were 
viable (Figure 5.8).
Figure 5.8 Characterisation of Staphylococcus epidermidis 1457 biofilm viability.
Biofilm growth as viewed by CLSM. Green fluorescence represents viable cells, and red 
fluorescence represents non viable cells.
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5.6 The effect of biofilm associated PIA on penetration of THP-1 cells
In order to evaluate biofilm -  monocyte interaction, and to examine the ability of THP-1 
cells to penetrate S. epidermidis 1457 biofilm, THP-1 cells were added to preformed 
biofilm and their migration assessed at three different time intervals (0-1, 1-2, 2-3 
hours). Staphylococcus epidermidis 1457 expressing GFP (Franke, Dobinsky et al., 
2007) was used and the THP-1 cells were stained with Cell Mask. CLSM was used to 
investigate the penetration of the leukocytes into the biofilm.
Serial sections of biofilm were obtained at 1.4pm intervals between 0-53.3pm from the 
substrate to the surface of the biofilm. THP-1 cells stained with Cell Mask were 
pseudocoloured purple, and the GFP expressing strain of S. epidermidis 1457 (Franke, 
Dobinsky et al. 2007) was depicted as green staining bacteria embedded in the PIA 
matrix. The biofilm matrix was seen as an unstained gap between the bacteria and 
monocytes (Figure 5.9 A-C). Biofilm penetration by the leukocytes was assessed in 
serial sections at different time points and the velocity of leukocyte migration measured 
as pm/h. Confocal images revealed that THP-1 cells had the ability to penetrate the 
biofilm. During the first hour of incubation THP-1 cells migrated about 6.8pm (53.3 to 
46.5pm), in the second hour migration was 19.2 pm (46.5 to 27.3pm), then in the third 
hour the THP-1 cells moved 5.5pm (27.3 to 21.8pm).
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cFigure 5.9 The effect of biofilm associated PIA on penetration of THP-1 cells.
A. 0-1 hours. B. 1-2 hours, C. 2-3hours.
137
5.7 The effect of biofilm associated PIA on cytokine production by 
THP-1 cells
Knowing that THP-1 cells can penetrate into S. epidermidis biofilm following 3 hours, 
the effect of biofilm associated PIA on the THP-1 cell cytokine profile following 3 hours 
was determined. Mature S. epidermidis 1457 biofilms were incubated with THP-1 cells 
for 6 hours in the presence of increasing doses of Dispersin B (DspB, 0.001, 0.01, 0.1, 1 
pg/ml). THP-1 cells with 1 pg/ml Dsp.B alone were used as controls and IL-8, TNF-a 
and IL-10 quantified by ELISA as previously described.
Biofilm associated PIA enhanced IL-8 release from THP-1 cells. Subsequent digestion 
of biofilm matrix with DspB diminished DL-8 release in a dose dependent manner. The 
IL-8 release in response to biofilm declined by more than the 57% when the biofilm was 
digested withlpg/ml DspB (decreasing from 714 to 312pg/ml respectively, P<0.05) 
(Figure 5.10).
THP-1 Bio. B io .+0.001 B io .+0.01 B io .+0.1 B io.+ l.O
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t r e a t m e n t
Figure 5.10 IL-8 cytokine release in THP-1 cells in response to S.epidermidis 1457 
biofilm treated with Dsp.B. The results shown are representative of 3 independent 
experiments. Star indicates significant difference P<0.05. Bio, biofilm. Dsp.B, Dispersin 
B concentratin provided in pg/ml.
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Furthermore, digestion of biofilm by Dsp.B decreased TNF-a release by THP-1 cells 
compared with biofilm, although results were not significant (Figure 5.11).
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Figure 5.11 TNF-a cytokine release by THP-1 cells in response to S.epidermidis 
1457 biofilm treated with Dsp.B. The results shown are representative of three 
independent experiments. Bio, biofilm. Dsp.B, Dispersin B concentratin provided in 
pg/ml.
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Adding THP-1 cells to mature biofilm had no effect on IL-10 release in comparison to 
control THP-1 cells. In contrast complete digestion of biofilm with Dsp.B increased IL- 
10 release, P< 0.05 (Figure 5.12).
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Figure 5.12 IL-10 cytokines release by THP-1 cells in response to S.epidermidis 
1457 biofilm treated with Dsp.B. The results shown are representative of 3 
independent experiments. Star indicates significant difference P<0.05. Bio, biofilm. 
Dsp.B, Dispersin B concentratin provided in pg/ml.
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5. 8 Discussion
To date, it is still unclear how S. epidermidis eludes killing by the human innate immune 
system. The role of cytokines and cell types other than IL-8 and neutrophils in S. 
epidermidis infection is not well studied. Monocytes are an important cell type which S. 
epidemidis may interact with to induce an inflammatory response.
In this chapter it was shown that cytokine responses by monocytic THP-1 cells were 
dependent on the form of PIA (cell associated, soluble or biofilm associated). These 
results showed that biofilm bacteria have phenotypically distinct characteristics from 
their planktonic forms, as when purified PIA was added to THP-1 cells there was no 
IL-8 release, but after addition of S. epidermidis 1457 in suspension, there was an 
enhanced IL-8 release compared with PIA negative S. epidermidis 1457-M10. 
Furthermore, digestion of S. epidermidis 1457 biofilms with Dsp.B led to reduced IL-8 
release. These results suggest that PIA may need to be bound to the bacterial surface to 
simulate cytokines release by macrophages. That is when it is bound to the bacterial 
surface it is held in the correct conformation to stimulate a receptor on the surface of 
THP-1 cells. Interestingly, for complete biofilm forming activity PIA needs to be 
deacetylated, through the function of the IcaB gene, the product of which is a surface 
protein that coordinate polysaccharide de-N-acetylation (Vuong, Kocianova et al., 2004; 
Cerca, Jefferson et al., 2007; Itoh, Rice et al., 2008). To date, it is unknown whether 
icaB is essential for inducing cytokine release.
The difference in the inflammatory response between S. epidermidis 1457 biofilm 
associated PIA and purified PIA could be because the biofilm matrix contains other 
antigens. These other antigen include extracellular DNA (eDNA) (Qin, Ou et al., 2007) 
and protein in addition to the carbohydrates poly-N-acetylglucosamine polysaccharides 
and extracellular teichoic acids (Mehlin, Headley et al., 1999; Sadovskaya, Vinogradov 
et al., 2004; Jones, Perris et al., 2005; Arciola, 2009; Jabbouri and Sadovskaya, 2010). 
Therefore, digestion of PIA by Dsp.B (Kaplan, 2009) could have caused disruption of 
biofilm structure and exposed bacteria and other components of the biofilm matrix and 
cell-walls leading contribute to a differential cytokine release as planktonic cells 
produced IL-8 and IL-10 but biofilm cells only produced IL-8. These findings correlate 
with those of Secor et al (Secor, James et al., 2011) who found a difference in
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inflammatory cytokine production between S. aureus biofilm and their planktonic 
equivalent. Similar findings were also demonstrated by Schommer et al and 
Spiliopoulou et al (Schommer, Christner et al., 2011; Spiliopoulou, Krevvata et al., 
2012). In contrast to the finding of Stevens et al (Stevens, Sadovskaya et al., 2009), our 
purified PIA did not induce cytokine release in THP-1 which could be due to difference 
in the purification method by which the present study obtained PIA. In addition, this 
present study used THP-1 cells whilst Steves et al employed astrocytes, which could be 
more sensitive to external stimuli (Sofroniew and Vinters, 2009).
The simultaneous up regulation of pro-inflammatory cytokines IL-8 and TNF-a and 
down regulation of the anti-inflammatory cytokine IL-10 by biofilm associated PIA is 
likely to increase the inflammatory response at the site of infection resulting in further 
damage to host tissue, as IL-8 induces infiltration of more neutrophils to the site of 
infection. However, macrophages use cytokines to deal with infection by different 
methods. Secreted chemokines like IL-8 will attract neutrophils to the site of infection, 
release cytokines and soluble mediators such as TNF, prostaglandin and platelet 
activating factor. These mediators then act on the endothelium to modify blood vessel 
permeability and allow more neutrophils and monocytes to leave blood and enter the 
tissues (Wood, 2011). Certainly, there is a suggestion that monocytic cells are an 
important contributor to the tissue damage caused by device associated infections. 
Similar findings have also been demonstrated in animal models of S. aureus infection 
where there was a strong inflammatory response induced at site of infection (Prabhakara, 
Harro et al. 2011). Figure 5.13 summarizes the inflammatory response toward different 
form of PIA.
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Figure 5.13 Inflammatory response of THP-1 cells toward different form of PIA.
CSLM images revealed the unique structure of biofilm plays an important role in 
bacterial protection, with the bacteria near the substratum being surrounded by 
heterogeneously distributed extracellular polysaccharide which may protect against host 
immune cell penetration and antibiotic diffusion. The increasing bioflm thickness with 
time suggested the continuing synthesis of the biofilm and may explain the difficulty of 
eradication of chronic implanted infection associated with biofilm formation, as 
increased biofilm thickness may further reduce the penetration for antibiotic and 
immune cells (Patel, 2005; Anderson and O'Toole, 2008). Kirby et al found that biofilm 
may act as a diffusion barrier protecting bacteria from the killing effect of antibiotics 
like Colistin, Streptomycin, and Gentamicin as planktonic bacteria were killed to a 
greater extent than those embedded within biofilms (Kirby, G am er et al., 2012). 
Therefore the organization o f bacterial cells within biofilms could in part explain the 
resistance o f this organism to antimicrobial agent. Studies by Schommer et al 
(Schommer, Christner et al., 2011) demonstrated the importance o f macroscopically and 
microscopically distinctive structure of S. epidermidis 1457 biofilm, as
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immunofluorescence microscopy images showed PIA as tether-like fibers pervading the 
biofilm in a string-like manner.
This present study also demonstrated that THP-1 cells had the ability to penetrate the 
biofilm over 1-3 hours. Interestingly, the penetration rate slowed with increased time 
and cells did not reach the bacteria bound to the substratum. Leid et al (Leid, Shirtliff et 
al., 2002) also demonstrated that leukocytes penetrate the biofilm, but they were not able 
to engulf bacteria inside the biofilm. This brake or paralysis at a certain point following 
contact with the biofilm remains a critical area for research as the phenotype of these 
penetrated leukocytes is unknown.
In conclusion, the structural characteristics of S. epidermidis biofilms together with the 
tethering of PIA to the bacterial cell surface (Ganesan, Stewart et al., 2013) have 
significant impact on the inflammatory response in THP-1 cells. In Chapter 6 these 
findings are extended to an ex vivo model of whole blood infection.
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Chapter 6
The effect of soluble, cell-associated and 
biofilm-associated PIA on whole blood: 
importance of humoral immunity and
C5a
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6.1 Introduction
Biofilm formation is a leading cause of health care associated infection involving 
implanted medical devices such as urinary catheters (Niveditha, Pramodhini et al., 
2012), central venous catheters, heart valves, coronary stents, neurosurgical ventricular 
shunts, and fracture-fixation devices (Costerton, Montanaro et al., 2005). In addition, 
there are many chronic diseases associated with biofilms, e.g. native valve endocarditis, 
periodontitis, chronic rhinosinusitis, and otitis media (Hou, Sun et al., 2012).
In previous studies investigating killing and phagocytosis of biofilm positive bacteria 
using cells such as neutrophils and monocytes, biofilm forming S. aureus were more 
resistant to neutrophils compared to planktonic counter parts (Barrio, Vangroenweghe 
et al., 2000). However, isolated leukocytes do seem to adhere and penetrate into S. 
aureus biofilms (Leid, Shirtliff et al. 2002).
In vivo, biofilm formation has been associated with persistent CoNS bacteremia in 
neonates in intensive-care units (Dimitriou, Fouzas et al., 2011). Furthermore, PIA 
forming Staphylococcal biofilms appear to be a major virulence factor in a biomaterial- 
associated infection model in rate and mice (Rupp, Ulphani et al., 1999; Rupp, Ulphani 
et al., 1999). The killing effect of S. epidermidis on Caenorhabditis elegans (nematode) 
is also diminished by infecting with PIA negative S. epidermidis strains (Begun, Gaiani 
et al., 2007). Gunether et al. found that 5. epidermidis biofilm were more resistance to 
phagocytosis by polymorphonuclear cells (PMN) than 5. aureus biofilm (Guenther, 
Stroh et al. 2009). In a mouse model of catheter-associated biofilm infection, S. 
aureus biofilms evad innate immunity, through inhibited macrophages phagocytosis and 
reduced proinflammatory immune responses (IL-1 (3 and TNF-a) (Thurlow, Hanke et al. 
2011).
Less is known about the functional effects of PIA dependent biofilms on human systems 
in vivo during infection. In this chapter an ex vivo whole blood model has been 
developed to display function and dysfunction. Using this model, exploration of the 
effect of functional modulation on whole blood killing and cytokine release, and whether 
killing and inflammatory responses to PIA/biofilm positive S. epidemidis differed to 
PIA/biofilm negative strain was undertake. The phagocytic receptor pathways by which 
the immune cells cleared S. epidermidis were examined. The different forms of PIA
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including purified PIA, cell associated PIA and biofilm associated PIA were all used in 
these experiments.
Specifically, this chapter investigated the:
• Development of an ex vivo model of whole blood infection in health and under 
immunosuppressive conditions
• Comparison of planktonic and biofilm associated PIA effects on whole blood
• PIA expression in whole blood
• Formation of biofilm in normal or immunosuppressed whole blood 
6.2 Methods
For whole blood killing assays, bacterial suspensions of S. epidermidis 1457 and S. 
epidermidis 1457-M10 were incubated with rotation at 37°C in whole blood or TSB for 
30 min, lh, 2h and 6h. Control cultures at zero time and those without blood were 
included. Bacterial viability was quantified through viable counts (section 2.12.2).
To study the effects of purified PIA extracts, 1ml of whole blood was added to a 1.5ml 
microcentirfuge tube and incubated with purified PIA extract and S. epidermidis 1457- 
M10 extract. Extracts at different concentrations (10, 30, and 60pg/ml) were incubated 
for 3 hours before adding S. epidermidis 1457-M10, as described in section 2.12.4. 
Suspensions were incubated with rotation (lOrpm) at 37°C for 6 hours and then viable 
counts assessed. Platelet poor plasma/serum was isolated as described in section 2.12.2. 
To investigate potential phagocytic receptors pathway blood was pretreated with either 
5|ig/ml anti CD1 lb antibody, 20pg/ml anti CD 18, or anti CD 16. Mouse IgG Isotype was 
used as a control. Incubation was for 30 minutes, before adding S. epidermidis 1457 and 
S. epidermidis 1457-M10. The blood was then incubated with the bacteria for 6 hours 
with rotation at 37°C. Bacterial viability was then assessed by counting CFU.
For cytokines production assays, samples from whole blood (pretreated with Dex., 
CytoD and PIA) were incubated with planktonic S. epidermidis 1457 and S. epidermidis 
1457-M10 for 6 hours and then tested for IL-8, TARC, IL-lp,TNF-a , IL-10 and C5a 
using ELISA as described in section 2.10.1. The RayBioHuman cytokine assay was used 
to determine cytokine expression profile in samples of whole blood preincubated with
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planktonic S. epidermidis 1457 and 5. epidermidis 1457-M10, purified PIA and controls 
as described in section 2.10.2.
For Immunocytochemistry ICC, cytospin preperations were prepared as described in 
section 2.13. Preparations were blocked with 200pl 1% BSA for 1 hour, then washed X3 
with PBS. Then, 200pl of anti-rabbit PIA antiserum (diluted 1:50) was applied. The 
slides were covered and after 30 minutes washed X3 with PBS. Slides were then stained 
with fluorescein-conjugated anti-rabbit IgG (Alexa flour 488, diluted 1:100) and 
propidium iodide (diluted 1:1000), covered and incubated for 30 minutes. Slides were 
washed X3 wih PBS and 25pl of vectashield hardset was added. A coverslip was gentaly 
placed on the preparation which was left in the fridge to harden. Slides were examined 
using an epifluorecent microscope as mentioned in section 2.16.1.
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Results
6.3 The effect of cell associated PIA on whole blood
To investigate the effect of cell associated PIA on whole blood, planktonic S. 
epidermidis 1457 (biofilm/PIA positive) and S. epidermidis 1457-M10 (biofilm/PIA 
negative) were compared in a variety of assays including; whole blood killing of 
bacteria, cytokine production and C5a production in blood.
Preliminary dose finding experiments used high (5.3 x lO 10 bactcria/ml), medium (2.4 x 
10s bacteria/ml) and low (5.1 x 107 bacteria/ml) doses of 5. epidermidis 1457-M10 
incubated for 30, 60 and 120 minutes with whole blood, before assesment of bacterial 
viability. Whole blood killing of S. epidermidis 1457-M10 was dose dependent with the 
lowest dose (5.1 x 107) used for the remaining whole blood killing experiments as it 
resulted in the greatest killing response (Figure 6.1).
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Figure 6.1 Dose responses of S. epidermidis 1457-M10 to whole blood killing. Three 
different doses of S. epidermidis 1457-M10 were used, and bacteria were incubated in 
either TSB or whole blood over 120 minutes. Results represent data from 3 independent 
experiments.
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To study the effect of cell associated PIA on whole blood killing assays bacterial 
suspensions of S. epidermidis 1457 and S. epidermidis 1457-M10 were incubated with 
rotation at 37°C in whole blood or TSB for 30, 60 and 120 minutes. Control cultures at 
zero time and without blood were also included and bacterial viability quantified 
through viable counts. No significant differences in whole blood killing (Figure 6.2, t=0 
compared to t=120) was detected between S. epidermidis 1457 and S. epidermidis 1457- 
M10 at early time points post infection (Figure 6.2). At t=120 there was a trend towards 
slower growth by S. epidermidis 1457 compared to its isogenic control (Figure 6.2 
orange vs yellow circles).
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Figure 6.2 Whole blood killing of S. epidermidis 1457 and S. epidermidis 1457-M10. 
Killing of both 1457 and 1457-M10 in blood compared to the normal growth in TSB at 
different time intervals (0, 30, 60, and 120 minutes). Results represent data from 3 
independent experiments.
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Further characterization of whole blood killing o f S. epiderm idis  after 6 hours 
demonstrated a 50-fold reduction in bacterial counts, but no differences between S. 
epiderm idis  1457 and S. epiderm idis  1457-M10 (Figure 6.3, Bar 1 and 2 vs Bar 5 and 6). 
Antibody blocking experiments showed that clearance of both S. epiderm idis  1457 
(biofilm/PIA positive) and S. epiderm idis  1457-M10 (biofilm/PIA negative) were 
CD 1 lb/CD 18 dependent (complement receptor 3), but independent of CD 16 (Fc 
receptor) (Figure 6.3).
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Figure 6.3 P hagocytic receptors pathw ay. A comparison in killing rate between S. 
epiderm idis  1457 (PIA/biofilm +) and 5. epiderm idis  1457-M10 (PIA/biofilm-) in blood 
pretreated with C D l lb ,  CD 18 and CD 16 blocking antibodies. Bl+Bact., blood with 
bacteria only. Bl+lso, blood with isotypc. CD1 lb, blood blocked with antihuman CD1 lb 
blocking antibody. CD 18, blood blocked with antihuman CD 18 blocking antibody. 
CD 16, blood blocked with antihuman CD 16 blocking antibody. Results represent data 
from 3 independent experiments.
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The consistently observed similarities between S. epiderm idis  1457 and S. epiderm idis  
1457-M10 prompted sudies to examine PIA expression in S. epiderm idis  1457 in whole 
blood. Immunocytochcmistry (ICC) assays were performed to detect PIA expression by 
S. epiderm idis  1457 in whole blood and cell culture media. In these studies S. 
epiderm idis  1457 was grown in TSB/G- (without glucose) overnight (which inhibite PIA 
expression) and subcultured into different media including TSB/G-, TSB/G+ (with 
glucose), IMDM, blood, blood+cytochalasin D (cyto.D). Samples were then taken after 
3h, 5h, and 24h (Figure 6.4). Samples were then dcposted on to microscope slides and 
stained as previously described for PIA using anti-PIA rabbit antibodies. Propidium 
iodide (PI) was used as a counterstain for bacteria and blood cells. S. epiderm idis  1457 
grown in TSB/G- showed no PIA expression both prior to and following subculture. In 
contrast, subculture into TSB/G+ and IMDM resulted in S. epiderm idis  1457 producing 
PIA as early as 3h to 5h with significantly robust staining by 24 hours.
In whole blood, no bacteria could be detected; suggesting clearance by blood leukocytes. 
Adding cytochalasin D to whole blood prevented killing and S. epiderm idis 1457 was 
then able to grow in this environment. Furthermore, PIA could be detected at t=5h to 
t=24h (Figure 6.4). Indeed PIA was observed surrounding bacteria, but also covering 
leukocytes. These studies suggested that PIA could be produced in whole blood (when 
treated with cytochalasin B) over the course of the earlier killing assays, and immune 
suppression was an advantage for bacterial growth and PIA expression.
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In addition, cytokine release was measured in whole blood in response to S. epidermidis 
1457 (PIA/Biofilim positive) and S. epidermidis 1457-M10 (PIA/biofilm negative) using 
a RayBioHuman cytokine array. Following 3 hours, cytokines could be detected in 
untreated whole blood. These cytokines included GRO-a. IL-7, IL-10, TARC, TG F-pl,  
TNF-a. Oncostatin M, Thrombopoietin, VEGF (Figure 6.5A). Infection of whole blood 
with S. epidermidis 1457 induced the release of IL-2, IL-6, SDF-1, EGF and MIG, in 
addition to cytokines detected in control blood (Figure 6.5 B). Whole blood infected 
with S. epidermidis 1457-M10 had increased levels of IL - la  and IL-ip  in addition to 
detectable levels of all the cytokines release in response to S. epidermidis 1457 (Figure 
6.5 C).
F igure  6.5 RayB ioH um an cytokine a r ra y  of blood incubated  with p lanktonic S.
epidermidis. A. Control blood, B. Blood with S. epidermidis 1457, C. Blood with S. 
epidermidis 1457-M 10
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Table 6.1 Cytokines release in blood in response to planktonic S.epidermidis 
bacteria
Cytokines Control blood S. epidermidis 
1457
S. epidermidis 
1457-M10
Positive control +++ +++ +++
IL-10 ++ +++ +++
TARC ++ ++ ++
IL-7 ++ ++ ++
IL-6 +++ +++
IL-la +
IL-ip +
IL-2 +++ +++
EGF +++ +++
TGF-pi + ++ ++
MIG ++ ++
SDF-1 ++ ++
TNF-a ++ +++ +++
Angiogenin + + +
Oncostatin M ++ ++ ++
Thrombopoietin ++ +++ +++
VEGF ++ +++ +++
GRO-a ++ ++ ++
Semi quantitative analyses of signals detected are: +, weak, ++; moderate, +++, 
strong signals.
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6.4 The effect of cell associated PIA on immunosuppressed whole blood
Cell associated PIA had very little effect on the killing response of whole blood from 
healthy volunteers. It was hypothesized that cell associated PIA may have more of an 
effect on whole blood killing using injured/dysfunctional phagocytes. A model of 
immunosuppressed whole blood was therefor developed by pre-treatment protocols 
including use of Cytochalasin D (cyto.D) and Dexamethasone.
Whole blood pre-incubated with two different concentrations of Cyto.D (lpg/ml and 
15pg/ml) was infected with S. epidermidis 1457 and S. epidermidis 1457-M10. The 
preparation was then incubated at 37°C for 6 hours with rotation. After incubation 
bacterial viable counts were determined. Whole blood killing at 6 h confirmed a 10-50 
fold decrease in bacterial numbers (Figure 6.6 vs Figure 6.3). Addition of Cyto.D 
resulted in a dose dependent inhibition of killing with complete suppression at the 
highest dose. No significant difference was observed between the killing of S. 
epidermidis 1457 and S. epiddermidi 1457-M10 (Figure 6.6).
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Figure 6.6 Whole blood killing of S. epidermidis 1457 and S. epidermidis 1457-M10 
in immuno suppressed blood. Whole blood was prc-incubated with two different 
eoncentrations of Cyto.D (1 fig/ml and 15pg/ml) or control media (Blood) and infected 
with S.epidermidis 1457 and S. epidermidis 1457-M10 and incubated at 37°C for 6 hours 
with rotation. Bacterial viable counts were determined after 6 hours. Viable counts were 
determined at t=0 in TSB and compared with counts 6h later in TSB, whole blood, and 
whole blood treated with Cyto.D (B1 + lpg/ml and B1 +15pg/ml). Results represent data 
from four independent experiments.
■ S. ep iderm id is  1457-M10
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Serum collected from the same experiment was used to evaluate the inflammatory 
response toward S. epidermidis 1457 and S. epidermidis 1457-M10 by ELISA. Cyokines 
and immune factors analysed included Interleukin 8 (IL-8), Thymus and activation- 
regulated chemokine (TARC), Interleukin-1 beta (IL-ip), Tumor necrosis factor alfa 
(TNF-a), Interleukin 10 (IL-10) and complement component 5 (C5a).
IL-8 levels were increased in blood infected with S. epidermidis 1457 and S. epidermidis 
1457-M10 compared to control blood without bacteria. There was however no 
difference in IL-8 level between whole blood infected with either of the two strains. 
Pretreatment with Cyto.D increased IL-8 levels, but no difference was detected 
following challenged with S. epidermidis 1457 and S. epidermidis 1457-M10 at the two 
Cyto.D concentrations used (Figure 6.7A).
IL-ip also increased in blood infected with S. epidermidis 1457 and S. epidermidis 
1457-M10 6 hours following infection, compared to untreated control blood. There was 
a trend towards increased IL-1 p levels in blood containg S. epidermidis 1457 compared 
with S. epidermidis 1457-M10. Pretreatment with lpg/ml Cyto.D decreased IL-1 p 
levels but there was no difference between the two strains. Pretreatment with 15pg/ml 
Cyto.D resulted in higher levels of IL-1 p being generated than the lpg/ml cyto.D 
treatment (Figure 6.7B).
In blood infected with S. epidermidis 1457 and S. epidermidis 1457-M10, TARC levels 
were similar to untreated blood, whilst pretreatment of blood with Cyto.D increased 
TARC levels with no difference in response between S. epidermidis 1457 and S. 
epidermidis 1457-M10 (Figure 6.7 C).
TNF-a levels increased in blood infected with S. epidermidis 1457 and S. epidermidis 
1457-M10, whilst pretreatment with Cyto.D decreased TNF-a release. No differences 
were detected between strains (Figure 6.7 D).
Finally, there were no differences in IL-10 levels in blood infected with S. epidermidis 
1457 and S. epidermidis\451-M\0 compared to untreated controls or blood pretreated 
with Cyto.D (Figure 6.7 E).
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Figure 6.7 Cytokine expression in blood pretreated with Cyto.D.
Scrum collected from whole blood pretreated with (1, 15 pg/ml) Cyto.D and infected 
with S. epidermidis 1457 and S. epidermidis 1457-M10 was subjected to ELISA 
determination. Panels represent A. IL-8, B. IL-lf3, C. TARC, D. TNFa, E. IL-10. Results 
represent data from four independent experiments.
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C5a complement levels in whole blood infected with S. epidermidis 1457 and S. 
epidermidis 1457-M10 increased slightly (but not significantly) compared to untreated 
blood. Pretreatment of blood with Cyto.D increased C5a level in a dose dependent 
manner (Figure 6.8).
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Figure 6.8 C5a complement expression in blood pretreated with Cyto.D. C5a levels 
in serum collected from whole blood prctrcated with (1, 15 pg/ml) Cyto.D and infected 
with S. epidermidis\A51 and S. epidermidis 1457-M10. Results represent data from four 
independent experiments.
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Whole blood was pre-incubated overnight with three different doses of dexamcthasone 
(0.1, 1 and lOpM). Staphylococcus epidermidis 1457 and S. epidermidis 1457-M10 were 
then added to the blood and incubated at 37’C with rotation for 6 hours. Bacteria were 
plated at t=0, and t=6 from TSB culture to assess bacterial viable counts and serum was 
collected for cytokine analysis using ELISA.
Healthy whole blood killed -80%  of 5. epidermidis 1457 and S. epidermidis 1457-M10 
with no difference between the isogenic strains (Figure 6.9). Addition of dexamethasone 
(0 . l-10pM ) had very little effect on S. epidermidis 1457-M10 killing, but resulted in a 
decrease in the killing of S. epidermidis 1457 which was statistically significant (P< 
0.05) (Black vs grey bars Figure 6.9).
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Figure 6.9 Whole blood killing with dexamethason pre-treatment. The graph shows 
the percentage killing of S. epidermidis 1457 and S. epidermidis 1457-M10 with 
different dexamethasone concentrations (0.1-lOpM). Whole blood was pre-incubated 
with three different concentrations of Dex. (0.1, 1, and lOpM) and infected with S. 
epidermidis 1457 and S. epidermidis 1457-M10 and incubated at 37 C for 6 hours with 
rotation, before bacterial viable counts were determined after 6 hours. Original 
percentage of killing of bacteria (t=0) was considered zero (blood). Stars indicate 
significant difference between S. epidermidis 1457 and S. epidermidis 1457-M10 
P<0.05. Results represent data from four independent experiments.
164
To investigate the effect of dexamethasone on cytokine release in whole blood, sera also 
collected and assayed by ELISA for IL-8, TARC, IL-1(3, TNFa, IL-10 and complement 
C5a, as described before in materials and methods (section 2.10.1).
Dexamethasone had a noticeable inhibitory effect on the release of the pro-inflammatory 
cytokines such as IL-8 (Figure 6.10A), IL -1 (3 (Figure 6.1 OB), and TNFa (Figure 6.10D), 
compared to whole blood infected with S. epidermidis 1457 and S. epidermidis 1457- 
M10 alone, but no statistical difference observed between the two strains. There was no 
difference in TARC or IL-10 (Figure 6.10 C and E) levels in blood pre-treated with 
dexamethasone compared to blood infected without prctrcatment.
A 1200
1000  -
-  800 -
600 -
=  400 -
200  -
S. epidermidis 1457 
S. epidermidis 1457-M10
Blood+ Bact. Dex. O.ljiM Dex. l| iM  Dex. lO^M Blood only 
treatm ent
B 160
140
120
E 100
CUD
80 -\ca
^  60 - 
40 
20
5. epidermidis 1457 
S. epidermidis 1457-M10
Blood+Bact. Dex. 0.1|iM Dex. l|a.M Dex. 10uM Blood only 
treatm ent
165
r  200 -1 
180 - 
160
-  140 -
I 120
J  100
i  80
-  60 
40 - 
20  -
0
S. epidermidis 1457
5. epidermidis 1457-M10
Mill
Blood+Bact. Dex. 0.1|iM Dex. l^ M  Dex. 10|+M Blood only
treatm ent
D 2250
2000
2? 1250
1000
p  750 -
S. epidermids 1457 
5. epidermidis 1457-M10
•  > ' .
Blood+Bact. Dex. 0.1(iM Dex. l( iM  Dex. 10|iM Blood only 
treatm ent
J7 500 -| •  5. epidermidis 1457
■ 5. epidermidis 1457-M10
400 - j  T
Blood+Bact. Dex. 0.1|+M Dex. 1|+M Dex. 10(iM Blood only 
treatm ent
Figure 6.10 Cytokines expression in blood pretreated with dexamethasone.
Cytokine analysis by ELISA of serum collected from blood pre-treatcd with different 
concentrations of dexamcthason, blood only and blood infected with bacteria alone. 
A. IL-8, B. ILl-p, C. TARC, D. TNFa, E. IL-10. Result represent data from four 
independent experiments.
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Complement component C5a was also measured in sera from infected whole blood 
pretreated with O.l-lOpM dexamethasone (Figure 6.11). Here, infection of whole blood 
did not induce C5a, although the basal levels were relatively high. Pretreatment with 
0. lp M  dexamethasone inhibited C5a release, but higher doses had no effect compared to 
infected controls (Figure 6.11).
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Figure 6.11 C5a Complement expression in blood pretreated with dexamethasone
Complement C5a ELISA of serum collected from blood prc-treated with different 
concentration of dexamethasone (0.1-lOpM). Results represent data from four 
independent experiments.
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6.5 The effect of soluble PIA on whole blood
To explore the effect of soluble PIA on killing effects of whole blood, increasing 
concentrations (10,30,60[ig/ml) of purified PIA extract (as obtained by IMDM method 
in Chapter 4) were pre-incubated with whole blood for 3 hours, then co-cultured with 
(PIA/biofilm) negative S. epidermidis 1457-M10 for 6 hours. The extract produced from 
S. epidermidis1457-M10 was used as negative control (NC). The effects of PIA and NC 
extract were compared in a variety of assays including; functional killing of bacteria, 
cytokine and C5a ELISA and RayBio Human cytokines arrays.
Pre-incubation of whole blood with purified PIA extract significantly (P<0.05) 
attenuated killing of S. epidermidis1457-M10 in comparison to whole blood pre- 
incubated with NC extract. The killing was inversely related to PIA concentration; as 
PIA concentration increased the killing rate decreased (Figure 6.12).
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Figure 6.12 The effect of soluble PIA on whole blood killing of S. epidermidis 1457- 
M10.
Whole blood was pre-treated with three different concentrations of PIA (lOpg/ml, 
30jjg/ml and 60pg/ml) or equal volumes of negative control (NC) and infected with S. 
epidermidis 1457-M10 and incubated at 37°C for 6 hours with rotation, before bacterial 
viable counts were determined after 6 hours. Viable counts was established in TSB at 
t=0, t=6, whole blood alone (Blood), or blood treated with cyto.D (cyto.), PIA or NC. 
Stars indicate significant difference P<0.5. Results represent data from four independent 
experiments.
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Cytokine (IL-8, TARC, IL-1 p. TNF-a and IL-10) and complement C5a levels in sera 
were determined by ELISA (Figure 6.13 A-D and 6.15). IL-8 release increased in PIA 
pre-treated blood compared to NC pretreated blood and blood infected with bacteria but 
effect was statistically not significant (Figure 6.13A). Prctreatmcnt with PIA had no 
effect on IL -1 (3, TARC, TNFa and IL-10 cytokine release (Figure 6.13 B-E).
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Figure 6.13 Cytokine expression in blood pretreated with PIA.
Cytokine ELISA of serum collected from blood pre-treated with different concentration 
of PIA, blood only and blood infected with bacteria alone used as control. 
A. IL-8 ELISA, B. IL-1 p ELISA, C. TARC ELISA, D. TNF-a ELISA, E. IL-10 ELISA. 
Blood+Bact., blood infected with S. epidermidis 1457-M10. PIA, Polysaccharide 
intercellular adhesin purified extract obtained by IMDM method from PIA/biofilm 
positive S. epidermidis 1457. NC, negative control extract obtained from PIA/biofilm 
negative S. epidermidis 1457-M10. Results represent data from four independent 
experiments.
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In contrast, prctrcatmcnt with PIA increased C5a release in compared to infected blood 
alone and this was statistically significant (PcO.Ol) (Figure 6.14).
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Figure 6.14 C5a Complement expression in blood pretreated with PIA extract.
The C5a levels in response to prctrcatmcnt with different concentration of PIA (10, 30 
and 60) pg/ml and equal volume of NC extract, blood and blood infected with bacteria 
alone were used as control. Stars indicate significant difference PcO.Ol. 
Blood+Bact., blood infected with S. epidermidis 1457-M10. PIA, Polysaccharide 
intercellular adhcsin purified extract obtained by IMDM method from PIA/biofilm 
positive S. epidermidis 1457. NC, negative control extract obtained from PIA/biofilm 
negative S. epidermidis 1457-M10. Results represent data from four independent 
experiments.
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To investigate the cytokine profiles induced in whole blood in response to purified PIA 
extract, serum from whole blood incubated with 60pg/ml of purified PIA extract and NC 
extract were analysed using the RayBio cytokine array (Figure 6.15 A-C). Cytokines 
detected in whole blood in response to purified PIA extract were similar to those found 
in untreated blood and whole blood treated with NC. Semi quantative differences arc 
summeriscd in Table 6.1. Specifically, increases in PIA or NC induced cytokines 
compared to the control were observed for TNF, Oncostatin M, Thrombopoietin and 
VEGF. Differences between PIA and NC treated blood were observed for IL-10 and 
MIG. No differences were observed for TARC, IL-7, TGFp, Angiogenin and GROa. 
The following cytokines were undetectable in whole blood; ENA-78, GCSF, GM-CSF, 
GRO, 1-309, IL-la , IL-l(3.IL-2, IL-3, IL-4, IL-5, IL-6, IL-8, IL -12.p40p70, IL-13, IL-15, 
IFN-v. MCP-1, MCP-2, MCP-3, MCSF, MDC, MIP-15. RANTES, SCF, SDF-1, TNF-P, 
EGF, IGF-1, PDGF-BB, and Lcptin.
&  f  Jg
Figure 6.15 RayBio cytokines array of blood in response to PIA extract.
A. Control blood B. Blood and purified PIA extract C. Blood and NC extract
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Table 6.2 Cytokines release in blood in response to PIA extract
Control Blood PIA extract NC extract
Pos. control +++ +++ +++
IL-10 ++ +++ +
TARC ++ ++ ++
IL-7 ++ ++ ++
TGF-pl + + +
TNF-a ++ +++ +++
Angiogenin + + +
Oncostatin M ++ +++ +++
Thrombopoietin ++ +++ +++
VEGF ++ +++ +++
GRO-a ++ ++ ++
MIG ++ +
Semi quantitative analyses of signals detected are: +, weak, ++; moderate, +++
strong signals.
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6.6 The effect of biofilm associated PIA on whole blood
It was shown previously in this chapter (Section 6.1) that S. epidermidis 1457 and S. 
epidermidis 1457-M10 can grow in immune suppressed blood and furthermore, 
immunocytochemistry (Figure 6.4) demonstrated that PIA can be secreted in 
immunosuppresed blood (pretreated with cyto.D). To test whether mature biofilms could 
form in both normal and/or immunosuppressed whole blood, biofilm and growth assays 
at four different dilutions (1:100 (2.4xl05), 1:1000(2.4x104), 1:10000(2.4x103), 
1:100000 (2.4x10 )) of overnight culture (18 hours) were investigated.
Growth results showed that healthy whole blood eradicated all bacteria at lower inocula 
(1:1000, 1:10000, and 1:10000 dilution), but not at the highest inocula (1:100 dilution), 
(Figure 6.16A). In contrast, S. epidermidis 1457 grown in immunosuppressed (Cyto. D 
treated) whole blood resulted in to noticeable increases in bacterial growth at all 
dilutions of starting inocula (Figure 6.16 B).
Regarding biofilm formation, untreated normal whole blood completely inhibited 
biofilm formation (Figure 6.17A), however under immunosuppressive conditions the 
lowest dilution of starting inocula progressed to form a defined biofilm (0.256 at 
OD=570), as biofilm positive is defined at OD=2nm and above (Figure 6.17 B).
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Figure 6.16 Growth of S.epidermidis 1457 in blood and TSB in presence and 
absence of cyto.D. A. Growth in normal whole blood B. Growth in whole blood with 
cyto.D (immunosuppressed). Results represent data from three independent experiments.
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Figure 6.17 Biofilm formation of S. epidermidis 1457 in blood and TSB in presence 
and absence of cyto.D.
A. Biofilm formation in normal whole blood B. Biofilm formation in whole blood with 
Cyto.D (immunosuppressed). Results represent data from three independent 
experiments.
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Finally, mature biofilms were used to investigate the effect of biofilm associated PIA on 
whole blood killing and cytokine production.
Previously in this chapter, whole blood had an inhibitory effect on bacterial growth and 
biofilm formation. Here whole blood killing (WBK) was undertaken on preformed S. 
epidermidis 1457 biofilm. Blood was added to biofilm for 6 hours at 37°C, after which 
the biofilm was digested with Dis.B and bacterial viability assessed through viable 
counts. Results showed that there was no difference in the number of viable bacteria 
from blood incubated with preformed biofilm for 6 hours compared with biofilm 
incubated with TSB (Figure 6.18).
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Figure 6.18 Whole blood killing on preformed biofilm. T=6 blood, represented viable 
bacterial count after 6 hours incubation with blood compared to original number of 
bacteria (t=0) and counts following 6 hours in TSB (t=6 TSB). Results represent data 
fron three independent experiments.
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Finally, to examine the effect o f  biofiim associated PIA on cytokine profiles produced 
by whole blood, preformed 5. epidermidis 1457 biofilm was incubated with 1ml of 
blood at 37 C with shaking for 3 hours, and the serum analysed using the RayBioHuman 
cytokine array.
The RayBioHuman cytokine array showed that S. epidermidis 1457 biofilms had an 
inhibitory effect on the release of specific cytokines and growth factors (TGF-(31, 
Angiogenin, Oncostatin M, Thrombopoietin, VEGF, TARC, TNF-a and GRO-a) compared to 
control blood. In addition, biofilms induced the release of other cytokines and growth 
factors (SDF-1, EGF and GRO-a ) (Figure 6.19). Furthermore, biofilm had an inhibitory 
effect on cytokine release (IL-2, IL-7, MIG, and EGF) in response to S. epidermidis 
1457 and S. epidermidis 1457-M10 (section 6.5).
Figure 6.19 RayBioHuman cytokines array detected from blood in response to S.
epidermidis biofilm. A. RayBio array of blood only B. Raybio array of S. epidermidis 
1457 biofilm
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6.7 Discussion
Studies on the effect of PIA and/or biofilm positive Staphylococci on whole blood are 
limited, as most previous studies have been done on isolated cells such as neutrophils 
and macrophages (Shiau and Wu, 1998; Leid, Shirtliff et al., 2002; Vuong, Voyich et al., 
2004). Whole blood experiments are an alternative method to reflect physiological 
conditions in vivo regarding cellular function and cytokine production as the normal 
constituents of the media are present and, in addition immune cells, are present in 
normal percentages (Hermann, von Aulock et al., 2003).
The whole blood experiments presented interesting data regarding whole blood killing 
(WBK) and inflammatory response. Immunocompetent blood killing of planktonic S. 
epidermidis was found to increase with incubation period (from 2-6 hours). However, 
there were no statistical differences between biofilm positive and negative strains. There 
are only a few studies on the killing effect of whole blood on biofilm forming bacteria. 
Anwar et al found that Pseudomonas aeruginosa in biofilms were more resistant to 
whole blood killing than their planktonic equivalents (Anwar, Strap et al., 1992). Blood 
platelets have also been shown to provide an antimicrobial effect (reduction in viable 
counts 50-87%) on planktonically grown S. aureus and an ability to reduce metabolic 
activity in biofilm cells by 7-38% (Rozalski, Micota et al., 2013).
To this author's knowledge, this study is the first demonstration of an ex vivo 
experimental model showing that immunosuppression is an advantage for the growth of 
PLA/biofilm positive S. epidermidis. Despite the low amounts of cell associated PIA 
produced, sufficient advantage is gained following treatment with the glucocorticoid 
drug dexamethasone. Glucocorticoids are immunosuppressive and anti-inflammatory 
agents that interfere with leukocytes function (Boumpas, Chrousos et al., 1993; 
Franchimont, Galon et al., 2000; Barnes, 2010). This property facilitated their use in 
whole blood experiments to investigate WBK under immunosuppressive conditions. 
Similar effects can be observed in the immature neonatal innate immune system (Levy, 
2007) where low cytokine production and complement response increase susceptibility 
to biofilm positive S. epidermidis sepsis (Sonntag, Brandenburg et al., 1998; Hartel, 
Osthues et al., 2008). In this regard, S. epidermidis is the most common causative agent
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of neonatal catheter-related blood stream infection and sepsis (Marchant, Boyce et al., 
2013). Interestingly, the difference in killing rate between S. epidermidis 1457 and S. 
epidermidis 1457-M10 could not be demonstrated with cyto.D treated blood, where both 
strains had an equal advantage. This was likely due to very different mechanism of 
action between glucocorticoids and chytochalasins. Cyto.D interferes with phagocytosis, 
which is actin-polymerization dependent, and sensitive to actin-polymerisation inhibitors 
(Elliott and Winn 1986). Cytochalasin D is a fungal metabolite with actin -  
polymerization inhibition ability (Weihing, 1978) that decreases oxidative burst of blood 
neutophils (Smits, Burvenich et al., 1997) and interferes with killing, regardless of PIA 
status. Dexamethasone inhibits the production of inflammatory cytokines from the 
immune cells, the proliferation of stimulated T and B cells, and leukocyte motility 
(Kurihara, Ojima et al., 1984; Zhang and Mosser, 2008).
Interestingly, differences in the inflammatory response were also noticed between 
dexamethasone and Cyto.D treatment of whole blood. Whilst immunosuppresed blood 
with dexamethasone had anti inflammatory properties seen as a decrease in IL-8, IL-ip 
and TNF-a, Cyto.D actually increased production of IL-8, TARC and complement C5a.
The experiments on soluble PLA pretreated whole blood support its role as an inhibitor 
of whole blood killing or an inducer of leukocyte dysfunction. Pre-incubation of whole 
blood with purified PIA extract (obtained by the IMDM method) inhibited killing of S. 
epidermidis 1457-M10 in a dose dependent manner. These results are consistent with 
previous studies showing that cell associated and biofilm associated PIA inhibit the 
killing effects of the immune system including action of antimicrobial peptides and 
phagocytosis (Vuong, Voyich et al., 2004; Conway Morris, Kefala et al., 2009; Morris, 
Brittan et al., 2011). Soluble PIA induced IL-8 and complement fragment C5a release, 
whilst decreasing IL-10 when compared to untreated blood. These findings are 
consistent with a study showing that PIA from S. epidermidis 1457, whether cell 
associated or biofilm associated, induced stronger complement activation when 
compared to S. epidermidis 1457-M10 (Fredheim, Granslo et al. 2011). Interestingly, 
neutrophils have recently been shown to be activated by S. epidermidis biofilm matrix 
components (Meyle, Brenner-Weiss et al., 2012).
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This present study is the first ex vivo model of WBK (both immune competent and 
immune suppressed) for investigating of S. epidermidis growth and biofilm formation. 
The data presented in this chapter indicated that whole blood collected from healthy 
volunteers had the ability to clear S. epidermids bacteria and also prevented biofilm 
formation. This effect appeared dependent on the number of bacteria in the initial 
inoculum as blood completely cleared 240 bacteria/ml, with 2.4X103 and 2.4X104CFU 
/ml persisting with restrained growth. The highest bacterial inoculum (2.4X105 CFXJ/ml) 
continued to grow to (1.2X107CFU/ml) which was significantly higher than for other 
bacterial inocula used. In immunosuppressed blood, bacteria grew even when used at the 
lowest bacterial concentration (2.4X10 CFU/ml) and also had biofilm formation ability. 
This findings correlate with these of Tunney et al (Tunney, Dunne et al., 2007) who 
demonstrated the importance of initial inculum size on antibiotic sensitivity and biofilm 
formation, as low initial inocula (~ lx l03CFU/ml) of S. epidermidis were killed by 
antibiotics, whilst high initial inocula resisted antibiotic killing and adhered to surfaces 
forming biofilms.
Neonateal sepsis with or without indwelling catheters is mainly caused by S. epidermidis 
and associated with the immature neonatal immune system (Stoll, Gordon et al., 1996; 
Stoll, Gordon et al., 1996; von Eiff, Jansen et al., 2005). In these cases quantitative 
neonatal blood cultures often reveal CoNS at concentrations of around 103 CFU/mL 
(Buttery, 2002). Bacteremia does not generally lead to sepsis as the bacteria tend to be 
are present in small numbers which are rapidly removed by a competent immune 
system. However, if bacteria are present in large enough numbers, in people with 
weakened immune systems, bacteremia can lead to sepsis.
In this present study whole blood was unable to clear preformed S. epidermidis biofilm 
and this has been noticed by others. Shiau and Wu (Shiau and Wu, 1998) found that 
"extracellular slime" produced by S. epidermidis interfered with macrophage phagocytic 
activity. Guenther et al demonstrated that S. epidermidis biofilm was more resistant to 
phagocytosis by neutrophils compared with S. aureus biofilm (Guenther, Stroh et al., 
2009). Other researchers have found the same protective effect of biofilm (Steinberg, 
Poran et al., 1999; Kristian, Birkenstock et al., 2008) or biofilm modulation of the
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immune response through attenuating leukocyte penetration into biofilm (Costerton, 
Stewart et al., 1999; Hoiby, Krogh Johansen et al., 2001).
To the author's knowledge this current study is the first demonstration of PIA expression 
in whole blood. ICC images revealed S. epidermidis 1457 expression of PIA under 
immnosuppressed conditions, whilst immune competent blood cleared the bacteria. It 
was also demonstrated that PIA expression by S. epidermidis 1457 in IMDM cell culture 
media occurred confirming the results of Chapter 3.
Phagocytosis of both S. epidermidis 1457 and S. epidermidis 1457-M10 was dependent 
on complement receptors CD1 lb/CD 18. The complex of CD 1 lb/CD 18 is present on 
neutrophils and mediate cellular clearance of pathogens (Hickstein, Ozols et al., 1987). 
Patients with leukocyte adhesion deficiency type I (LAD I) have severe or total 
deficiency of the CD11/CD18 on the cell surface, which leads to serious and fatal 
infections (Lekstrom-Himes and Gallin, 2000; Bonilla and Geha, 2003). Interestingly 
CD 1 lb/CD 18 expression on human neutrophils has been shown to be upregulated by 
staphylococcal supernatant (Veldkamp, Van Kessel et al., 1997; Meyle, Brenner-Weiss 
et al., 2012) but this was not measured in our study, and could be an area for future 
work.
The inhibitory effect of PLA/biofilm on WBK and inflammatory responses supports the 
growing evidence of a pathogenic role of this molecule. In this research the mechanism 
behind this effect was studied. The research demonstrated that purified PIA increased 
blood C5a level in a dose dependant manner, which may cause dysfunction of 
phagocytic cells (Figure 6.20). Interestingly, it was previously been shown that 
neutrophil dysfunction is medicated by C5a through inhibition of phagocytosis through 
preventing actin polymerization, in critically ill patients (Conway Morris, Kefala et al., 
2009; Morris, Brittan et al., 2011). This also correlates with work in this chapter where 
Cyto.D increased C5a levels, suggesting an extra activity for Cyo.D in addition to its 
role as an actin -polymerization inhibitor (Weihing, 1978).
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Figure 6.20 Whole blood immune response toward PIA/ biofdm. Immunosuppresion 
and size of initial bacterial inoculum > 1()3 CFU/ml arc an advantage for growth and 
biofilm formation of S. epidermidis 1457 in blood, lead to increase in IL-8 cytokine and 
C5a complement release. C5a complement may have a role in phagocytosis dysfunction. 
Phagocytosis of 5. epidermidis is CD1 lb and CD 18 complement receptors dependent.
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Chapter 7
Discussion
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Bacterial biofilms are acknowledged as causes of persistent infection. In the case of 
health care associated infections (HAIs) related to implantation of a medical device 
theses are often accompanied with a destructive inflammatory response 
(Broekhuizen, de Boer et al., 2007). Staphylococcus epidermidis causes about 50% 
of infections associated with catheters, artificial joints and heart valves (Khalil, 
Williams et al., 2007). According to the National Healthcare Safety Network 
(NHSN) the most common cause of (HAIs) are CoNS (15%), followed by S. aureus 
(14%) (Jemigan and Kallen, 2008). In the UK, the cost of implant-associated 
infections is approximately £7-11 million per year (Harris and Richards, 2006). 
Given the importance of such infections, this research thesis investigated biofilm 
molecules associated with S. epidermidis, including PIA, Aap and Embp, under 
conditions that more accurately reflect those of the host environment.
In chapter 3, biofilm formation by S. epidermidis was investigated under 
physiological media. It has been long-established that glucose is an essential 
nutritional requirement for S. epidermidis biofilm formation (Mack, Siemssen et al., 
1992; Dobinsky, Kiel et al., 2003). Few studies have been undertaken to identify 
minimal nutritional requirement needed to generate a S. epidermidis biofilm. Hussain 
et al identified a chemically defined medium called Hussain-Hastings-White 
modified medium (HHWm) that supported biofilm formation (Hussain, Hastings et 
al., 1991). Chapter 3 describes the study of specific cell culture media to support 
biofilm formation of S. epidermidis strains with different mechanisms of biofilm 
accumulation. The study showed that cell culture media support growth and biofilm 
formation to different degree depending on the mechanisms of biofilm accumulation. 
This effect is likely due to the specific nutrients in these media that regulate PIA, 
Aap and Embp expression and resultant biofilm formation. For instance, it was 
shown that the amino acid glutamine, induces biofilm in S. epidermidis 1585-RA and 
S. epidermidis 1585 whilst was non-essential for biofilm formation by S. epidermidis 
5179-R1 and was inhibitory for S. epidermidis 1457 biofilm. Recently, other purified 
nutrients have proved to be important with D-glucosamine addition to TSB shown to 
inhibit S. epidermidis biofilm formation (Aiassa, Barnes et al., 2012). Indeed, a 
similar effect was demonstrated by Enche et al, with adherence of Candida 
albicans to human epithelial oesophageal cell line partially inhibited in the presence 
of D-glucosamine, but not with D-glucose, L-fucose or D-galactose (Enache,
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Eskandari et al., 1996). In addition, the presence of Mg and Ca are important for 
biofilm formation (Ozerdem Akpolat, Elci et al., 2003). A study by Cerca et al 
showed the importance of environmental conditions, such as high levels of Ca and 
Mg in cell culture medium for S. epideremidis evasion of the host immune response, 
as they supported dormancy within the biofilm which was more resistant to antibiotic 
and immune effects (Cerca, Andrade et al., 2011).
IMDM was able to support the growth and biofilm formation of S. epidemidis strains 
with different mechanisms of biofilm formation including S. epidermidis 1457, S. 
epidermidis 5179-R1 and S. epidermidis 1585-RA. Furthermore, culture conditions 
that promoted biofilm production in the biofilm negative strain S. epidermidis 1585 
were also identified. Accordingly, biofilm production was demonstrated in IMDM, 
RPMI+ and DMEM, which may be due to the lack of iron. Some studies have 
previously suggested the role of iron deprivation on biofilm formation (Johnson, 
Cockayne et al., 2005; Johnson, Cockayne et al., 2008).
To investigate the host factors responsible for the pathogenic transformation of S. 
epidermidis from skin commensal to pathogenic microorganism, the effect of human 
and bovine serum on biofilm formation was assessed. Both FBS and PS had no effect 
on S. epidermidis growth, however biofilm formation by strains had differing 
sensitivities to serum. Accumulation of PIA dependent biofilm was less sensitive 
than Aap and Embp dependent biofilms. In addition, PS was more inhibitory than 
FBS, which correlated with findings of Abraham and Jefferson (Abraham and 
Jefferson, 2010). The inhibitory activity of FBS and PS was found to be due to high 
molecular weight components of serum. Previously, a number of surface factors have 
been shown to regulate biofilm formation including surface chemistry (Patel, Ebert et 
al., 2003; MacKintosh, Patel et al., 2006; Abraham and Jefferson, 2010), surface 
roughness (Harris and Richards, 2006) and bacterial surface hydrophobicity 
(Sudagidan, Erdem et al., 2010). In this present study, pre-coating the polystyrene 
surface of the wells of microtiter plates with serum was found to prevent biofilm 
formation by the protein -dependent biofilm former, S. epidermidis 5179-R1, S. 
epidermidis 1585-RA and the biofilm negative (induced) S. epidermidis 1585.
The findings from Chapter 3 informed experiments undertaken in chapter 4 to purify 
PIA on a larger scale (milligrams). Characterisation of a purification method that can
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purify PIA on a large scale (milligrams) for use in cell culture studies, without any 
contamination with LPS, was essential for accuracy of subsequent host pathogens 
interaction work. This is because macrophages can be activated by LPS 
concentrations as low as 15pg/ml (Wakelin, Sabroe et al., 2006). Therefore IMDM 
cell culture medium was used that supported S. epidermidis 1457 biofilm formation. 
The amount of PIA purified by the IMDM method in glass beakers was lower than 
the PIA obtained by the Mack Method (Mack, Nedelmann et al., 1994). However, 
using cell culture plates and increasing the surface area (from 6-24 plates) to which 
the bacteria adhered, the amount of PIA was greatly enhanced in comparison to the 
Mack method. Increasing the surface area 4X (6 to 24 plates) increased the amount 
of PIA obtained by 6-1 OX (lOOpg/ml from 6 plates to 600-lOOOpg/ml in 24 plates). 
It seems that using cell culture plates also provided different substrata to glass 
beakers which increased biofilm accumulation. Adherence and biofilm formation by
S. epidermidis can be affected by biomaterials and their chemical and physical 
surface properties (Patel, Ebert et al., 2003; Patel, Ebert et al., 2007). Bacterial 
adherence and biofilm formation to intraocular lenses are increased when they are 
made from polymethyl methacrylate, silicone as bacteria have greater avidity for the 
irregular surface (Kodjikian, Roques et al., 2006; Baillif, Ecochard et al., 2009).
In chapter 5 the effect of PIA on THP-1 macrophages were investigated. Biofilm 
formation mediated by PIA is a major virulence factor of S. epidermidis and 
important for its pathogenesis (Nedelmann, Sabottke et al., 1998; Li, Xu et al., 2005; 
Fredheim, Granslo et al., 2011). PIA is synthesized by enzymes encoded in the 
icaADBC operon (Heilmann, Schweitzer et al., 1996). The majority of commensal S. 
epidermidis lack the icaADBC operon (Kozitskaya, Olson et al., 2005).
Remarkably, in chapter 5 it was shown that different forms of PIA had varying 
influences on the immune response elicited by monocytic THP-1 cells. Cytokine 
responses were dependent on cell associated or biofilm associated PIA, as when 
purified PIA was added to THP-1 cells there was no IL-8 release. After S. 
epidermidis 1457 was added in suspension there was enhanced EL-8 release than that 
generated by S. epidermidis 1457-M10. Furthermore, digestion of S. epidermidis 
1457 biofilms with Dsp.B reduced IL-8 release. These results confirm that PIA may 
need to be bound to the bacterial surface to cause its effects. These results highlight 
the importance of PIA tethering; that is when PIA is bound to the bacterial surface it
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is held in the correct conformation to stimulate a receptor on the THP-1 cells. 
Interestingly, for complete biofilm forming activity, PIA needs to be deacetylated, 
through the function of the IcaB gene, the product of which is a surface protein in 
charge of polysaccharide de-N-acetylation (Vuong, Kocianova et al., 2004; Cerca, 
Jefferson et al., 2007; Itoh, Rice et al., 2008). Deacetylation has been shown to be 
essential for S. epidermidis biofilm formation, immune evasion and virulence in 
animal models of implant infection (Vuong, Kocianova et al., 2004). Another 
explanation for the effects of PIA biofilm is mediator synergy, in which PIA requires 
another stimulus to be present; PIA plus other component of biofilm such as 
extracellular DNA, teichoic acids and peptidoglycans to show its biological effect. 
Thus, when PIA is added alone there is no response, but when PIA is bound to S. 
epidermidis there is a biological effect (Mehlin, Headley et al., 1999; Sadovskaya, 
Vinogradov et al., 2004; Jones, Perris et al., 2005; Qin, Ou et al., 2007). 
Interestingly, other researchers have added combinations of purified PIA, LPS, 
peptidoglycans and pro-inflammatory cytokines without cytokines induction 
suggesting that mediator synergy may not be so important (Wilkinson, Yokoyama 
and Armstrong unpublished observations).
CSLM revealed that the unique structure of biofilm may play an important role in 
bacterial evasion of leukocytes. Staphylococcus epidermidis were seen to locate near 
the substratum and were surrounded by heterogeneously distributed extracellular 
polysaccharide which could protect the bacteria against host immune cell 
penetration and antibiotic diffusion. Schommer et al (Schommer, Christner et al., 
2011) demonstrated that biofilm embedded bacteria were killed to a lesser degree by 
macrophages than planktonic equivalents. Kirby et al found that the biofilm matrix 
may act as a diffusion barrier protecting bacteria from the killing effect of antibiotics 
like Colistin, Streptomycin, and Gentamicin, as planktonic bacteria were killed to a 
greater extent than those embedded within biofilms (Kirby, Gamer et al., 2012). 
Furthermore, S. epidermidis biofilm restricted THP-1 cell migration into biofilms in 
vivo', similar findings were also demonstrated by Thurlow et al, as S. aureus biofilm 
limited macrophages penetration (Thurlow, Hanke et al., 2011).
In chapter 6 biofilm interactions with the host was examined in an ex vivo model of 
infection to demonstrate the immune response toward different forms of S. 
epidermidis PIA (cell associated, biofilm associated and purifies). Pre-treatment of
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blood with purified PIA extract significantly reduced S. epidermidis killing in dose 
dependant manner which supports the role of PIA as an inducer of leukocyte 
dysfunction. Studies have demonstrated the role of PIA in protecting S. epidermidis 
from phagocytosis and reducing opsonization with C3b and IgG binding on the 
bacterial surface (Vuong, Voyich et al., 2004; Cerca, Jefferson et al., 2006; Kristian, 
Birkenstock et al., 2008). However, the exact mechanism of phagocytosis inhibition 
is not clear. Staphylococcus epidermidis PIA was found to induce C5a, which may 
lead to phagocytosis inactivation thus possibly explaining the observed decrease in 
WBK in blood pre-treated with PIA. Previous studies have suggested that C5a 
induces paralysis of phagocytic cells (Ward, 2004; Ward, 2008; Conway Morris, 
Kefala et al., 2009). Fredhem et al showed that whilst purified PIA induced 
complement activation it also decreased activation of granulocytes (Fredheim, 
Granslo et al., 2011). Satorious et al showed that C5a levels induced by S. 
epidermidis PIA biofilm could be lower than needed for leukocytes activation 
(Satorius, Szafranski et al., 2013). In addition, bacteria inside the biofilm appear 
more resistant to killing by whole blood. Indeed Thurlow et al confirmed the 
protective mechanisms of biofilm against host innate immune response (Thurlow, 
Hanke et al., 2011). Killing bacteria in a biofilm has been reported to require 
antibiotic concentrations 10 to 1,000 times that needed to kill free-living bacteria 
(Drinka, 2009).
This study is the first demonstration of an ex vivo experimental model showing that
immunosuppression is an advantage for the growth of PIA/biofilm positive S.
epidermidis. Here, dexamethasone pre-treated blood significantly decreased killing
of S. epidermidis 1457 PIA/biofilm positive bacteria in comparison to S. epidermidis
1457-M10 PIA /biofilm negative bacteria. This study is also the first ex vivo model of
the use of WBK (both immune competent and immune suppressed) for investigating
of S. epidermidis growth and biofilm formation. The importance of blood immune
status and size of bacterial initial inocula in the outcome of bacterial infection has
been demonstrated. Immune suppression was also shown to be advantageous for
2
bacterial growth and biofilm formation. Inocula of -10 cfu of S. epidermidis were 
required to form biofilms in whole blood. This finding correlates with those of
Tunney et al who demonstrated the importance of initial inoculm size on antibiotic
-2
sensitivity and biofilm formation, as low initial inocula (-1x10 CFU/ml) of S.
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epidermidis were killed by antibiotic, whilst high initial inoculum resisted antibiotic 
killing and generated biofilm (Tunney, Dunne et al., 2007).
This study is also the first to demonstrate PIA expression in whole blood, as ICC 
images revealed the ability of S. epidermidis 1457 to express PIA under 
immnosuppressed conditions. Immunocompetent blood did however have the ability 
to clear bacteria. Moreover, phagocytosis of both S. epidermidis 1457 and S. 
epidermidis 1457-M10 was dependent on complement receptors CDllb/CD18. The 
expression of CD 1 lb/CD 18 on human neutrophils has been shown to be upregulated 
by staphylococcal supernatant (Veldkamp, Van Kessel et al., 1997; Meyle, Brenner- 
Weiss et al., 2012).
This thesis has therefore investigated and identified host factors that stimulate and 
regulate biofilm formation in S. epidermidis. The study has brought attention to the 
importance of differential nutrient requirements needed for each biofilm 
accumulation mechanism. Studies using macrophages in vitro have identified the 
importance of PIA forms for final biological response. 3D modelling stressed the 
importance of structural characteristic of PIA biofilm which may have a barrier 
function that protects bacteria inside biofilm from the killing effect of immune 
system and antibiotic. Studies in ex vivo whole blood have suggested that PIA can 
induce C5a which is a critical mediator of leukocyte dysfunction and has allowed a 
biological advantage for biofilm under immunosuppressive conditions to be 
demonstrated (Figure 7.1).
Recognizing the nature of the immune response towards biofilms, as well as the 
optimal conditions needed for PIA expression and biofilm formation in blood, will be 
vital for the development of treatments for S. epidermidis biofilm infection on 
implanted medical devices.
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Figure 7.1 Schematic representations of results from this thesis. This thesis 
identified the importance of initial bacterial inoculums size (> 1()3 CFU/ml) on S. 
epidermidis biofilm formation. In addition, it recognized factors that induce or inhibit 
biofilm formation. A difference in the inflammatory response detected with different 
form of PIA (soluble PIA, biofilm associated PIA or cell associated PIA). Also, it 
was found that PIA induces C5a complement which may lead to dysfunction of 
immune cells and inhibit phagocytosis.
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Future perspective
This study has identified a number of issues that may form the basis for future 
experiments. There is a need to:
1. Further investigate the nature of high molecular weight serum 
components that inhibits biofilm formation.
2. Further investigate the inhibitory effect of serum on biofilm formation by 
determination of the key interactions between the serum component and 
the bacterial cell surface through antibody blocking and Western blot 
analysis of cell extracts.
3. Investigate whole blood killing in both immune competent and immune 
compromised whole blood towards different forms of biofilm 
accumulation mechanisms (Aap and Embp).
4. Investigate serum responses in patients with medical device related 
infections.
5. Study the cytokines profile of whole blood in response to different forms 
of biofilm accumulation mechanism; comparison between PIA, Aap and 
Embp in different form (cells associated and biofilm associated).
6. Undertaken antibody blocking experiments to confirm that C5a blocking 
antibodies can inhibit PIA induced leukocyte dysfunction.
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